Mechanisms and Regulation of Cellular Senescence
Open accessAbstract
Cellular senescence entails a state of an essentially irreversible proliferative arrest in which cells remain metabolically active and secrete a range of pro-inflammatory and proteolytic factors as part of the senescence-associated secretory phenotype. There are different types of senescent cells, and senescence can be induced in response to many DNA damage signals. Senescent cells accumulate in different tissues and organs where they have distinct physiological and pathological functions. Despite this diversity, all senescent cells must be able to survive in a nondividing state while protecting themselves from positive feedback loops linked to the constant activation of the DNA damage response. This capacity requires changes in core cellular programs. Understanding how different cell types can undergo extensive changes in their transcriptional programs, metabolism, heterochromatin patterns, and cellular structures to induce a common cellular state is crucial to preventing cancer development/progression and to improving health during aging. In this review, we discuss how senescent cells continuously evolve after their initial proliferative arrest and highlight the unifying features that define the senescent state.
AI snapshot
Written from the paper’s full text.
TL;DR
This review synthesizes mechanisms and regulation of cellular senescence, emphasizing heterogeneity, cell-cycle arrest via p53/p21 and p16/RB, the SASP, metabolic/chromatin changes, and positive feedback loops. It discusses senescence’s dual roles in cancer and aging and therapeutic implications including senolytics.
Key findings
- Senescence is an essentially irreversible proliferative arrest with continued metabolic activity and a SASP; cell-cycle exit can occur in G1 or G2, with p53/p21 as early markers and p16/ARF as late markers. Acute DNA damage can trigger rapid exit within 24 h, and the G2/M checkpoint responds to 10–20 DNA breaks.
- Replicative senescence is driven by telomere erosion; mean telomere length in human senescent fibroblasts ranges between 6 and 8 kbp, with a few extremely short telomeres. Persistent DDR at telomeres, partly because TRF2 blocks repair, sustains arrest.
- The SASP is regulated by NF-κB/C/EBP-β, ATM, p38MAPK, GATA4, mTOR, epigenetic factors, and cGAS–STING signaling; it can reinforce senescence and drive inflammaging and paracrine senescence.
- Senescence has dual roles: it acts as a barrier to tumorigenesis, but SASP factors can promote cancer progression; senescent cell accumulation contributes to aging, and clearance via senolytics or INK-ATTAC alleviates age-related dysfunction and extends healthspan in mice.
Methods
- Narrative review; no primary experiments. It synthesizes published literature on mammalian cellular senescence mechanisms, regulation, and roles in cancer and aging.
- Covers in vitro and in vivo studies, including mouse models, human cells/tissues, and clinical observations; main analysis is thematic synthesis of signaling pathways, transcriptional/post-transcriptional control, metabolism, organelles, autophagy, epigenetics, and immune clearance.
- No systematic search or meta-analysis is described.
Limitations
- Stated: lack of specific biomarkers to identify and follow senescent cells in vivo; much knowledge comes from cultured cells that do not recapitulate organism complexity; findings need in vivo confirmation; heterogeneity complicates assigning exact roles.
- Stated: it remains challenging to study how senescent cells are induced in vivo, how the SASP changes over time, when the SASP acquires damaging traits, and how senescent cell clearance is regulated.
- Evident: as a narrative review, it does not provide a systematic or quantitative synthesis and reports no primary data to assess causality.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 530 cited sources checked · 0 supported · 0 flagged
- Interpretationreasoning
The capacity of senescent cells to survive in a nondividing state requires changes in core cellular programs.
“This capacity requires changes in core cellular programs.”
Quote in the paperSubstantial claim - Interpretationcitation
The proliferative arrest imposed by cellular senescence represents an early barrier against cancer initiation by preventing the propagation of damaged DNA to the next generation of cells.
“The proliferative arrest imposed by cellular senescence represents an early barrier against cancer initiation by preventing the propagation of damaged DNA to the next generation of cells [18,20].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Senescence can be triggered by intrinsic and extrinsic factors including replicative stress, oxidative damage, metabolism dysfunctions, cytokines, oncogene activation, and chemotherapy agents.
“Senescence can also be triggered by many other intrinsic and extrinsic factors, particularly, replicative stress, oxidative damage, metabolism dysfunctions, cytokines, oncogene activation, and chemotherapy agents.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] 2008, Living on a break: Cellular senescence as a DNA-damage response, Nat. Rev. Cancer source
Not checked in the free run.
- Premisecitation
Senescence is an important contributor to cancer and aging.
“Senescence is an important contributor to cancer and aging, two processes characterized by a time-dependent accumulation of cell damage and dysfunction.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] 2017, The Fountain of Youth by Targeting Senescent Cells?, Trends Mol. Med. source
Not checked in the free run.
- Premisecitation
Cellular senescence occurs not only in vitro but also in various tissues in vivo.
“Cellular senescence occurs not only in vitro (i.e., cell culture models), but also in various tissues in vivo [13,14,15,16].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [13] Baker, 2016, Naturally occurring p16Ink4a-positive cells shorten healthy lifespan, Nature source
Not checked in the free run.
- cites [14] Chang, 2016, Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat. Med. source
Not checked in the free run.
- cites [15] Yosef, 2016, Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL, Nat. Commun. source
Not checked in the free run.
- cites [16] 2017, The Fountain of Youth by Targeting Senescent Cells?, Trends Mol. Med. source
Not checked in the free run.
- Premisecitation
Stem cell senescence caused by telomere shortening can negatively affect tissue homeostasis and regeneration.
“Moreover, stem cell senescence caused by telomere shortening can negatively affect tissue homeostasis and regeneration [25].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Ju, 2007, Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment, Nat. Med. source
Not checked in the free run.
- Premisecitation
Senescence markers are detected in premalignant tumor lesions but not at later stages of tumor development.
“Senescence markers are detected in premalignant tumor lesions but not at later stages of tumor development [17,18,19].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [17] Chen, 2005, Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis, Nature source
Not checked in the free run.
- cites [18] Collado, 2005, Senescence in premalignant tumours, Nature source
Not checked in the free run.
- cites [19] Michaloglou, 2005, BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature source
Not checked in the free run.
- Premisecitation
Senescent cells accumulate in different tissues and organs where they have distinct physiological and pathological functions.
“Senescent cells accumulate in different tissues and organs where they have distinct physiological and pathological functions.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [13] Baker, 2016, Naturally occurring p16Ink4a-positive cells shorten healthy lifespan, Nature source
Not checked in the free run.
- cites [14] Chang, 2016, Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat. Med. source
Not checked in the free run.
- cites [15] Yosef, 2016, Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL, Nat. Commun. source
Not checked in the free run.
- cites [16] 2017, The Fountain of Youth by Targeting Senescent Cells?, Trends Mol. Med. source
Not checked in the free run.
- Premisecitation
During aging, senescent cell accumulation in various tissues promotes chronic inflammation that accelerates age-related dysfunctions.
“During aging, senescent cell accumulation in various tissues promotes chronic inflammation that accelerates age-related dysfunctions [16].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] 2017, The Fountain of Youth by Targeting Senescent Cells?, Trends Mol. Med. source
Not checked in the free run.
- Premisecitation
Senescent fibroblasts can influence their local environment by turning into proinflammatory cells that promote the growth of transformed or preneoplastic neighboring epithelial cells in culture and in vivo.
“On the other hand, senescent fibroblasts can influence their local environment by turning into proinflammatory cells that can promote the growth of transformed or preneoplastic neighboring epithelial cells in culture and in vivo [22,23,24].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [22] Krtolica, 2001, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [23] Parrinello, 2005, Stromal-epithelial interactions in aging and cancer: Senescent fibroblasts alter epithelial cell differentiation, J. Cell Sci. source
Not checked in the free run.
- cites [24] Campisi, 2013, Aging, Cellular Senescence, and Cancer, Annu. Rev. Physiol. source
Not checked in the free run.
- Premisecitation
Senescent cells present unique morphological and molecular characteristics and functions that distinguish them from quiescent cells and terminally differentiated cells.
“Senescent cells present unique morphological and molecular characteristics and functions that distinguish them from other nondividing cell populations, such as quiescent cells and terminally differentiated cells [4,5,6].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [4] Campisi, 2007, Cellular senescence: When bad things happen to good cells, Nat. Rev. Mol. Cell Biol. source
Not checked in the free run.
- cites [5] Collado, 2007, Cellular Senescence in Cancer and Aging, Cell source
Not checked in the free run.
- cites [6] 2008, Living on a break: Cellular senescence as a DNA-damage response, Nat. Rev. Cancer source
Not checked in the free run.
- Premisereasoning
Persistent activation of RB prevents G1 to S phase progression by sequestering E2F transcription factors.
“Persistent activation of RB prevents G1 to S phase progression by sequestering E2F transcription factors.”
Quote in the paperSubstantial claim - Premisecitation
The growth arrest of senescent cells occurs through a cell cycle blockade in the G1 phase to prevent DNA replication initiation in damaged cells.
“It is generally thought that the growth arrest of senescent cells occurs through a cell cycle blockade in the G1 phase to prevent DNA replication initiation in damaged cells [4,6].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
p21 depletion ameliorates the regenerative capacity of proliferative tissues, such as the intestine and hematopoietic stem cells, in late-generation telomerase-deficient mice that experience telomere shortening and age-related degeneration.
“Importantly, p21 depletion ameliorates the regenerative capacity of proliferative tissues, such as the intestine and hematopoietic stem cells, in late-generation telomerase-deficient mice that experience telomere shortening and age-related degeneration [43].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Choudhury, 2007, Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation, Nat. Genet. source
Not checked in the free run.
- Premisecitation
High p21 or p16 expression level is sufficient to induce cell cycle arrest in early-passage human fibroblasts in culture.
“High p21 or p16 expression level is sufficient to induce cell cycle arrest in early-passage human fibroblasts in culture [35,36].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [35] McConnell, 1998, Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts, Curr. Biol. source
Not checked in the free run.
- cites [36] Rodier, 2011, Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype, J. Biol. Chem. source
Not checked in the free run.
- Interpretationreasoning
Entry into senescence and the long-term cell cycle exit are regulated through different changes in gene expression, metabolism, and cell organization.
“Therefore, entry into senescence and the long-term cell cycle exit are regulated through different changes in gene expression, metabolism, and cell organization.”
Quote in the paperNot a substantial claim - Premisecitation
Compared with p21, p16 accumulation is relatively slow in replicatively senescent fibroblasts.
“Compared with p21, p16 accumulation is relatively slow in replicatively senescent fibroblasts [38,39].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [38] Alcorta, 1996, Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [39] Stein, 1999, Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts, Mol. Cell. Biol. source
Not checked in the free run.
- Premisecitation
Unlike chronic senescence, the acute induction of cellular senescence represents a transient physiological response during embryonic development and adult tissue homeostasis.
“Indeed, unlike chronic senescence (i.e., accumulation of deleterious senescent cells with aging), the acute induction of cellular senescence represents a transient physiological response during embryonic development [27,28] and adult tissue homeostasis (e.g., to facilitate tissue repair after liver damage, in skin fibrosis, and wound healing) [29,30,31].”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [27] Maraver, 2013, Programmed Cell Senescence during Mammalian Embryonic Development, Cell source
Not checked in the free run.
- cites [28] Storer, 2013, Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning, Cell source
Not checked in the free run.
- cites [29] Krizhanovsky, 2008, Senescence of Activated Stellate Cells Limits Liver Fibrosis, Cell source
Not checked in the free run.
- cites [30] Jun, 2010, The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing, Nat. Cell Biol. source
Not checked in the free run.
- cites [31] Demaria, 2014, An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA, Dev. Cell source
Not checked in the free run.
- Premisenone given
CDK regulation through the expression of CDK inhibitors including p21, p15, and p16 is of special relevance in all senescence types.
“CDK regulation through the expression of CDK inhibitors, including p21 (CDKN1A), p15 (CDKN2B), and p16 (CDKN2A), is of special relevance in all senescence types.”
Quote in the paperNot a substantial claim - Premisecitation
Rodent and human senescent cells in culture and in many tissues typically display high levels of p21 and p16 proteins during normal aging.
“Rodent and human senescent cells in culture and in many tissues typically display high levels of these proteins during normal aging [37,38,39].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [37] Noda, 1994, Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression Screen, Exp. Cell Res. source
Not checked in the free run.
- cites [38] Alcorta, 1996, Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [39] Stein, 1999, Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts, Mol. Cell. Biol. source
Not checked in the free run.
- Interpretationreasoning
Inhibition of cyclin-CDK complexes by p21 and p16 results in persistent activation of RB, which represses cell cycle progression by sequestering E2F family members.
“Ultimately, inhibition of cyclin–CDK complexes by p21 and p16 results in the persistent activation of RB, that represses cell cycle progression by sequestering E2F family members.”
Quote in the paperSubstantial claim - Premisereasoning
In senescent cells, p21 enforces G1 arrest by inhibitory binding to cyclin E-CDK2 and cyclin A-CDK2 complexes, ensuring that RB remains hypo-phosphorylated and active.
“In senescent cells, p21 enforces G1 arrest by inhibitory binding to cyclin E–CDK2 and cyclin A–CDK2 complexes, thus ensuring that RB remains hypo-phosphorylated and active.”
Quote in the paperSubstantial claim - Interpretationreasoning
In senescence, p16 induction could represent the major switch to RB engagement in its active form and to irreversible cell cycle arrest.
“In senescence, p16 induction could represent the major switch to RB engagement in its active form and to irreversible cell cycle arrest (discussed further below).”
Quote in the paperNot a substantial claim - Premisereasoning
Senescence signaling typically acts by decreasing cyclin-CDK activity or increasing CDK inhibitor levels.
“Due to the critical regulatory role of these cell cycle factors, senescence signaling typically acts by decreasing cyclin–CDK activity or increasing CDK inhibitor levels.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Senescent cells may also stop in G2 to block mitosis in the presence of DNA damage.
“Senescent cells may also stop in G2 to block mitosis in the presence of DNA damage [32] (Figure 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Gire, 2015, Senescence from G2 arrest, revisited, Cell Cycle source
Not checked in the free run.
- Premisecitation
As primary fibroblasts divide in culture, telomere shortening activates p53.
“As primary fibroblasts divide in culture, telomere shortening activates p53 [40].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Bond, 1996, Evidence That Transcriptional Activation by P53 Plays a Direct Role in the Induction of Cellular Senescence, Oncogene
Not checked in the free run.
- Premisereasoning
Among the p53 target genes, p21 is induced rapidly upon telomere damage.
“Among the p53 target genes, p21 is induced rapidly upon telomere damage.”
Quote in the paperNot a substantial claim - Premisecitation
The absence of mitotic CDK activity promotes the premature activation of APC/C-CDH1 that targets cyclin B1 and other mitotic regulators for degradation.
“As cyclin B1–CDK1 complexes inhibit APC/C in complex with its co-activator CDH1 (APC/C CDH1) [64], the absence of mitotic CDK activity promotes the premature activation of APC/C CDH1 that targets cyclin B1 and other mitotic regulators for degradation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] Zachariae, 1998, Control of Cyclin Ubiquitination by CDK-Regulated Binding of Hct1 to the Anaphase Promoting Complex, Science source
Not checked in the free run.
- Premisecitation
p16 induction is robust in response to oncogenic stimuli, even in cells that undergo replicative senescence with low p16 levels.
“At the same time, p16 induction is robust in response to oncogenic stimuli, even in cells that undergo replicative senescence with low p16 levels [52].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Bartkova, 2011, Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16 ink4a, Cell Cycle source
Not checked in the free run.
- Premisecitation
In senescent embryonic cells, p21 is not induced by p53 or DNA damage but is regulated by the TGF-beta/SMAD and PI3K/FOXO signaling pathways.
“Moreover, p21 is not induced by p53 or DNA damage but is regulated by the transforming growth factor (TGF)-β/SMAD and PI3K/Forkhead box O (FOXO) signaling pathways [27].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Maraver, 2013, Programmed Cell Senescence during Mammalian Embryonic Development, Cell source
Not checked in the free run.
- Premisecitation
When acute telomere damage is caused by inhibition of the telomere binding protein TRF2, p16 protein levels increase in senescent cells.
“When acute telomere damage is caused by inhibition of the telomere binding protein, TRF2, p16 protein levels increase in senescent cells [49].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] Jacobs, 2004, Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence, Curr. Biol. source
Not checked in the free run.
- Premisecitation
In human fibroblasts that carry p16 gene inactivating mutations, senescence is bypassed.
“In human fibroblasts that carry p16 gene inactivating mutations, senescence is bypassed [53].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Brookes, 2002, INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence, EMBO J. source
Not checked in the free run.
- Premisecitation
Cellular senescence can also start during the G2 phase in response to telomere damage, DNA damage, or oncogene activation.
“Although traditionally described as an irreversible form of G1 arrest, cellular senescence can also start during the G2 phase in response to telomere damage [57], DNA damage [58], or oncogene activation [59].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [57] Jullien, 2013, Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response, Nucleic Acids Res. source
Not checked in the free run.
- cites [58] Krenning, 2014, Transient Activation of p53 in G2 Phase Is Sufficient to Induce Senescence, Mol. Cell source
Not checked in the free run.
- cites [59] Johmura, 2014, Necessary and Sufficient Role for a Mitosis Skip in Senescence Induction, Mol. Cell source
Not checked in the free run.
- Premisecitation
Unlike G1 arrest, cell cycle exit in G2 occurs rapidly, within few hours after damage.
“Unlike, G1 arrest, cell cycle exit in G2 occurs rapidly, within few hours after damage [58].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] Krenning, 2014, Transient Activation of p53 in G2 Phase Is Sufficient to Induce Senescence, Mol. Cell source
Not checked in the free run.
- Premisecitation
Developmental senescence is not required for embryogenesis because embryos lacking p21 show minimal or no developmental defects.
“Surprisingly, developmental senescence is not required for embryogenesis because embryos lacking p21 show minimal or no developmental defects [56].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Brugarolas, 1995, Radiation-Induced Cell Cycle Arrest Compromised by P21 Deficiency, Nature source
Not checked in the free run.
- Interpretationcitation
Other mechanisms, such as apoptosis, may partially compensate for the loss of developmental senescence in embryos lacking p21.
“Other mechanisms, such as apoptosis, may partially compensate for the loss of developmental senescence in such embryos [27,28].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Senescence can occur in mouse and human embryos.
“Senescence is classically viewed as a stress response but can also occur in mouse and human embryos [27,28].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Over time, telomere damage signaling can promote the progression of transiently arrested cells to full senescence through p16 upregulation.
“Over time, telomere damage signaling can promote the progression of transiently arrested cells to full senescence through p16 upregulation [48].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Krtolica, 2003, Reversal of human cellular senescence: Roles of the p53 and p16 pathways, EMBO J. source
Not checked in the free run.
- Premisecitation
Unscheduled degradation of mitotic regulators is believed to result in cell cycle exit in G2.
“Their unscheduled degradation is believed to result in cell cycle exit in G2 [32].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Gire, 2015, Senescence from G2 arrest, revisited, Cell Cycle source
Not checked in the free run.
- Premisenone given
p21 can indirectly activate RB family proteins that transcriptionally repress mitotic regulators, therefore stopping G2/M progression.
“Moreover, p21 can indirectly activate RB family proteins that transcriptionally repress mitotic regulators, therefore stopping G2/M progression.”
Quote in the paperSubstantial claim - Premisecitation
After expression of an activated oncogene such as RASV12, p21 and p16 accumulate concomitantly and rapidly in human fibroblasts, resulting in oncogene-induced senescence.
“After expression of an activated oncogene such as RASV12, p21 and p16 accumulate concomitantly and rapidly in human fibroblasts, resulting in oncogene-induced senescence (OIS) [51].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Serrano, 1997, Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a, Cell source
Not checked in the free run.
- Interpretationreasoning
p21 has a primary role in the initial steps of the cell cycle arrest.
“This indicates that p21 has a primary role in the initial steps of the cell cycle arrest.”
Quote in the paperSubstantial claim - Interpretationnone given
Telomere damage and oncogenic stress induce p16 through different mechanisms.
“Telomere damage and oncogenic stress induce p16 through different mechanisms.”
Quote in the paperNot a substantial claim - Premisecitation
The initial senescence arrest is reversible because senescent cells that express low levels of p16 can re-enter the cell cycle upon p53 inactivation.
“This initial arrest is reversible because senescent cells that express low levels of p16 can re-enter the cell cycle upon p53 inactivation [47,48].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [47] Gire, 1998, Reinitiation of DNA Synthesis and Cell Division in Senescent Human Fibroblasts by Microinjection of Anti-p53 Antibodies, Mol. Cell. Biol. source
Not checked in the free run.
- cites [48] Krtolica, 2003, Reversal of human cellular senescence: Roles of the p53 and p16 pathways, EMBO J. source
Not checked in the free run.
- Premisecitation
Benign melanocytic lesions, which are melanoma precursors in humans, express high p16 and are an in vivo example of OIS.
“Benign melanocytic lesions, which are melanoma precursors in humans, express high p16 and are an in vivo example of OIS [19,55].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In senescent embryonic cells, p21, but not p16, enforces cell cycle arrest, together with p15.
“In senescent embryonic cells, p21, but not p16, enforces cell cycle arrest, together with p15 that is a p16-related CDK inhibitor.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Maraver, 2013, Programmed Cell Senescence during Mammalian Embryonic Development, Cell source
Not checked in the free run.
- Interpretationcitation
G2 and G1, for cells with 4N DNA content after mitosis by-pass, might be the phases at which senescent cells exit the cell cycle upon acute and robust DNA damage that induces a rapid cell response, typically within 24 h.
“Therefore, G2 and G1 (for cells with 4N DNA content after mitosis by-pass) might be the phases at which senescent cells exit the cell cycle upon acute and robust DNA damage that induces a rapid cell response, typically within 24 h [58,59].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Mouse embryonic fibroblasts lacking p53 but not Ink4a (p16) or RB escape Ras-induced senescence.
“For example, mouse embryonic fibroblasts (MEFs) lacking p53 [72] but not Ink4a (p16) or RB [73,74,75] escape Ras-induced senescence.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [72] Kamijo, 1997, Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF, Cell source
Not checked in the free run.
- cites [73] Sage, 2000, Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization, Genes Dev. source
Not checked in the free run.
- cites [74] Krimpenfort, 2001, Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice, Nature source
Not checked in the free run.
- cites [75] Sharpless, 2001, Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis, Nature source
Not checked in the free run.
- Interpretationreasoning
Senescent cells invariably display high levels of at least one key cell cycle inhibitor, a molecular hallmark of cellular senescence.
“Therefore, senescent cells invariably display high levels of at least one of these key cell cycle inhibitors, a molecular hallmark of cellular senescence.”
Quote in the paperSubstantial claim - Interpretationreasoning
The multiplicity of senescence markers represents different senescence stages.
“This multiplicity of senescence markers represents different senescence stages.”
Quote in the paperNot a substantial claim - Premisenone given
EZH2 histone methyltransferase catalyzes trimethylation of lysine 27 on histone 3 (H3K27me3), a repressive mark, on chromatin to silence the CDKN2A locus.
“The EZH2 histone methyltransferase (a component of the PRC2 complex) catalyzes trimethylation of lysine 27 on histone 3 (H3K27me3), a repressive mark, on chromatin to silence the CDKN2A locus.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Some effectors are common to the majority of known senescent states.
“Nevertheless, some effectors are common to the majority of known senescent states.”
Quote in the paperNot a substantial claim - Premisecitation
Upon telomere erosion, senescing human fibroblasts show a prolonged G2 arrest, indicative of some mitotic entry delay.
“Upon telomere erosion, senescing human fibroblasts show a prolonged G2 arrest, indicative of some mitotic entry delay [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Jullien, 2013, Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response, Nucleic Acids Res. source
Not checked in the free run.
- Premisecitation
In senescent cells, p53 transcriptional activity is increased through DNA damage response-dependent signals mainly driven by unresolved DNA damage signaling due to telomere erosion and oncogene hyperproliferation.
“In senescent cells, p53 transcriptional activity is increased through DNA damage response (DDR)-dependent signals mainly driven by unresolved DNA damage signaling due to telomere erosion and oncogene hyperproliferation [10,11,69,70,71].”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [10] Reaper, 2003, A DNA Damage Checkpoint Response in Telomere-Initiated Senescence, Nature source
Not checked in the free run.
- cites [11] Gire, 2004, DNA damage checkpoint kinase Chk2 triggers replicative senescence, EMBO J. source
Not checked in the free run.
- cites [69] Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature source
Not checked in the free run.
- cites [70] Fumagalli, 2006, Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication, Nature source
Not checked in the free run.
- cites [71] Takai, 2003, DNA Damage Foci at Dysfunctional Telomeres, Curr. Biol. source
Not checked in the free run.
- Premisecitation
Loss of functional p16 but not of p53 enables human fibroblasts to avoid Ras-induced senescence.
“Conversely, loss of functional p16 [53] but not of p53 [51,76] enables human fibroblasts to avoid Ras-induced senescence.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [53] Brookes, 2002, INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence, EMBO J. source
Not checked in the free run.
- cites [51] Serrano, 1997, Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a, Cell source
Not checked in the free run.
- cites [76] Wei, 2001, Role of p14 ARF in Replicative and Induced Senescence of Human Fibroblasts, Mol. Cell. Biol. source
Not checked in the free run.
- Interpretationnone given
Different senescence stimuli engage different signaling pathways that ultimately converge to influence the levels of senescent state regulators.
“Altogether, different senescence stimuli engage different signaling pathways that ultimately converge to influence the levels of senescent state regulators.”
Quote in the paperSubstantial claim - Premisenone given
Cell cycle exit during OIS is strictly dependent on the activation of RB that acts downstream of p16.
“Cell cycle exit during OIS is strictly dependent on the activation of RB that acts downstream of p16.”
Quote in the paperNot a substantial claim - Premisecitation
In proliferative cells, polycomb repressive complexes PRC1 and PRC2 are recruited by the long noncoding RNA ANRIL to the CDKN2A locus.
“In proliferative cells, polycomb repressive complexes (PRC1 and PRC2) are recruited by the long noncoding RNA ANRIL to the CDKN2A locus [79].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Yap, 2010, Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a, Mol. Cell source
Not checked in the free run.
- Premisecitation
Loss of RB can trigger p53 upregulation via ARF or DNA damage signaling, thereby providing a safeguard to prevent senescence escape and malignant transformation.
“For example, loss of RB can trigger p53 upregulation via ARF or DNA damage signaling, thereby providing a safeguard to prevent senescence escape and malignant transformation [50,68].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [50] Bond, 1999, Control of Replicative Life Span in Human Cells: Barriers to Clonal Expansion Intermediate Between M1 Senescence and M2 Crisis, Mol. Cell. Biol. source
Not checked in the free run.
- cites [68] Chicas, 2010, Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence, Cancer Cell source
Not checked in the free run.
- Premisenone given
Cells can become senescent in response to different damaging stimuli, including DNA damage, metabolic stresses, inflammatory cytokines/chemokines, and damage signals.
“Cells can become senescent in response to different damaging stimuli. Most common inducers include DNA damage (e.g., telomere shortening or dysfunction, oncogene activation, oxidative damage, radiation); metabolic stresses (e.g., mitochondrial dysfunction, redox states changes), inflammatory cytokines/chemokines and damage signals (e.g., protein misfolding, autophagy disruption).”
Quote in the paperNot a substantial claim - Interpretationreasoning
p53 and p16 may not be universal OIS mediators in human cells.
“Therefore, p53 and p16 may not be universal OIS mediators in human cells.”
Quote in the paperSubstantial claim - Premisereasoning
The H3K27me3 mark is recognized and enforced by PRC1 that contains BMI1, CBX7, and CBX8.
“This epigenetic mark is recognized and enforced by PRC1 that contains B-cell-specific Moloney murine leukemia virus integration region 1 (BMI1), chromobox protein homologue 7 (CBX7), and chromobox protein homologue 8 (CBX8).”
Quote in the paperSubstantial claim - Premisenone given
The p53/ARF and RB/p16 tumor suppressor pathways act in a cooperative and interconnected way to block the cell cycle and implement the senescence programs.
“Namely, the p53/ARF and RB/p16 tumor suppressor pathways act in a cooperative and interconnected way to block the cell cycle and implement the senescence programs.”
Quote in the paperSubstantial claim - Premisecitation
Mitotic by-pass, which results from insufficient levels of mitotic proteins, is sufficient and necessary for OIS both in vitro and in vivo.
“Most notably mitotic by-pass, which results from insufficient levels of mitotic proteins, is sufficient and necessary for OIS both in vitro and in vivo [59].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Johmura, 2014, Necessary and Sufficient Role for a Mitosis Skip in Senescence Induction, Mol. Cell source
Not checked in the free run.
- Interpretationnone given
Unlike acute senescence, replicative senescence results from chronic, low-level macromolecular damage caused by telomere erosion and increased reactive oxygen species levels due to mitochondrial dysfunction and/or environmental insults.
“Unlike acute senescence, replicative senescence results from chronic, low-level macromolecular damage caused by telomere erosion and increased reactive oxygen species (ROS) levels (due to mitochondrial dysfunction and/or environmental insults).”
Quote in the paperNot a substantial claim - Premisecitation
When this mechanism fails, cells that are long-term arrested in G2 can enter a permanent G1-like state without going through mitosis, thereby generating tetraploid cells.
“When this mechanism fails, cells that are long-term arrested in G2 can enter a permanent G1-like state without going through mitosis (mitosis by-pass), thereby generating tetraploid cells [59] (Figure 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Johmura, 2014, Necessary and Sufficient Role for a Mitosis Skip in Senescence Induction, Mol. Cell source
Not checked in the free run.
- Interpretationreasoning
Cellular senescence is associated with various phenotypes whose characteristics depend on the signals that induced senescence, the originating cell type, the time elapsed since senescence initiation, and the site where senescent cells are located.
“Due to the multiplicity of stress signals and effector pathways involved in its execution, cellular senescence is associated with various phenotypes the characteristics of which depend on the signals that induced senescence, the originating cell type, the time elapsed since senescence initiation, and the site where senescent cells are located.”
Quote in the paperNot a substantial claim - Premisenone given
At these foci, γH2AX rapidly concentrates and anchors DNA repair proteins, such as 53BP1, MDC1, and NBS1, in the vicinity of telomeric lesions.
“At these foci, γH2AX rapidly concentrates and anchors DNA repair proteins, such as 53BP1, MDC1, and NBS1, in the vicinity of telomeric lesions.”
Quote in the paperNot a substantial claim - Premisecitation
Shelterin allows the efficient suppression of non-homologous end joining and ATM activation at chromosome ends.
“Shelterin allows the efficient suppression of non-homologous end joining (NHEJ) and ATM activation at chromosome ends [89].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] Ruis, 2021, The end protection problem—An unexpected twist in the tail, Genes Dev. source
Not checked in the free run.
- Premisecitation
In proliferating cells, telomere shortening is not exclusively due to the end-replication problem; random damage to telomeres through oxidative damage, exonucleolytic processing events, nucleases, secondary structures in telomeric DNA, and sporadic loss of large telomeric stretches can accelerate telomere shortening and dysfunction.
“Indeed, random damage to telomeres through oxidative damage [91], exonucleolytic processing events, nucleases [92], secondary structures in telomeric DNA [93], and sporadic loss of large telomeric stretches [94] also can accelerate telomere shortening and dysfunction.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [91] 2002, Oxidative stress shortens telomeres, Trends Biochem. Sci. source
Not checked in the free run.
- cites [92] Lydall, 2003, Hiding at the ends of yeast chromosomes: Telomeres, nucleases and checkpoint pathways, J. Cell Sci. source
Not checked in the free run.
- cites [93] Ding, 2004, Regulation of Murine Telomere Length by Rtel: An Essential Gene Encoding a Helicase-like Protein, Cell source
Not checked in the free run.
- Premisecitation
Foci of phosphorylated histone H2AX (γH2AX), which mark the presence of DNA breaks, accumulate at telomeres in human senescent fibroblasts.
“In this situation, foci of phosphorylated histone H2AX (γH2AX), which mark the presence of DNA breaks, accumulate at telomeres in human senescent fibroblasts [10,11,12].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [10] Reaper, 2003, A DNA Damage Checkpoint Response in Telomere-Initiated Senescence, Nature source
Not checked in the free run.
- cites [11] Gire, 2004, DNA damage checkpoint kinase Chk2 triggers replicative senescence, EMBO J. source
Not checked in the free run.
- cites [12] Herbig, 2004, Telomere Shortening Triggers Senescence of Human Cells through a Pathway Involving ATM, p53, and p21CIP1, but Not p16INK4a, Mol. Cell source
Not checked in the free run.
- Interpretationreasoning
Too short telomeres might retain sufficient telomere length and TRF2 to suppress chromosome end-to-end fusions via the NHEJ pathway but not to efficiently protect telomeres against ATM activation.
“Therefore, too short telomeres might retain sufficient telomere length and TRF2 to suppress chromosome end-to-end fusions via the NHEJ pathway but not to efficiently protect telomeres against ATM activation.”
Quote in the paperNot a substantial claim - Premisecitation
γH2AX focus formation correlates with the activation of the DNA damage effector kinases ATM, CHK1, and CHK2.
“γH2AX focus formation correlates with the activation of the DNA damage effector kinases ATM, CHK1, and CHK2 [10,11,12].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [10] Reaper, 2003, A DNA Damage Checkpoint Response in Telomere-Initiated Senescence, Nature source
Not checked in the free run.
- cites [11] Gire, 2004, DNA damage checkpoint kinase Chk2 triggers replicative senescence, EMBO J. source
Not checked in the free run.
- cites [12] Herbig, 2004, Telomere Shortening Triggers Senescence of Human Cells through a Pathway Involving ATM, p53, and p21CIP1, but Not p16INK4a, Mol. Cell source
Not checked in the free run.
- Premisecitation
In senescent human cells, short telomeres do not recapitulate the intermediate state phenotype predicted by the model of an ATM-activated but NHEJ-repressed state.
“However, in senescent human cells, short telomeres do not recapitulate the intermediate state phenotype predicted by this model (i.e., mild ATM activation without evidence of significant CHK2 and p53 activation) [10,11,12,57].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [10] Reaper, 2003, A DNA Damage Checkpoint Response in Telomere-Initiated Senescence, Nature source
Not checked in the free run.
- cites [11] Gire, 2004, DNA damage checkpoint kinase Chk2 triggers replicative senescence, EMBO J. source
Not checked in the free run.
- cites [12] Herbig, 2004, Telomere Shortening Triggers Senescence of Human Cells through a Pathway Involving ATM, p53, and p21CIP1, but Not p16INK4a, Mol. Cell source
Not checked in the free run.
- cites [57] Jullien, 2013, Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response, Nucleic Acids Res. source
Not checked in the free run.
- Premisecitation
Telomeres shorten at each cell replication because of the end-replication problem and post replicative end-processing.
“Telomeres shorten at each cell replication because of the end-replication problem and post replicative end-processing [89,90].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Loss of G-overhangs in senescent cells, possibly due to perturbations in end-protection, restricts t-loop formation.
“As t-loops require a G-overhang, loss of G-overhangs in senescent cells, possibly due to perturbations in end-protection, restricts t-loop formation [100].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Stewart, 2003, Erosion of the telomeric single-strand overhang at replicative senescence, Nat. Genet. source
Not checked in the free run.
- Interpretationreasoning
It is unlikely that the inability to properly repair DNA breaks in telomeres is the only mechanism by which senescence is induced following exposure to exogenous DNA damaging agents.
“Nevertheless, it is unlikely that the inability to properly repair DNA breaks in telomeres is the only mechanism by which senescence is induced following exposure to exogenous DNA damaging agents.”
Quote in the paperNot a substantial claim - Premisecitation
When cells are exposed to oxidative or DNA damaging agents, if the damage occurs in telomeric regions, TRF2 inhibits its repair and contributes to an unresolved DDR, which helps to stabilize the senescence arrest.
“Similarly, when cells are exposed to oxidative or DNA damaging agents, if the damage occurs in telomeric regions, TRF2 inhibits its repair and contributes to an unresolved DDR, which helps to stabilize the senescence arrest [115].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [115] Fumagalli, 2012, Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Accumulation of γH2AX foci in senescent cells in culture and in cells derived from aged individuals can mark also non-repaired DNA breaks that are not necessarily the result of critically short telomeres.
“Accumulation of γH2AX foci in senescent cells in culture and in cells derived from aged individuals can mark also non-repaired DNA breaks that are not necessarily the result of critically short telomeres [106].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [106] Sedelnikova, 2004, Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Progression to mitosis in cells with residual damage or fused chromosomes contributes to the generation of micronuclei upon cytokinesis.
“Progression to mitosis in cells with residual damage or fused chromosomes contributes to the generation of micronuclei upon cytokinesis [105].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Ivanov, 2013, Lysosome-mediated processing of chromatin in senescence, J. Cell Biol. source
Not checked in the free run.
- Premisecitation
Telomere dysfunction, assessed by the association of DDR proteins with telomeres, increases with age in vivo in baboon skin fibroblasts and in mouse liver and gut.
“For example, telomere dysfunction, assessed by the association of DDR proteins with telomeres, increases with age in vivo in baboon skin fibroblasts [107,108] and in mouse liver and gut [109].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [107] Herbig, 2006, Cellular Senescence in Aging Primates, Science source
Not checked in the free run.
- cites [108] Jeyapalan, 2007, Accumulation of senescent cells in mitotic tissue of aging primates, Mech. Ageing Dev. source
Not checked in the free run.
- cites [109] Hewitt, 2012, Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence, Nat. Commun. source
Not checked in the free run.
- Premisecitation
These age-associated foci occur despite the presence of long telomeres and active telomerase in mice.
“These age-associated foci occur despite the presence of long telomeres and active telomerase in mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] Hewitt, 2012, Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence, Nat. Commun. source
Not checked in the free run.
- Premisecitation
Telomerase expression in human fibroblasts does not protect them against senescence induced by oxidative damage and OIS.
“Conversely, telomerase expression in human fibroblasts does not protect them against senescence induced by oxidative damage [112] and OIS [113].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [112] Chainiaux, 2002, Stress-induced premature senescence in BJ and hTERT-BJ1 human foreskin fibroblasts, FEBS Lett. source
Not checked in the free run.
- cites [113] Wei, 1999, Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts, Cancer Res.
Not checked in the free run.
- Premisecitation
Lesions in or next to telomeres are refractory to repair as a result of TRF2 presence.
“In fact, lesions in or next to telomeres are refractory to repair as a result of TRF2 presence.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [109] Hewitt, 2012, Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence, Nat. Commun. source
Not checked in the free run.
- cites [115] Fumagalli, 2012, Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Culture of primary mouse and human fibroblasts at low physiological oxygen levels prevents senescence activation after long culturing or upon expression of activated Ras.
“Culture of primary mouse and human fibroblasts at low physiological oxygen levels prevents senescence activation after long culturing (increasing passage number) or upon expression of activated Ras [54,111].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [54] Benanti, 2004, Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence, Mol. Cell. Biol. source
Not checked in the free run.
- cites [111] Parrinello, 2003, Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts, Nat. Cell Biol. source
Not checked in the free run.
- Interpretationcitation
Consequently, the cell cycle stalls in G2 to provide time for the re-establishment of the folded structure after replication.
“Consequently, the cell cycle stalls in G2 to provide time for the re-establishment of the folded structure after replication [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Jullien, 2013, Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response, Nucleic Acids Res. source
Not checked in the free run.
- Interpretationreasoning
Inherited dysfunctional telomeres and additional DNA breaks following mitosis will cause G1 arrest in the resulting daughter cells.
“Inherited dysfunctional telomeres and additional DNA breaks following mitosis will cause G1 arrest in the resulting daughter cells (Figure 1).”
Quote in the paperNot a substantial claim - Premisecitation
High telomerase activity prevents the activation of DNA damage signals originating from stalled replication forks inside telomeres, thus allowing OIS bypass.
“However, high telomerase activity prevents the activation of DNA damage signals originating from stalled replication forks inside telomeres, thus allowing OIS bypass [114].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [114] Suram, 2012, Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions: Telomere Dysfunction Limits Cancer Progression in Humans, EMBO J. source
Not checked in the free run.
- Premisecitation
DNA damage signaling is involved in the initiation of stress-induced premature senescence in response to acute cellular stresses, such as oxidative damage generated by ROS and oncogene activation.
“DNA damage signaling is also involved in the initiation of stress-induced premature senescence in response to acute cellular stresses, such as oxidative damage generated by ROS [117] and oncogene activation [69,70].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [117] Colavitti, 2005, Reactive Oxygen Species as Mediators of Cellular Senescence, IUBMB Life source
Not checked in the free run.
- cites [69] Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature source
Not checked in the free run.
- cites [70] Fumagalli, 2006, Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication, Nature source
Not checked in the free run.
- Interpretationcitation
The accumulation of persistent and unresolved telomeric damage might be explained by the cell inability to efficiently repair damaged telomeres.
“The accumulation of persistent and unresolved telomeric damage might be explained by the cell inability to efficiently repair damaged telomeres [109,115].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [109] Hewitt, 2012, Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence, Nat. Commun. source
Not checked in the free run.
- cites [115] Fumagalli, 2012, Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation, Nat. Cell Biol. source
Not checked in the free run.
- Interpretationreasoning
As telomeres shorten, the frequency of t-loop occurrence would decrease due to reduced occupancy by TRF2 required to form a functional t-loop structure after DNA replication.
“As telomeres shorten, the frequency of t-loop occurrence would decrease due to reduced occupancy by TRF2 required to form a functional t-loop structure after DNA replication.”
Quote in the paperSubstantial claim - Premisereasoning
Cells with a low number of DNA breaks can enter mitosis.
“Therefore, cells with a low number of DNA breaks can enter mitosis [103,104].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [103] Deckbar, 2007, Chromosome breakage after G2 checkpoint release, J. Cell Biol. source
Not checked in the free run.
- cites [104] Krempler, 2007, An Imperfect G2M Checkpoint Contributes to Chromosome Instability Following Irradiation of S and G2Phase Cells, Cell Cycle source
Not checked in the free run.
- Rests on an assumption: The G2/M checkpoint only responds to 10–20 DNA breaks.
- Premisecitation
Cells approaching senescence may proceed to mitosis despite the presence of residual (4 to 5) γH2AX-marked unstable telomere structures.
“Alternatively, cells approaching senescence may proceed to mitosis despite the presence of residual (4 to 5) γH2AX-marked unstable telomere structures [102].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Kaul, 2012, Five dysfunctional telomeres predict onset of senescence in human cells, EMBO Rep. source
Not checked in the free run.
- Premisecitation
In addition to aberrant DNA replication, unrepaired telomeres contribute to DDR signaling in OIS, without significant telomere shortening.
“In addition to aberrant DNA replication, unrepaired telomeres contribute to DDR signaling in OIS, without significant telomere shortening.”
Quote in the paperNot a substantial claim - Premisecitation
In mouse models, deficiency of one or both proteins encoded by the CDKN2A locus results in tumor-prone animals.
“In mouse models, deficiency of one or both proteins encoded by the CDKN2A locus results in tumor-prone animals [123].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] Kim, 2006, The Regulation of INK4/ARF in Cancer and Aging, Cell source
Not checked in the free run.
- Premisecitation
Efficient ARF induction mainly reflects a transcription-based mechanism under continuous oncogenic activation.
“Conversely, efficient ARF induction mainly reflects a transcription-based mechanism under continuous oncogenic activation [129].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Evangelou, 2013, The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis, Cell Death Differ. source
Not checked in the free run.
- Premisecitation
ARF acts mainly by binding to MDM2, a p53-specific E3 ubiquitin ligase, to prevent its effect on p53 inactivation, thereby stabilizing and enhancing p53 activity.
“ARF acts mainly by binding to MDM2, a p53-specific E3 ubiquitin ligase, to prevent its effect on p53 inactivation, thereby stabilizing and enhancing p53 activity.”
Quote in the paperNot a substantial claim - Premisecitation
The ARF locus is more commonly deleted or silenced than mutated in melanoma.
“Indeed, its locus is more commonly deleted or silenced than mutated in melanoma, the more malignant later stage of disease [19,55].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
N-RAS- or B-RAF-activating mutations are commonly found in benign melanocytic nevi that show features of senescence, such as elevated p16 levels, but that do not express appreciable levels of ARF or p53.
“For example, N-RAS- or B-RAF-activating mutations are commonly found in benign melanocytic nevi that show features of senescence, such as elevated p16 levels, but that do not express appreciable levels of ARF or p53 [19,55].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisenone given
Activated oncogenes deregulate cell cycle entry by increasing the activities of CDKs that function as positive S phase regulators.
“Activated oncogenes deregulate cell cycle entry by increasing the activities of CDKs that function as positive S phase regulators.”
Quote in the paperSubstantial claim - Premisecitation
Oncogene-induced replication stress and DNA breaks account for early DDR activation mediated primarily by phosphorylation-dependent signaling.
“Oncogene-induced replication stress and DNA breaks account for the early DDR activation mediated primarily by phosphorylation-dependent signaling [69].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature source
Not checked in the free run.
- Premisecitation
Such telomeres are not visibly shorter than functional telomeres in human melanocytic nevi with frequent BRAF mutations, a typical OIS feature in vivo.
“Indeed, such telomeres are not visibly shorter than functional telomeres [114] in human melanocytic nevi with frequent BRAF mutations, a typical OIS feature in vivo [19].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [114] Suram, 2012, Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions: Telomere Dysfunction Limits Cancer Progression in Humans, EMBO J. source
Not checked in the free run.
- cites [19] Michaloglou, 2005, BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature source
Not checked in the free run.
- Premisecitation
Oncogenes, typified by oncogenic Ras, that deliver strong mitogenic signals engage senescence-related cell cycle arrest when expressed in normal fibroblasts in culture.
“Oncogenes, typified by oncogenic Ras, that deliver strong mitogenic signals engage senescence-related cell cycle arrest when expressed in normal fibroblasts in culture [51].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Serrano, 1997, Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a, Cell source
Not checked in the free run.
- Premisecitation
In humans, Ras activation appears to induce only p16.
“In humans, Ras activation appears to induce only p16 [19,127].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [19] Michaloglou, 2005, BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature source
Not checked in the free run.
- cites [127] Munro, 1999, Role of the alternative INK4A proteins in human keratinocyte senescence: Evidence for the specific inactivation of p16INK4A upon immortalization, Cancer Res.
Not checked in the free run.
- Premisecitation
Oxidative stress may amplify DNA damage signaling in oncogene-overexpressing cells because high ROS levels have been detected in these cells.
“Oxidative stress also may amplify DNA damage signaling in oncogene-overexpressing cells because high ROS levels have been detected in these cells [120].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [120] Lee, 1999, Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species, J. Biol. Chem. source
Not checked in the free run.
- Premisecitation
Oncogenes may induce associated DNA damage by transcriptionally downregulating ribonucleotide reductase M2 (RRM2), a regulator of the nucleotide metabolic pathway that ultimately affects the metabolism and decreases dNTP levels.
“Oncogenes may induce associated DNA damage by transcriptionally downregulating ribonucleotide reductase M2 (RRM2), a regulator of the nucleotide metabolic pathway that ultimately affects the metabolism and decreases dNTP levels [119].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Aird, 2013, Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence, Cell Rep. source
Not checked in the free run.
- Premisecitation
A second DNA damage-independent pathway leading to p53 activation in OIS involves ARF (murine p19ARF and human p14ARF), encoded by a gene in the CDKN2A locus overlapping with INK4A.
“A second DNA damage-independent pathway leading to p53 activation in OIS involves ARF (murine p19ARF and human p14ARF) that is encoded by a gene located in the CDKN2A locus and overlapping with INK4A [123].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] Kim, 2006, The Regulation of INK4/ARF in Cancer and Aging, Cell source
Not checked in the free run.
- Premisecitation
Mouse, but not human, p19ARF is upregulated by various oncogenes (e.g., Ras and E2F), leading to p53 activation and senescence.
“Notably, mouse, but not human, p19ARF is upregulated by various oncogenes (e.g., Ras and E2F), leading to p53 activation and senescence [125,126].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [125] Ferbeyre, 2002, Oncogenic ras and p53 Cooperate to Induce Cellular Senescence, Mol. Cell. Biol. source
Not checked in the free run.
- cites [126] Rowland, 2002, E2F transcriptional repressor complexes are critical downstream targets of p19ARF/p53-induced proliferative arrest, Cancer Cell source
Not checked in the free run.
- Premisecitation
ROS can damage DNA directly or through oxidative lesions that increase replication fork collapse by preventing its progression, thereby exacerbating the formation of DNA breaks and DDR activation.
“ROS can damage DNA directly or through oxidative lesions that increase replication fork collapse by preventing its progression, thereby exacerbating the formation of DNA breaks and DDR activation [121,122].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [121] Moiseeva, 2009, Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence, Mol. Cell. Biol. source
Not checked in the free run.
- cites [122] Weyemi, 2012, ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence, Oncogene source
Not checked in the free run.
- Interpretationcitation
The stochastic accumulation of mutations might be needed for OIS induction.
“As the endogenous expression levels of oncogenes are unlikely to cause OIS, the stochastic accumulation of mutations might be needed for OIS induction [118].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Collado, 2006, The power and the promise of oncogene-induced senescence markers, Nat. Rev. Cancer source
Not checked in the free run.
- Rests on an assumption: Endogenous expression levels of oncogenes are unlikely to cause OIS.
- Premisecitation
Oncogenic Ras drives the initial hyperproliferative phase that deregulates the usage of DNA replication origins, resulting in increased replication errors, DNA breaks, and DDR initiation.
“Consequently, oncogenic Ras drives the initial hyperproliferative phase that deregulates the usage of DNA replication origins, resulting in increased replication errors, DNA breaks, and DDR initiation [69,70].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [69] Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature source
Not checked in the free run.
- cites [70] Fumagalli, 2006, Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication, Nature source
Not checked in the free run.
- Premisecitation
Genes encoding factors that promote cell cycle arrest, such as CDK inhibitors, are upregulated upon senescence induction.
“Genes encoding factors that promote cell cycle arrest, such as CDK inhibitors, are upregulated upon senescence induction [139,140].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Most SASP regulators converge to C/EBP-β and NF-κB transcription factors that cooperatively regulate SASP factor induction in various senescence contexts.
“Most SASP regulators converge to the CCAAT/enhancer-binding protein β (C/EBP-β) and nuclear factor kappa-B (NF-κB) transcription factors that cooperatively regulate SASP factors induction in various senescence contexts [153,154,155].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [153] Acosta, 2008, Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence, Cell source
Not checked in the free run.
- cites [154] Kuilman, 2008, Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network, Cell source
Not checked in the free run.
- cites [155] Chien, 2011, Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity, Genes Dev. source
Not checked in the free run.
- Interpretationreasoning
Downregulation of genes encoding proteins that ensure mitotic fidelity might increase aneuploidy and genomic instability.
“The downregulation of genes encoding proteins that ensure mitotic fidelity might increase aneuploidy and genomic instability.”
Quote in the paperNot a substantial claim - Premisecitation
The SASP response relies on positive autocrine and paracrine feedback loops to provide a highly sensitive and robust mechanism of global SASP amplification.
“It is also clear that the SASP response relies on positive autocrine and paracrine feedback loops to provide a highly sensitive and robust mechanism of global SASP amplification [152].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [152] Herranz, 2018, Mechanisms and functions of cellular senescence, J. Clin. Investig. source
Not checked in the free run.
- Premisecitation
In senescence-associated transcriptome signatures, genes involved in growth factor signaling, cell cycle progression, DNA replication, and mitosis progression control are downregulated.
“In these senescence-associated signatures, genes involved in growth factor signaling, cell cycle progression, DNA replication, and mitosis progression control are downregulated [68,136,137,138,139,140].”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [68] Chicas, 2010, Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence, Cancer Cell source
Not checked in the free run.
- cites [136] Shelton, 1999, Microarray analysis of replicative senescence, Curr. Biol. source
Not checked in the free run.
- cites [137] Ly, 2000, Mitotic Misregulation and Human Aging, Science source
Not checked in the free run.
- cites [138] Zhang, 2003, Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [139] Kim, 2013, Implications of time-series gene expression profiles of replicative senescence, Aging Cell source
Not checked in the free run.
- cites [140] Lackner, 2014, A genomics approach identifies senescence-specific gene expression regulation, Aging Cell source
Not checked in the free run.
- Premisecitation
Many global gene expression analyses to identify gene expression signatures of senescence have highlighted highly variable and heterogeneous profiles depending on cell of origin, mode of induction, and time after induction.
“Many global gene expression analyses to identify gene expression signatures of senescence have highlighted highly variable and heterogeneous profiles in function of the cell of origin, the mode of induction, and the time after induction of the senescence program [133,134].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
RB family members have redundant activity in repressing replication genes during quiescence.
“Conversely, RB family members have redundant activity in repressing these genes during quiescence [73].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [73] Sage, 2000, Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization, Genes Dev. source
Not checked in the free run.
- Premisecitation
Senescence is associated with upregulation of anti-apoptotic proteins of the BCL-2 family, particularly BCL-2, BCL-Xl, and BCL-W.
“Senescence also is associated with upregulation of anti-apoptotic proteins of the BCL-2 family, particularly BCL-2, BCL-Xl, and BCL-W [14,15,143,144]”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [14] Chang, 2016, Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat. Med. source
Not checked in the free run.
- cites [15] Yosef, 2016, Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL, Nat. Commun. source
Not checked in the free run.
- cites [143] Wang, 1995, Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved, Cancer Res.
Not checked in the free run.
- cites [144] Yosef, 2017, p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling, EMBO J. source
Not checked in the free run.
- Premisecitation
Time-series transcriptomic profiling studies indicate that SASP composition changes in a temporal manner during the establishment of cellular senescence.
“Time-series transcriptomic profiling studies indicate that the SASP composition changes in a temporal manner during the establishment of cellular senescence [150].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [150] Hoare, 2016, NOTCH1 mediates a switch between two distinct secretomes during senescence, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Mitochondrial genes, particularly nuclear-encoded components of the electron transport chain, are downregulated at senescence.
“Mitochondrial genes, particularly nuclear-encoded components of the electron transport chain [142], also are downregulated at senescence, in line with the substantial decrease in mitochondrial function and marked ROS production (discussed below).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [142] Vizioli, 2020, Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence, Genes Dev. source
Not checked in the free run.
- Interpretationcitation
Delayed ARF expression increase probably reflects the complex organization of responsive elements within the ARF promoter.
“The delayed ARF expression increase probably reflects the complex organization of the responsive elements within the ARF promoter [130,131,132].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [130] Robertson, 1998, The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53, Mol. Cell. Biol. source
Not checked in the free run.
- cites [131] Inoue, 1999, Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [132] Berkovich, 2003, E2F and Ras Synergize in Transcriptionally Activating p14ARFExpression, Cell Cycle source
Not checked in the free run.
- Premisecitation
In senescent cells, biosynthetic activity is decreased due to downregulation of genes required for DNA, RNA, and protein synthesis, as well as genes with a role in glucose and fatty acid metabolism.
“For instance, in senescent cells, biosynthetic activity is decreased due to the downregulation of genes required for DNA, RNA, and protein synthesis, as well as of genes with a role in glucose and fatty acid metabolism [133].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Melov, 2017, Unmasking Transcriptional Heterogeneity in Senescent Cells, Curr. Biol. source
Not checked in the free run.
- Premisecitation
RB is uniquely required to repress transcription of replication genes and then to stop DNA synthesis during senescence.
“Nevertheless, RB is uniquely required to repress the transcription of replication genes and then to stop DNA synthesis during senescence [68].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Chicas, 2010, Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence, Cancer Cell source
Not checked in the free run.
- Premisecitation
A group of genes encoding proteins involved in spindle assembly and chromosome segregation, such as CENP-E, are downregulated in senescent cells.
“Moreover, a group of genes encoding proteins involved in spindle assembly and chromosome segregation, such as CENP-E, are downregulated [137,140].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Senescent cells are programmed to secrete different chemokines, pro-inflammatory cytokines, growth factors, and matrix-remodeling enzymes that define the SASP.
“In addition to the downregulation of cell cycle genes, senescent cells are programmed to secrete different chemokines, pro-inflammatory cytokines, growth factors, and matrix-remodeling enzymes that define the SASP [136,147,148].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [136] Shelton, 1999, Microarray analysis of replicative senescence, Curr. Biol. source
Not checked in the free run.
- cites [147] Coppé, J.-P., Patil, C.K., Rodier, F., Sun, Y., Muñoz, D.P., Goldstein, J.N., Nelson, P.S., Desprez, P.-Y., and Campisi, J. (2008). Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor. PLoS Biol., 6. source
Not checked in the free run.
- cites [148] Rodier, 2009, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Genes involved in membrane trafficking and intercellular signaling, such as cell-cell adhesion molecules and cell-surface receptors, are upregulated in senescent cells.
“Conversely, genes involved in membrane trafficking and intercellular signaling, such as cell–cell adhesion molecules and cell–surface receptors, are upregulated in senescent cells [133,140].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
DNA repair and chromatin organization genes are downregulated in senescent cells.
“DNA repair and chromatin organization genes are downregulated [133,139,140].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [133] Melov, 2017, Unmasking Transcriptional Heterogeneity in Senescent Cells, Curr. Biol. source
Not checked in the free run.
- cites [139] Kim, 2013, Implications of time-series gene expression profiles of replicative senescence, Aging Cell source
Not checked in the free run.
- cites [140] Lackner, 2014, A genomics approach identifies senescence-specific gene expression regulation, Aging Cell source
Not checked in the free run.
- Premisecitation
Senescence is associated with altered p53 signaling that might protect senescent cells against apoptosis.
“and altered p53 signaling [146] that might protect senescent cells against apoptosis (discussed below).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [146] Seluanov, 2001, Change of the Death Pathway in Senescent Human Fibroblasts in Response to DNA Damage Is Caused by an Inability to Stabilize p53, Mol. Cell. Biol. source
Not checked in the free run.
- Premisecitation
Single-cell transcriptomics studies revealed that senescent cell populations are composed of a mixture of cells with different mRNA expression profiles.
“Similarly, single-cell transcriptomics studies revealed that senescent cell populations are composed of a mixture of cells with different mRNA expression profiles [135].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [135] Wiley, 2017, Analysis of individual cells identifies cell-to-cell variability following induction of cellular senescence, Aging Cell source
Not checked in the free run.
- Premisecitation
Half of the genes differentially expressed by senescent fibroblasts, regardless of the senescence inducer, are not shared with quiescent cells.
“Half of the genes differentially expressed by senescent fibroblasts (regardless of the senescence inducer) are not shared with quiescent cells [133].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Melov, 2017, Unmasking Transcriptional Heterogeneity in Senescent Cells, Curr. Biol. source
Not checked in the free run.
- Premisecitation
Senescence is associated with downregulation of apoptotic effectors such as caspase-3.
“downregulation of apoptotic effectors, such as caspase-3 [145]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [145] Marcotte, 2004, Senescent fibroblasts resist apoptosis by downregulating caspase-3, Mech. Ageing Dev. source
Not checked in the free run.
- Premisecitation
GATA4 induces the SASP through a distinct p53- and p16-independent branch of the DDR signaling pathway to facilitate senescence.
“GATA4 induces the SASP through a distinct (p53- and p16-independent) branch of the DDR signaling pathway to facilitate senescence [160].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Kang, 2015, The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4, Science source
Not checked in the free run.
- Premisecitation
Persistent DNA damage leads to proteasomal degradation of major histone H3K9 dimethyltransferases, resulting in a decrease in H3K9me2 at promoters of SASP genes that enhances IL-6 and IL-8 induction.
“For example, persistent DNA damage leads to proteasomal degradation of major histone H3K9 dimethyltransferases. This results in a decrease in histone H3 lysine 9 dimethylation (H3K9me2; a repressive chromatin modification) at the promoters of SASP genes that subsequently enhances IL-6 and IL-8 induction [165].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [165] Takahashi, 2012, DNA Damage Signaling Triggers Degradation of Histone Methyltransferases through APC/CCdh1 in Senescent Cells, Mol. Cell source
Not checked in the free run.
- Premisecitation
NF-κB signaling can be activated by p38MAPKα, independent of the DDR.
“NF-κB signaling can be activated by p38MAPKα, independent of the DDR [159].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [159] Freund, 2011, p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype: P38 Regulates the Senescence Secretory Phenotype, EMBO J. source
Not checked in the free run.
- Premisecitation
NF-κB inhibition in senescent cells selectively represses SASP genes that require this transcription factor.
“Considering the central role of NF-κB transcriptional activity in SASP induction, NF-κB inhibition in senescent cells selectively represses SASP genes that require this transcription factor [155].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [155] Chien, 2011, Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity, Genes Dev. source
Not checked in the free run.
- Premisecitation
IκB degradation allows NF-κB translocation into the nucleus where it transactivates several SASP genes.
“IκB degradation allows NF-κB translocation into the nucleus where it transactivates several SASP genes [156,157].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [156] Miyamoto, 2011, Nuclear initiated NF-κB signaling: NEMO and ATM take center stage, Cell Res. source
Not checked in the free run.
- cites [157] Zhao, 2020, ATM is a key driver of NF-κB-dependent DNA-damage-induced senescence, stem cell dysfunction and aging, Aging source
Not checked in the free run.
- Premisecitation
Hypoxia impairs mTOR activity, leading to reduced IL-1α translation to support NF-κB activity and SASP induction.
“Hypoxia impairs mammalian target of rapamycin (mTOR) activity, leading to reduced IL-1α translation to support NF-κB activity and SASP induction [162,163].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [162] Herranz, 2015, mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype, Nat. Cell Biol. source
Not checked in the free run.
- cites [163] Laberge, 2015, MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Cytoplasmic DNA in early senescent cells can originate from micronuclei produced due to chromosome segregation errors during mitosis.
“Mechanistically, cytoplasmic DNA in early senescent cells can originate from micronuclei produced due to chromosome segregation errors during mitosis [175,176].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [175] Harding, 2017, Mitotic progression following DNA damage enables pattern recognition within micronuclei, Nature source
Not checked in the free run.
- cites [176] MacKenzie, 2017, cGAS surveillance of micronuclei links genome instability to innate immunity, Nature source
Not checked in the free run.
- Interpretationcitation
In senescent cells, cytoplasmic DNA acts as a danger signal and activates innate immune sensing mechanisms to trigger the SASP.
“In senescent cells, cytoplasmic DNA also acts as a danger signal and activates the innate immune sensing mechanisms to trigger the SASP.”
Quote in the paperSubstantial claim - Premisecitation
Upregulation of SASP genes is balanced by a negative feedback loop whereby macroH2A1 activates DDR signaling that leads to macroH2A1 removal from the chromatin of SASP genes, reducing their expression.
“Upregulation of SASP genes is balanced by a negative feedback loop whereby macroH2A1 activates DDR signaling that leads to macroH2A1 removal from the chromatin of SASP genes, thus reducing their expression [168].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [168] Chen, 2015, MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype, Mol. Cell source
Not checked in the free run.
- Premisecitation
Increased expression of the H3K79 methyltransferase DOT1L during OIS promotes H3K79me2/3 occupancy at the IL1A locus, contributing to SASP gene expression.
“The increased expression of the H3K79 methyltransferase DOT1L during OIS promotes H3K79me2/3 occupancy at the IL1A locus, contributing to SASP gene expression [166].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [166] Leon, 2021, DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A, J. Cell Biol. source
Not checked in the free run.
- Premisecitation
A high level of membrane-bound NOTCH activity restrains C/EBPβ activity, leading to negative regulation of inflammatory cytokine production.
“Mechanistically, a high level of membrane-bound NOTCH activity restrains C/EBPβ activity, leading to the negative regulation of inflammatory cytokine production.”
Quote in the paperSubstantial claim - Premisecitation
In hypoxic senescent cells, mTOR activity decrease is mediated by activation of AMPK that helps maintain energy balance under low-oxygen conditions.
“In hypoxic senescent cells, mTOR activity decrease is mediated by activation of AMP-activated protein kinase (AMPK) that helps to maintain the energy balance under low-oxygen conditions [161,164].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [161] Wang, 2021, Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression, Mol. Cell source
Not checked in the free run.
- cites [164] Hall, 2020, AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control, Cell Metab. source
Not checked in the free run.
- Premisecitation
In the early stage of senescence, production of IL-1α initiates a feed-forward loop to strengthen C/EBPβ and NF-κB activity and amplify SASP signaling.
“In the early stage of senescence, the production of interleukin IL-1α (IL-1α), which acts intracellularly or as a cell membrane-bound protein, initiates a feed-forward loop to strengthen C/EBPβ and NF-κB activity and amplify SASP signaling [153].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [153] Acosta, 2008, Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence, Cell source
Not checked in the free run.
- Premisecitation
IL-1α and IL-1 receptor maintain the upregulation of IL-6 and IL-8 that engage a positive feedback loop via amplification of C/EBPβ activation.
“In addition, IL-1α and IL-1 receptor maintain the upregulation of IL-6 and IL-8 that in turn engage a positive feedback loop via amplification of C/EBPβ activation [154,158].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [154] Kuilman, 2008, Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network, Cell source
Not checked in the free run.
- cites [158] Orjalo, 2009, Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- Premisecitation
Extrachromosomal DNA molecules released into the cytoplasm of senescent cells recruit cGAS.
“Extrachromosomal DNA molecules released into the cytoplasm of senescent cells recruit specifically the cytosolic DNA-sensor cyclic GMP–AMP synthase (cGAS).”
Quote in the paperSubstantial claim - Premisecitation
NOTCH activity in OIS enables a switch from an early pro-regenerative secretome associated with TGF-β to a late secretome rich in inflammatory factors.
“Particularly, NOTCH activity in OIS enables a switch from an early pro-regenerative secretome associated with TGF-β to a late secretome rich in inflammatory factors (i.e., inflammatory SASP) [150].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [150] Hoare, 2016, NOTCH1 mediates a switch between two distinct secretomes during senescence, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
SASP gene expression is directly regulated by the histone variant macroH2A1 that accumulates during senescence.
“SASP gene expression is also directly regulated by the histone variant macroH2A1 that accumulates during senescence [167].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [167] Zhang, 2005, Formation of MacroH2A-Containing Senescence-Associated Heterochromatin Foci and Senescence Driven by ASF1a and HIRA, Dev. Cell source
Not checked in the free run.
- Premisereasoning
CCFs are recognized by cGAS and engage cGAS-STING signaling that is critical for activation of NF-κB and the inflammatory SASP.
“Similar to micronuclei, CCFs are recognized by cGAS and engage cGAS-STING signaling that is critical for the activation of NF-κB and the inflammatory SASP.”
Quote in the paperSubstantial claim - Premisecitation
Increased aerobic glycolysis compensates for reduced ATP production caused by mitochondrial respiration decline during senescence.
“Increased aerobic glycolysis compensates for the reduced adenosine triphosphate (ATP) production caused by mitochondrial respiration decline during senescence [1,208,209,210].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [1] Yu, 2013, Synthetic lethal metabolic targeting of cellular senescence in cancer therapy, Nature source
Not checked in the free run.
- cites [208] Passos, 2012, Mitochondrial dysfunction and cell senescence—Skin deep into mammalian aging, Aging source
Not checked in the free run.
- cites [209] Kaplon, 2013, A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence, Nature source
Not checked in the free run.
- cites [210] James, 2015, Senescent Human Fibroblasts Show Increased Glycolysis and Redox Homeostasis with Extracellular Metabolomes That Overlap with Those of Irreparable DNA Damage, Aging, and Disease, J. Proteome Res. source
Not checked in the free run.
- Interpretationreasoning
Reduction in NF90 levels amplifies production of several SASP factors.
“Consequently, the reduction in NF90 levels amplifies the production of several SASP factors.”
Quote in the paperSubstantial claim - Interpretationcitation
An increase in transcription of LINE-1 during senescence could partly contribute to accumulation of DNA fragments in the cytoplasm.
“Alternatively, an increase in the transcription of long-interspersed element-1 (LINE-1 or L1), the only human retro-transposable element, during senescence could partly contribute to the accumulation of DNA fragments in the cytoplasm [177].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [177] Ito, 2019, L1 drives IFN in senescent cells and promotes age-associated inflammation, Nature source
Not checked in the free run.
- Premisecitation
Loss of cGAS and/or STING function reduces SASP factor levels in primary human cells and in mouse models of DNA damage-induced senescence.
“Consistently, loss of cGAS and/or STING function reduces SASP factor levels in primary human cells and in mouse models of DNA damage-induced senescence [171,172,173].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [171] Dou, 2017, Cytoplasmic chromatin triggers inflammation in senescence and cancer, Nature source
Not checked in the free run.
- cites [172] Guey, 2017, Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence, Nat. Cell Biol. source
Not checked in the free run.
- cites [173] Yang, 2017, cGAS is essential for cellular senescence, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- Interpretationreasoning
Accumulation of extranuclear DNA (CCFs, mitochondrial DNA, cDNA, and nuclear buds) activates cGAS-STING signaling to regulate SASP expression.
“Therefore, accumulation of extranuclear DNA (CCFs, mitochondrial DNA, cDNA, and nuclear buds) activates cGAS–STING signaling to regulate SASP expression.”
Quote in the paperSubstantial claim - Premisecitation
Senescent cells express reduced levels of NF90, an RNA-binding protein that suppresses translation of SASP factors such as MCP1, GROα, and IL-6.
“Senescent cells express reduced levels of nuclear factor (NF90), an RNA-binding protein that suppresses the translation of SASP factors, such as MCP1, GROα, and IL-6 [186].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [186] Abdelmohsen, 2012, NF90 coordinately represses the senescence-associated secretory phenotype, Aging source
Not checked in the free run.
- Premisecitation
L1 activation results in cDNA accumulation in the cytoplasm that reinforces cGAS signaling activation to produce the SASP response in senescent cells and chronic inflammation in aged mice.
“As L1 displays high reverse transcriptase activity, its activation results in cDNA accumulation in the cytoplasm that reinforces cGAS signaling activation to produce the SASP response in senescent cells and chronic inflammation in aged mice [177,178].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationcitation
In non-dividing fully senescent cells, chromatin protrusions or nuclear budding from the primary nucleus might be the major route to form CCFs, as a consequence of lamin B1 downregulation that causes collapse of the nuclear envelope.
“In non-dividing fully senescent cells, chromatin protrusions or nuclear budding from the primary nucleus might be the major route to form cytoplasmic chromatin fragments (CCFs), as a consequence of nuclear lamin B1 downregulation that causes the collapse of the nuclear envelope [105].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [105] Ivanov, 2013, Lysosome-mediated processing of chromatin in senescence, J. Cell Biol. source
Not checked in the free run.
- Premisecitation
Post-transcriptional regulatory pathways contribute to control senescence through the action of RBPs and noncoding RNAs, particularly specific miRNAs.
“Post-transcriptional regulatory pathways also contribute to control senescence through the action of mRNA-binding proteins (RBPs) and noncoding RNAs, particularly specific microRNAs (miRNAs), the levels of which help to mediate the senescence state [179,180].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
RBPs such as HuR, AUF1, and TTP can directly or indirectly control the turnover and translation of mRNAs that encode senescence proteins.
“RBPs, such as human antigen R (HuR), AU-binding factor 1 (AUF1), and tristetraprolin (TTP), can directly or indirectly control the turnover and translation of mRNAs that encode senescence proteins [181,182,183].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [181] Abdelmohsen, 2008, miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [182] Bartel, 2009, MicroRNAs: Target Recognition and Regulatory Functions, Cell source
Not checked in the free run.
- cites [183] Sanduja, 2009, The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase, Aging source
Not checked in the free run.
- Premisecitation
p16 mRNA stability is reduced by the RBPs hnRNP A1, hnRNP A2, and AUF1.
“For example, p16 mRNA stability is reduced by the RBPs hnRNP A1, hnRNP A2, and AUF1 [184,185].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [184] Zhu, 2002, Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: Implications for cellular senescence, J. Cell. Physiol. source
Not checked in the free run.
- cites [185] Wang, 2005, Increased stability of the p16 mRNA with replicative senescence, EMBO Rep. source
Not checked in the free run.
- Premisecitation
In the early stage of senescence, mitochondria display impaired oxidative phosphorylation capacity and reduced inner membrane potential, resulting in ROS overproduction.
“In the early stage of senescence, mitochondria do not function properly and display impaired oxidative phosphorylation capacity and reduced inner membrane potential, resulting in ROS overproduction [120,121,208,211].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [120] Lee, 1999, Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species, J. Biol. Chem. source
Not checked in the free run.
- cites [121] Moiseeva, 2009, Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence, Mol. Cell. Biol. source
Not checked in the free run.
- cites [208] Passos, 2012, Mitochondrial dysfunction and cell senescence—Skin deep into mammalian aging, Aging source
Not checked in the free run.
- cites [211] Lu, 2009, Free radicals and senescence, Exp. Cell Res. source
Not checked in the free run.
- Premisecitation
Cytoplasmic mitochondrial DNA derived from dysfunctional mitochondria can be sensed by the cGAS-STING pathway.
“Lastly, cytoplasmic mitochondrial DNA derived from dysfunctional mitochondria also can be sensed by the cGAS–STING pathway [142].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] Vizioli, 2020, Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence, Genes Dev. source
Not checked in the free run.
- Premisecitation
Removal of mitochondria in senescent cells disrupts the feedforward cycle involving ROS production and persistent DDR activation, while preserving cell cycle arrest.
“Removal of mitochondria in senescent cells disrupts the feedforward cycle that involves ROS production and persistent DDR activation, while preserving their cell cycle arrest [215].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [215] Marques, 2016, Mitochondria are required for pro-ageing features of the senescent phenotype, EMBO J. source
Not checked in the free run.
- Premisecitation
AMPK signaling is induced by a reduced cytosolic NAD+/NADH ratio as a result of mitochondrial defects.
“AMPK signaling is also induced by the reduced cytosolic NAD+/NADH ratio as a result of mitochondrial defects [225].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [225] Wiley, 2016, Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype, Cell Metab. source
Not checked in the free run.
- Premisecitation
Chemotherapy-resistant senescent cells can engulf neighboring normal and tumor cells by phagocytosis for survival advantage.
“Although still poorly understood, chemotherapy-resistant senescent cells can engulf neighboring normal and tumor cells by phagocytosis for survival advantage [229].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [229] Frey, 2019, Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival, J. Cell Biol. source
Not checked in the free run.
- Premisecitation
Senescent cells display ER expansion and biogenesis to adapt their capacity to the high amount of synthesis, maturation, and secretion of factors involved in the SASP.
“Senescent cells also display ER expansion and biogenesis to adapt their capacity to the high amount of synthesis, maturation, and secretion of factors involved in the SASP [1,78,236,237].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [1] Yu, 2013, Synthetic lethal metabolic targeting of cellular senescence in cancer therapy, Nature source
Not checked in the free run.
- cites [78] Denoyelle, 2006, Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway, Nat. Cell Biol. source
Not checked in the free run.
- cites [236] Zhu, 2014, The Nuclear Receptor Peroxisome Proliferator-activated Receptor-β/δ (PPARβ/δ) Promotes Oncogene-induced Cellular Senescence through Repression of Endoplasmic Reticulum Stress, J. Biol. Chem. source
Not checked in the free run.
- cites [237] Matos, 2015, ER Stress Response in Human Cellular Models of Senescence, J. Gerontol. Ser. A Boil. Sci. Med. Sci.
Not checked in the free run.
- Premisecitation
Senescent cells display characteristic morphological alterations, including flattened, enlarged cell shape and an increase in focal adhesions due to CDK5-dependent activation of ezrin.
“Senescent cells display characteristic morphological alterations, including flattened, enlarged cell shape and an increase in focal adhesions due to CDK5-dependent activation of the cytoskeleton protein ezrin [230].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [230] Yang, 2003, Increased Ezrin Expression and Activation by CDK5 Coincident with Acquisition of the Senescent Phenotype, Mol. Cell source
Not checked in the free run.
- Premisecitation
A metabolic shift from glycolysis towards mitochondrial oxidative respiration through activation of mitochondrial pyruvate dehydrogenase is required to establish and stabilize OIS-associated cell growth arrest.
“Accordingly, a metabolic shift from glycolysis towards mitochondrial oxidative respiration through activation of mitochondrial pyruvate dehydrogenase is required to establish and stabilize the OIS-associated cell growth arrest [209].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [209] Kaplon, 2013, A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence, Nature source
Not checked in the free run.
- Premisecitation
MAPKAPK2 phosphorylates ZFP36L1, preventing its binding to and ability to degrade SASP RNAs.
“MAPKAPK2 phosphorylates the RNA-binding protein ZFP36L1, thus preventing its binding to and its ability to degrade SASP RNAs [162].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [162] Herranz, 2015, mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype, Nat. Cell Biol. source
Not checked in the free run.
- Premisenone given
Lipofuscin are lysosomal aggregates of non-degradable oxidized protein, lipid, and metal that accumulate in senescent cells.
“Lipofuscin are lysosomal aggregates of non-degradable oxidized protein, lipid, and metal that also accumulate in senescent cells.”
Quote in the paperNot a substantial claim - Premisereasoning
Chronic AMPK activation promotes senescence via multiple mechanisms.
“Additionally, chronic AMPK activation promotes senescence via multiple mechanisms.”
Quote in the paperNot a substantial claim - Premisecitation
In fully senescent cells, RB stimulates mitochondrial oxidative phosphorylation.
“In fully senescent cells, RB also stimulates mitochondrial oxidative phosphorylation [227].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [227] Takebayashi, 2015, Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene-induced senescent cells, Aging Cell source
Not checked in the free run.
- Premisecitation
Growth arrest due to these mitochondrial perturbations was rescued by exogenous supply of electron acceptors pyruvate and potassium ferricyanide that artificially restore NAD+ levels.
“Growth arrest due to these mitochondrial perturbations was rescued by the exogenous supply of the electron acceptors pyruvate and potassium ferricyanide that artificially restore NAD+ levels.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [225] Wiley, 2016, Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype, Cell Metab. source
Not checked in the free run.
- Premisecitation
An increase in mTORC1 activity is essential for implementing the SASP by modulating translation of IL-1α and MAPKAPK2.
“The increase in mTORC1 activity is essential for implementing the SASP by modulating the translation of IL-1α and MAP kinase-activated protein kinase 2 (MAPKAPK2) [162,163].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [162] Herranz, 2015, mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype, Nat. Cell Biol. source
Not checked in the free run.
- cites [163] Laberge, 2015, MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation, Nat. Cell Biol. source
Not checked in the free run.
- Interpretationreasoning
Imbalanced NAD+/NADH levels are a stress signal secondary to mitochondrial dysfunction.
“This identifies imbalanced NAD+/NADH levels as a stress signal secondary to mitochondrial dysfunction.”
Quote in the paperSubstantial claim - Premisecitation
Senescent cells are characterized by an expanded lysosomal compartment and vacuoles.
“Senescent cells are characterized by an expanded lysosomal compartment and vacuoles [231].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [231] Kurz, 2000, Senescence-Associated β-Galactosidase Reflects an Increase in Lysosomal Mass during Replicative Ageing of Human Endothelial Cells, J. Cell Sci. source
Not checked in the free run.
- Premisecitation
AMPK regulates cell cycle arrest and senescence by activating p53 that upregulates p21 transcription.
“Indeed, AMPK regulates cell cycle arrest and senescence by activating p53 that upregulates p21 transcription [223].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [223] Jones, 2005, AMP-Activated Protein Kinase Induces a p53-Dependent Metabolic Checkpoint, Mol. Cell source
Not checked in the free run.
- Premisecitation
CCFs formation is required to reinforce OIS by initiating the SASP program.
“Therefore, CCFs formation relies on the constitutive interaction between lamin B1 and LC3, and CCFs formation is required to reinforce OIS by initiating the SASP program [171,172].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
GATA4 initiates synthesis of SASP factors via NF-κB activation, partly mediated by IL-1α production.
“Then, GATA4 initiates the synthesis of SASP factors via NF-κB activation, partly mediated by IL-1 α production [160].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Kang, 2015, The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4, Science source
Not checked in the free run.
- Premisecitation
CCFs formation relies on constitutive interaction between lamin B1 and LC3.
“Therefore, CCFs formation relies on the constitutive interaction between lamin B1 and LC3, and CCFs formation is required to reinforce OIS by initiating the SASP program [171,172].”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Overall, autophagy can both promote and inhibit senescence in different contexts because it modulates several effectors with opposite functions in senescence regulation.
“Overall, autophagy can both promote and inhibit senescence in different contexts because it modulates several effectors with opposite functions in senescence regulation.”
Quote in the paperSubstantial claim - Premisecitation
Autophagy is required for execution of the senescence program because its inhibition delays senescence-related cell cycle arrest and SASP factor accumulation, at least in OIS.
“Autophagy is also required for the execution of the senescence program because its inhibition delays the senescence-related cell cycle arrest and SASP factor accumulation, at least in OIS [244].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [244] Young, 2009, Autophagy mediates the mitotic senescence transition, Genes Dev. source
Not checked in the free run.
- Premisecitation
Upon oncogene activation, lamin B1 and LC3 interact with lamina-associated domains and are extruded through nuclear blebbing into cytoplasm, forming CCFs that are degraded by cytoplasmic autophagy.
“Conversely, upon oncogene activation, lamin B1 and LC3 interact with lamina-associated domains (i.e., transcriptionally inactive heterochromatin) and are extruded through nuclear blebbing into the cytoplasm, forming CCFs that are then degraded by cytoplasmic autophagy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [247] Dou, 2015, Autophagy mediates degradation of nuclear lamina, Nature source
Not checked in the free run.
- Premisecitation
Upon irradiation or oncogene hyperactivation, ATM and ATR activation suppresses selective autophagy by promoting GATA4 dissociation from SQSTM1/p62, resulting in GATA4 stabilization.
“Conversely, upon irradiation or oncogene hyperactivation, activation of ATM and ATR suppresses selective autophagy by promoting GATA4 dissociation from SQSTM1/p62, resulting in GATA4 stabilization.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [160] Kang, 2015, The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4, Science source
Not checked in the free run.
- Premisecitation
The simultaneous activation of mTOR and autophagy in oncogenic Ras-induced senescence is possible through spatiotemporal sub-compartmentalization of mTOR and autophagy.
“This paradoxical outcome is possible through the spatiotemporal sub-compartmentalization of mTOR and autophagy that allows their simultaneous activation [246].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [246] Narita, 2011, Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes, Science source
Not checked in the free run.
- Premisecitation
Autophagy is activated at a later stage than DDR signaling to sustain bioenergetic needs and supply metabolites for SASP factor synthesis.
“Functionally, autophagy is activated at a later stage than DDR signaling to sustain the bioenergetic needs and to supply metabolites for SASP factor synthesis [245].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [245] Vanzo, 2020, Autophagy role(s) in response to oncogenes and DNA replication stress, Cell Death Differ. source
Not checked in the free run.
- Premisecitation
Lipidated LC3B interacts with lamin B1 at the nuclear lamina.
“The lipidated form of the autophagic protein LC3B, which is involved in autophagy, membrane trafficking, and substrate delivery [248], interacts with lamin B1 at the nuclear lamina.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [248] Rogov, 2014, Interactions between Autophagy Receptors and Ubiquitin-like Proteins Form the Molecular Basis for Selective Autophagy, Mol. Cell source
Not checked in the free run.
- Premisecitation
In the TASCC, mTOR is closely associated with lysosomes/autolysosomes that generate a high flux of recycled amino acids and other metabolites.
“In the TASCC, mTOR is closely associated with lysosomes/autolysosomes that generate a high flux of recycled amino acids and other metabolites.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [246] Narita, 2011, Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes, Science source
Not checked in the free run.
- Premisecitation
Selective autophagy of GATA4, which accumulates during senescence induction, can prevent senescence.
“Conversely, selective autophagy, for instance of GATA4 that accumulates during senescence induction [160], can prevent senescence [160,246].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Autophagy inhibition maintains nuclear envelope integrity in senescent cells by suppressing lamin B1 degradation and CCFs formation.
“Importantly, autophagy inhibition maintains the nuclear envelope integrity in senescent cells by suppressing lamin B1 degradation and CCFs formation [247].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [247] Dou, 2015, Autophagy mediates degradation of nuclear lamina, Nature source
Not checked in the free run.
- Interpretationnone given
Under basal conditions, the interaction between LC3B and lamin B1 does not result in lamin B1 degradation by autophagy.
“However, this interaction, does not result in lamin B1 degradation by autophagy under basal conditions.”
Quote in the paperSubstantial claim - Premisereasoning
In OIS, increased ROS production caused by ER stress leads to DNA damage that activates ATM.
“For example, in OIS, the increased ROS production caused by ER stress leads to DNA damage that activates ATM.”
Quote in the paperNot a substantial claim - Premisecitation
CCFs clearance by autophagy represses senescence by preventing CCFs-induced cGAS/STING activation and SASP production.
“Accordingly, CCFs clearance by autophagy represses senescence by preventing CCFs-induced cGAS/STING activation and SASP production [249].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [249] Han, 2020, Autolysosomal degradation of cytosolic chromatin fragments antagonizes oxidative stress–induced senescence, J. Biol. Chem. source
Not checked in the free run.
- Interpretationreasoning
General autophagy can promote senescence through the TASCC.
“Senescence can be promoted by general autophagy through the TASCC.”
Quote in the paperSubstantial claim - Premisecitation
Recycled amino acids are used by mTOR to support increased biosynthetic demand during acquisition of the OIS phenotype.
“These amino acids are then used by mTOR to support the increased biosynthetic demand during the acquisition of the OIS phenotype [246].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [246] Narita, 2011, Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes, Science source
Not checked in the free run.
- Interpretationreasoning
Autophagy might be a protective pathway against micronucleus formation and CCFs accumulation.
“Therefore, autophagy might be a protective pathway against micronucleus formation and CCFs accumulation.”
Quote in the paperSubstantial claim - Premisecitation
Cells that could not become senescent due to p53 deletion were not targeted by macrophages.
“Conversely, cells that could not become senescent due to p53 deletion were not targeted by macrophages [266].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [266] Lujambio, 2013, Non-Cell-Autonomous Tumor Suppression by p53, Cell source
Not checked in the free run.
- Interpretationreasoning
If senescent cells are not efficiently eliminated by the immune system, their pro-survival phenotype promotes their persistence within tissues.
“Therefore, if senescent cells are not efficiently eliminated by the immune system, their pro-survival phenotype promotes their persistence within tissues.”
Quote in the paperSubstantial claim - Premisecitation
Senescent cells can be cleared by the immune system rather than directly through apoptosis.
“Senescent cells can be cleared by the immune system [27,263,264] rather than directly through apoptosis.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [27] Maraver, 2013, Programmed Cell Senescence during Mammalian Embryonic Development, Cell source
Not checked in the free run.
- cites [263] Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature source
Not checked in the free run.
- cites [264] Yun, 2015, Recurrent turnover of senescent cells during regeneration of a complex structure, eLife source
Not checked in the free run.
- Premisecitation
The switch from transient to irreversible growth arrest involves positive feedback loops in which mitochondrial dysfunction via ROS, pro-inflammatory SASP factors, extensive chromatin remodeling, and/or nuclear lamina and chromatin degradation reinforce DDR signaling.
“The switch from transient to irreversible growth arrest involves positive feedback loops in which mitochondrial dysfunction via ROS [215,250], pro-inflammatory SASP factors [147,154,252], extensive chromatin remodeling [253], and/or nuclear lamina and chromatin degradation [105,171,247] reinforce DDR signaling (Figure 3).”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [215] Marques, 2016, Mitochondria are required for pro-ageing features of the senescent phenotype, EMBO J. source
Not checked in the free run.
- cites [250] Passos, 2010, Feedback between p21 and reactive oxygen production is necessary for cell senescence, Mol. Syst. Biol. source
Not checked in the free run.
- cites [147] Coppé, J.-P., Patil, C.K., Rodier, F., Sun, Y., Muñoz, D.P., Goldstein, J.N., Nelson, P.S., Desprez, P.-Y., and Campisi, J. (2008). Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor. PLoS Biol., 6. source
Not checked in the free run.
- cites [154] Kuilman, 2008, Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network, Cell source
Not checked in the free run.
- cites [252] Acosta, 2013, A complex secretory program orchestrated by the inflammasome controls paracrine senescence, Nat. Cell Biol. source
Not checked in the free run.
- cites [253] Narita, 2003, Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence, Cell source
Not checked in the free run.
- Premisecitation
Autophagy inhibition leads to toxic cell waste accumulation and elevated ROS levels that can induce senescence.
“On the other hand, autophagy inhibition leads to toxic cell waste accumulation and elevated ROS levels that can induce senescence [261].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [261] Tai, 2017, Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence, Autophagy source
Not checked in the free run.
- Premisecitation
Escalating ROS production by dysfunctional mitochondria aggravates nuclear DNA damage and stabilizes chronic DDR activation, contributing to maintenance of the pro-inflammatory and pro-oxidant senescent phenotype upon DNA damage.
“The escalating ROS production by dysfunctional mitochondria aggravates nuclear DNA damage and stabilizes the chronic DDR activation, contributing to the maintenance of the pro-inflammatory and pro-oxidant senescent phenotype upon DNA damage [215,250].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [215] Marques, 2016, Mitochondria are required for pro-ageing features of the senescent phenotype, EMBO J. source
Not checked in the free run.
- cites [250] Passos, 2010, Feedback between p21 and reactive oxygen production is necessary for cell senescence, Mol. Syst. Biol. source
Not checked in the free run.
- Premisecitation
Increased autophagic flux promotes senescent cell survival by facilitating degradation of damaged proteins and dysfunctional organelles.
“In addition, increased autophagic flux promotes senescent cell survival by facilitating the degradation of damaged proteins and dysfunctional organelles [260].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [260] Filomeni, 2015, Oxidative stress and autophagy: The clash between damage and metabolic needs, Cell Death Differ. source
Not checked in the free run.
- Premisecitation
Senescent cells formed following tissue damage can promote their own clearance by secreting chemo-attractants that recruit and activate immune cells.
“Indeed, senescent cells formed following tissue damage can promote their own clearance by secreting chemo-attractants that recruit and activate immune cells [265].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [265] Hoenicke, 2012, Immune surveillance of senescent cells—Biological significance in cancer- and non-cancer pathologies, Carcinogenesis source
Not checked in the free run.
- Premisecitation
Inhibition of anti-apoptotic BCL2, BCL-W, and BCL-XL proteins induces apoptosis of senescent cells and their elimination in mice.
“For example, inhibition of the anti-apoptotic BCL2, BCL-W, and BCL-XL proteins induces apoptosis of senescent cells and their elimination in mice [3,14].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [3] Zhu, 2015, The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs, Aging Cell source
Not checked in the free run.
- cites [14] Chang, 2016, Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat. Med. source
Not checked in the free run.
- Premisecitation
SAHF formation promotes cell survival by protecting senescent cells against excessive DNA damage signaling during oncogenic stress.
“Senescence-associated heterochromatic focus (SAHF) formation (discussed below) also promotes cell survival by protecting senescent cells against excessive DNA damage signaling during oncogenic stress [259].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [259] Sulli, 2011, Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Senescent cells do not undergo apoptosis despite high and irreparable levels of DNA damage.
“Senescent cells do not undergo apoptosis [143] despite the presence of high and irreparable levels of DNA damage.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [143] Wang, 1995, Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved, Cancer Res.
Not checked in the free run.
- Premisecitation
Senescent cells rely on upregulation of pro-survival pathways, such as BCL-2 and Ephrins, that actively inhibit apoptosis.
“For this, senescent cells rely on the upregulation of pro-survival pathways (e.g., BCL-2 and Ephrins) that actively inhibit apoptosis [3,14,15].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [3] Zhu, 2015, The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs, Aging Cell source
Not checked in the free run.
- cites [14] Chang, 2016, Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat. Med. source
Not checked in the free run.
- cites [15] Yosef, 2016, Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL, Nat. Commun. source
Not checked in the free run.
- Interpretationreasoning
Autocrine loops lock the cell into the senescence phenotype.
“Overall, these autocrine loops lock the cell into the senescence phenotype.”
Quote in the paperSubstantial claim - Premisecitation
Some SASP factors that strongly accumulate in secreting senescent cells reinforce senescence signaling in an autocrine fashion.
“In turn, some SASP factors that strongly accumulate in the secreting senescent cells reinforce the senescence signaling in an autocrine fashion [154,252].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [154] Kuilman, 2008, Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network, Cell source
Not checked in the free run.
- cites [252] Acosta, 2013, A complex secretory program orchestrated by the inflammasome controls paracrine senescence, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
IL-8 and other CXCR2 ligands strengthen growth arrest in senescent cells by activating a self-amplifying secretory loop through boosting DDR signaling.
“Specifically, the chemokine IL-8 and other chemokine receptor 2 (CXCR2) ligands strengthen growth arrest in senescent cells by activating a self-amplifying secretory loop through their ability to boost DDR signaling.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [153] Acosta, 2008, Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence, Cell source
Not checked in the free run.
- Premisecitation
Selective and specific removal of mitochondria in senescent cells normalizes ROS levels.
“Indeed, the selective and specific removal of mitochondria in senescent cells normalizes ROS levels [215].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [215] Marques, 2016, Mitochondria are required for pro-ageing features of the senescent phenotype, EMBO J. source
Not checked in the free run.
- Premisecitation
In response to senescence-inducing stimuli, senescent cells produce type I interferons in a cGAS-dependent manner that have pro-senescence and anti-proliferative activities.
“In response to senesce-inducing stimuli, senescent cells produce, in a cGAS-dependent manner, type I interferons that have pro-senescence and anti-proliferative activities.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [273] Takaoka, 2003, Integration of Interferon-a/b Signalling to P53 Responses in Tumour Suppression and Antiviral Defence, Nature source
Not checked in the free run.
- cites [274] Moiseeva, 2006, DNA Damage Signaling and P53-Dependent Senescence after Prolonged b-Interferon Stimulation, Mol. Biol. Cell source
Not checked in the free run.
- Premisecitation
Senescence is accompanied by global changes in chromatin structure with formation of compact heterochromatic regions known as SAHF.
“Senescence is accompanied by global changes in the chromatin structure with the formation of compact heterochromatic regions, known as SAHF.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [253] Narita, 2003, Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence, Cell source
Not checked in the free run.
- cites [276] Zhang, 2007, Molecular Dissection of Formation of Senescence-Associated Heterochromatin Foci, Mol. Cell. Biol. source
Not checked in the free run.
- Premisecitation
SAHF are enriched in repressive chromatin marks H3K9me3 and HP1.
“They are enriched in repressive chromatin marks, such as trimethylation of lysine 9 on histone H3 (H3K9me3) and heterochromatin protein 1 (HP1) [253,276].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [253] Narita, 2003, Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence, Cell source
Not checked in the free run.
- cites [276] Zhang, 2007, Molecular Dissection of Formation of Senescence-Associated Heterochromatin Foci, Mol. Cell. Biol. source
Not checked in the free run.
- Premisecitation
SASP factor production requires continuous DNA damage signaling.
“SASP factor production requires continuous DNA damage signaling [148].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [148] Rodier, 2009, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Senescent cells undergo extensive epigenome and chromatin organization changes that contribute to persistent proliferative arrest and progression to full senescence.
“Senescent cells undergo extensive epigenome and chromatin organization changes that contribute to the persistent proliferative arrest and progression to full senescence (Figure 2).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [133] Melov, 2017, Unmasking Transcriptional Heterogeneity in Senescent Cells, Curr. Biol. source
Not checked in the free run.
- cites [136] Shelton, 1999, Microarray analysis of replicative senescence, Curr. Biol. source
Not checked in the free run.
- cites [275] Shah, 2013, Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape, Genes Dev. source
Not checked in the free run.
- Premisecitation
Downstream of DDR effectors, p16-PKC delta and p21-p38MAPK-TGF-β signaling contribute to ROS production.
“Downstream of DDR effectors, p16-Protein Kinase C delta (PKC delta) and p21-p38MAPK-TGF-β signaling also contribute to ROS production [250,268].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [250] Passos, 2010, Feedback between p21 and reactive oxygen production is necessary for cell senescence, Mol. Syst. Biol. source
Not checked in the free run.
- cites [268] Takahashi, 2006, Mitogenic signalling and the p16INK4a–Rb pathway cooperate to enforce irreversible cellular senescence, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Cell surface-bound IL-1α and its receptors can sustain senescence by maintaining high IL-6 and IL-8 secretion.
“Moreover, cell surface-bound IL-1 α and its receptors can sustain senescence by maintaining the high IL-6 and IL-8 secretion [158].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [158] Orjalo, 2009, Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- Premisecitation
Mitochondrial dysfunction is the main cause of elevated ROS production in senescence.
“Mitochondrial dysfunction is the main cause of elevated ROS production in senescence.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [215] Marques, 2016, Mitochondria are required for pro-ageing features of the senescent phenotype, EMBO J. source
Not checked in the free run.
- Premisecitation
Short telomeres and a sharp increase in genome instability are observed in early stages of breast cancer before telomerase activation and genome stabilization.
“Short telomeres and a sharp increase in genome instability are observed in the early stages of breast cancer before telomerase activation and genome stabilization [353].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [353] Chin, 2004, In situ analyses of genome instability in breast cancer, Nat. Genet. source
Not checked in the free run.
- Premisecitation
Studies on telomere dynamics and karyotype analysis in many human tumor types revealed telomeric fusions indicative of telomere crisis.
“studies on telomere dynamics and karyotype analysis in many human tumor types revealed telomeric fusions, indicative of telomere crisis [347,352,354,355].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [347] Roger, 2013, Extensive Telomere Erosion in the Initiation of Colorectal Adenomas and Its Association with Chromosomal Instability, JNCI J. Natl. Cancer Inst. source
Not checked in the free run.
- cites [352] Jones, 2014, Escape from Telomere-Driven Crisis Is DNA Ligase III Dependent, Cell Rep. source
Not checked in the free run.
- cites [354] Lin, 2010, Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: Evidence for a telomere crisis, Blood source
Not checked in the free run.
- cites [355] Tanaka, 2012, Telomere fusions in early human breast carcinoma, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- Premisecitation
Heterochromatin incorporated into SAHF results from redistribution of pre-existing repressive heterochromatin marks rather than newly formed heterochromatin on genomic regions.
“Heterochromatin incorporated into SAHF results from the redistribution of pre-existing repressive heterochromatin marks rather than newly formed heterochromatin on genomic regions [167,253,278,279].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [167] Zhang, 2005, Formation of MacroH2A-Containing Senescence-Associated Heterochromatin Foci and Senescence Driven by ASF1a and HIRA, Dev. Cell source
Not checked in the free run.
- cites [253] Narita, 2003, Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence, Cell source
Not checked in the free run.
- cites [278] Chandra, 2012, Independence of Repressive Histone Marks and Chromatin Compaction during Senescent Heterochromatic Layer Formation, Mol. Cell source
Not checked in the free run.
- cites [279] Sadaie, 2013, Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence, Genes Dev. source
Not checked in the free run.
- Premisecitation
SAHF formation is not a universal feature of senescence.
“However, SAHF formation is not a universal feature of senescence.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [52] Bartkova, 2011, Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16 ink4a, Cell Cycle source
Not checked in the free run.
- cites [259] Sulli, 2011, Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer, Nat. Cell Biol. source
Not checked in the free run.
- Premisenone given
Almost all cancer cells show defects in senescence-controlling signaling pathways downstream of telomere erosion (p53 and RB) that allow proliferation to telomere crisis.
“Almost all cancer cells show defects in senescence-controlling signaling pathways downstream of telomere erosion (i.e., the p53 and RB pathways) that allow them to proliferate to the point of telomere crisis.”
Quote in the paperSubstantial claim - Premisecitation
Too short telomeres can induce senescence.
“and too short telomeres can induce senescence.”
Quote in the paperSubstantial claim - Premisecitation
Fused chromosomes can initiate bridge-breakage-fusion cycles, causing more chromosome rearrangements and genomic instability that promote mitotic crisis.
“These fused chromosomes can initiate bridge–breakage–fusion cycles, causing more chromosome rearrangements and genomic instability that promote mitotic crisis [349,350].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisenone given
Under some conditions, senescence acts as a potent tumor-suppressive barrier by blocking the proliferation of damaged cells.
“Under some conditions, it represents a potent tumor-suppressive barrier by blocking the proliferation of damaged cells.”
Quote in the paperSubstantial claim - Interpretationnone given
Cellular senescence plays important but contrasting roles in different steps of tumorigenesis, including tumor initiation, establishment, and escape.
“Cellular senescence plays important but contrasting roles in different steps of tumorigenesis, such as tumor initiation, establishment, and escape.”
Quote in the paperSubstantial claim - Premisecitation
Unlimited proliferation is the main means of acquiring oncogenic mutations and fixing successive genomic alterations that drive clonal expansion and cancer progression.
“Unlimited proliferation is the main means of acquiring oncogenic mutations and fixing the successive genomic alterations that drive clonal expansion and cancer progression [345].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [345] Artandi, 2010, Telomeres and telomerase in cancer, Carcinogenesis source
Not checked in the free run.
- Interpretationreasoning
The proliferative arrest of preneoplastic cells is a protective barrier because cancer cells must replicate to produce a macroscopic tumor.
“The proliferative arrest of preneoplastic cells represents a protective barrier because cancer cells must replicate to produce a macroscopic tumor.”
Quote in the paperSubstantial claim- Rests on an assumption: Cancer cells must replicate to produce a macroscopic tumor.
- Premisecitation
SAHF formation is strongly correlated with loss of lamin B1 that allows redistribution and relocation of repressive histone marks from the nuclear periphery into SAHF.
“SAHF formation is strongly correlated with the loss of lamin B1 [279,280,281] that allows the redistribution and relocation of repressive histone marks from the nuclear periphery into SAHF.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [279] Sadaie, 2013, Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence, Genes Dev. source
Not checked in the free run.
- cites [280] Shimi, 2011, The role of nuclear lamin B1 in cell proliferation and senescence, Genes Dev. source
Not checked in the free run.
- cites [281] Freund, 2012, Lamin B1 loss is a senescence-associated biomarker, Mol. Biol. Cell source
Not checked in the free run.
- Premisecitation
Critically shortened telomeres are frequently observed in early neoplastic lesions.
“Critically shortened telomeres are frequently observed in early neoplastic lesions [86,346,347]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [86] 2005, Shelterin: The protein complex that shapes and safeguards human telomeres, Genes Dev. source
Not checked in the free run.
- cites [346] Meeker, 2004, Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis, Clin. Cancer Res. source
Not checked in the free run.
- cites [347] Roger, 2013, Extensive Telomere Erosion in the Initiation of Colorectal Adenomas and Its Association with Chromosomal Instability, JNCI J. Natl. Cancer Inst. source
Not checked in the free run.
- Premisecitation
Loss of lamin B1 is not sufficient for SAHF formation.
“However, it is not sufficient for SAHF formation [279].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [279] Sadaie, 2013, Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence, Genes Dev. source
Not checked in the free run.
- Premisenone given
The senescence program can be activated in normal, pre-neoplastic, and malignant cells in response to a wide variety of stimuli.
“The senescence program can be activated in normal, pre-neoplastic, and malignant cells in response to a wide variety of stimuli.”
Quote in the paperSubstantial claim - Premisecitation
Many SASP factors exert tumor-suppressive activities through autocrine and paracrine signaling cascades that enforce senescence cell cycle exit and transmit senescence to neighboring cell types.
“Many SASP factors exert tumor-suppressive activities through autocrine and paracrine signaling cascades that enforce senescence cell cycle exit and transmit senescence to different neighboring cell types [153,154,263,271,272,358].”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [153] Acosta, 2008, Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence, Cell source
Not checked in the free run.
- cites [154] Kuilman, 2008, Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network, Cell source
Not checked in the free run.
- cites [263] Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature source
Not checked in the free run.
- cites [271] Wajapeyee, 2008, Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7, Cell source
Not checked in the free run.
- cites [272] Kortlever, 2006, Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence, Nat. Cell Biol. source
Not checked in the free run.
- cites [358] Xue, 2007, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature source
Not checked in the free run.
- Premisecitation
Secretion of cytokines by pre-malignant hepatocytes undergoing senescence upon oncogenic Ras expression resulted in their clearance mediated by CD4+ T cells.
“secretion of cytokines by pre-malignant hepatocytes undergoing senescence upon oncogenic Ras expression resulted in their clearance mediated by CD4+T cells [263].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [263] Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature source
Not checked in the free run.
- Premisecitation
In mouse models, restoration of senescence in growing tumors causes their regression.
“In mouse models, inactivating the senescence machinery results in the acceleration of tumor development, while restoration of senescence in growing tumors causes their regression consistent with the role of senescence in suppressing cancer [266,358].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
In a mouse model of hepatocellular carcinoma, cancer development is kept under control by immune system capacity to specifically identify and eliminate senescent pre-malignant cells.
“In a mouse model of hepatocellular carcinoma, cancer development is kept under control by the immune system capacity to specifically identify and eliminate senescent pre-malignant cells.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [263] Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature source
Not checked in the free run.
- Premisecitation
DDR activation and senescence, presumably owing to unscheduled DNA replication, are frequently observed in early stages of cancer lesions.
“DDR activation and senescence, presumably owing to unscheduled DNA replication, are frequently observed in the early stages of cancer lesions, [69,70,356,357].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [69] Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature source
Not checked in the free run.
- cites [70] Fumagalli, 2006, Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication, Nature source
Not checked in the free run.
- cites [356] Bartkova, 2005, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis, Nature source
Not checked in the free run.
- cites [357] Gorgoulis, 2005, Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions, Nature source
Not checked in the free run.
- Interpretationnone given
Replication stress induced by some oncogenes is a second stringent tumor suppressive mechanism in which persistent DDR signal could cause senescence.
“Replication stress induced by some oncogenes is a second stringent tumor suppressive mechanism in which the persistent DDR signal could cause senescence.”
Quote in the paperSubstantial claim - Premisenone given
Senescent cells communicate with and influence neighboring cells partly through SASP factors.
“Senescent cells communicate with and influence the behavior of neighboring cells, partly through SASP factors.”
Quote in the paperSubstantial claim - Premisecitation
SASP effects are beneficial or detrimental depending on the cell type, senescence stimulus, and neighboring environment.
“SASP effects are beneficial or detrimental depending on the cell type, senescence stimulus, and the neighboring environment [24].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Campisi, 2013, Aging, Cellular Senescence, and Cancer, Annu. Rev. Physiol. source
Not checked in the free run.
- Premisecitation
The SASP can exert non-cell autonomous tumor suppression by attracting and activating immune cells to promote innate and adaptive anti-tumor immune response.
“The SASP can also exert non-cell autonomous tumor suppression by attracting and activating immune cells to actively promote the innate and adaptive anti-tumor immune response.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Malignant progression requires a period similar to telomere crisis that can result in large-scale genome rearrangements commonly seen in tumors.
“These observations indicate that malignant progression requires a period similar to the telomere crisis that can result in large-scale genome rearrangements of the kind commonly seen in tumors [349,351].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
In mouse models, inactivating the senescence machinery accelerates tumor development.
“In mouse models, inactivating the senescence machinery results in the acceleration of tumor development, while restoration of senescence in growing tumors causes their regression consistent with the role of senescence in suppressing cancer [266,358].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Senescence occurs during formation of benign cutaneous melanocytic nevi that express an oncogenic form of BRAF.
“senescence occurs during the formation of benign cutaneous melanocytic nevi that express an oncogenic form of BRAF [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Michaloglou, 2005, BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature source
Not checked in the free run.
- Premisecitation
Impaired immune clearance of pre-malignant senescent hepatocytes in severe combined immune-compromised mice promoted liver cancer development.
“impaired immune clearance of pre-malignant senescent hepatocytes in severe combined immune-compromised mice promoted liver cancer development [263].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [263] Kang, 2011, Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature source
Not checked in the free run.
- Interpretationreasoning
Paracrine signaling is central to the tumor-suppressive and tumor-promoting consequences of the senescence response.
“This paracrine signaling is central to the tumor-suppressive and tumor-promoting consequences of the senescence response.”
Quote in the paperSubstantial claim - Premisecitation
Some tumor cells can enter senescence in response to DNA damaging therapies.
“some tumor cells can enter senescence in response to DNA damaging therapies [363,364].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
The main advantage of the senescence response caused by traditional chemotherapeutic agents is that cancer cell senescence can be induced with lower doses than those used to cause cancer cell death, thus possibly reducing adverse side effects.
“The main advantage of the senescence response caused by traditional chemotherapeutic agents is that cancer cell senescence can be induced with lower doses than those used to cause cancer cell death, thus possibly reducing the adverse side effects [363,367].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Senescent stromal cells can induce epithelial-to-mesenchymal transition of neighboring cells, a major mechanism of tumor progression.
“senescent stromal cells can induce an epithelial-to-mesenchymal transition of neighboring cells, a major mechanism of tumor progression [23].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Parrinello, 2005, Stromal-epithelial interactions in aging and cancer: Senescent fibroblasts alter epithelial cell differentiation, J. Cell Sci. source
Not checked in the free run.
- Premisecitation
Conditioned medium from senescent fibroblasts promotes growth of pre-malignant and malignant breast epithelial cells, prostate epithelial cells, keratinocytes, and melanocytes but not normal cells.
“Conditioned medium from senescent fibroblasts promotes growth of pre-malignant and malignant breast epithelial cells, prostate epithelial cells, keratinocytes, and melanocytes but not normal cells [22,147].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [22] Krtolica, 2001, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [147] Coppé, J.-P., Patil, C.K., Rodier, F., Sun, Y., Muñoz, D.P., Goldstein, J.N., Nelson, P.S., Desprez, P.-Y., and Campisi, J. (2008). Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor. PLoS Biol., 6. source
Not checked in the free run.
- Premisecitation
Unlike normal cells, senescence of tumor cells can be incomplete because cell cycle exit might not be irreversible in these cells.
“unlike normal cells, senescence of tumor cells can be incomplete because cell cycle exit might not be irreversible in these cells [365].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [365] Lee, 2019, The dynamic nature of senescence in cancer, Nat. Cell Biol. source
Not checked in the free run.
- Premisecitation
Senescence markers have been detected in human breast cancer samples from patients treated with chemotherapy.
“senescence markers have been detected in human breast cancer samples from patients treated with chemotherapy [343].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [343] Sanoff, 2014, Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients with Breast Cancer, JNCI J. Natl. Cancer Inst. source
Not checked in the free run.
- Premisecitation
Senescent cell populations are generally highly heterogeneous in function of the cell type, the senescence-initiating insult, and the interactions within the microenvironment.
“Senescent cell populations are generally highly heterogeneous in function of the cell type, the senescence-initiating insult, and the interactions within the microenvironment [133,134,135].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [133] Melov, 2017, Unmasking Transcriptional Heterogeneity in Senescent Cells, Curr. Biol. source
Not checked in the free run.
- cites [134] Casella, 2019, Transcriptome signature of cellular senescence, Nucleic Acids Res. source
Not checked in the free run.
- cites [135] Wiley, 2017, Analysis of individual cells identifies cell-to-cell variability following induction of cellular senescence, Aging Cell source
Not checked in the free run.
- Premisecitation
The secretome of directly affected tumor cells or adjacent senescent stromal fibroblasts can induce paracrine senescence of nearby tumor cells.
“the secretome of directly affected tumor cells or adjacent senescent stromal fibroblasts can induce paracrine senescence of nearby tumor cells [270]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [270] Nelson, 2012, A senescent cell bystander effect: Senescence-induced senescence, Aging Cell source
Not checked in the free run.
- Interpretationreasoning
ECM remodeling through ECM-degrading proteases can relax tumor microenvironment structure, potentially promoting tumor cell motility, invasion, and metastasis.
“ECM remodeling through the activity of ECM-degrading proteases can relax the structure of the tumor microenvironment, potentially promoting tumor cell motility and invasion, and consequently metastasis formation.”
Quote in the paperSubstantial claim - Premisecitation
Peritumoral tissue senescence is associated with poor survival in patients with hepatocellular carcinoma.
“peritumoral tissue senescence has been associated with poor survival in patients with hepatocellular carcinoma [362].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [362] Eggert, 2016, Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression, Cancer Cell source
Not checked in the free run.
- Premisecitation
The secretome of directly affected tumor cells or adjacent senescent stromal fibroblasts can recruit immune cells to contribute to cancer cell removal, reinforcing the tumor suppressive role of senescent tumor cells.
“and can recruit immune cells to contribute to cancer cell removal, reinforcing the tumor suppressive role of senescent tumor cells [263,266].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The secretome of senescent tumor cells can drive tumor progression by promoting inflammation and potentially stimulating growth and invasiveness of nearby tumor cells.
“the secretome of senescent tumor cells can also drive tumor progression by promoting inflammation and potentially stimulating the growth and invasiveness of nearby tumor cells [148,154,163].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [148] Rodier, 2009, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nat. Cell Biol. source
Not checked in the free run.
- cites [154] Kuilman, 2008, Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network, Cell source
Not checked in the free run.
- cites [163] Laberge, 2015, MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation, Nat. Cell Biol. source
Not checked in the free run.
- Premisenone given
Tissue culture systems do not recapitulate the complexity found in an organism, for instance the multitude of signals from the microenvironment.
“Although tissue culture systems have been crucial for understanding cellular senescence, they do not recapitulate the complexity found in an organism, for instance the multitude of signals from the microenvironment.”
Quote in the paperSubstantial claim - Premisecitation
SASP inhibition by mTOR inhibitor rapamycin can suppress capacity of senescent fibroblasts to stimulate prostate tumor growth in mice.
“SASP inhibition by the mTOR inhibitor rapamycin can suppress the capacity of senescent fibroblasts to stimulate prostate tumor growth in mice [163].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [163] Laberge, 2015, MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation, Nat. Cell Biol. source
Not checked in the free run.
- Premisenone given
Accumulation of senescent cells during aging creates a pro-inflammatory microenvironment that promotes progressive decline in tissue function.
“accumulation of senescent cells during aging creates a pro-inflammatory microenvironment that promotes the progressive decline in tissue function.”
Quote in the paperSubstantial claim - Premisecitation
SASP factors exert tumor suppression activity by promoting recruitment and instruction of immune cells that contribute to elimination of damaged cells.
“SASP factors also exert a tumor suppression activity by promoting the recruitment and instruction of immune cells that contribute to the elimination of damaged cells [290].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [290] Prata, 2018, Senescent cell clearance by the immune system: Emerging therapeutic opportunities, Semin. Immunol. source
Not checked in the free run.
- Premisenone given
The secretome of senescent tumor cells impairs elimination of senescent tumor cells from the immune system.
“It also impairs the elimination of senescent tumor cells from the immune system.”
Quote in the paperSubstantial claim - Premisecitation
Senescent cells can arise within a tumor following anticancer treatments.
“Senescent cells can also arise within a tumor following anticancer treatments.”
Quote in the paperNot a substantial claim - Premisenone given
In vivo, the SASP of senescent hepatocytes accelerates tumor growth in mice in later stages of liver disease.
“In vivo, the SASP of senescent hepatocytes accelerates tumor growth in mice in the later stages of liver disease.”
Quote in the paperNot a substantial claim - Interpretationnone given
In senescent cells, continuous DDR signaling stimulates an inflammatory secretome that can act extrinsically to drive neoplastic progression of premalignant cells.
“in senescent cells, continuous DDR signaling stimulates an inflammatory secretome that can act extrinsically to drive neoplastic progression of premalignant cells.”
Quote in the paperSubstantial claim - Interpretationcitation
Development of a tumor cell population that escapes from senescence and restarts proliferating may contribute to cancer relapse.
“The development of a tumor cell population that escapes from senescence and restarts proliferating may contribute to cancer relapse [342].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [342] DeMaria, 2017, Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse, Cancer Discov. source
Not checked in the free run.
- May combine two claims. 114
- Classified as probably not a substantial claim. 12
May combine two claims.
PremisecitationCellular senescence entails an essentially irreversible proliferative arrest in which cells remain metabolically active and secrete pro-inflammatory and proteolytic factors as part of the senescence-associated secretory phenotype.
“Cellular senescence entails a state of an essentially irreversible proliferative arrest in which cells remain metabolically active and secrete a range of pro-inflammatory and proteolytic factors as part of the senescence-associated secretory phenotype.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [1] Yu, 2013, Synthetic lethal metabolic targeting of cellular senescence in cancer therapy, Nature source
Not checked in the free run.
- cites [2] Childs, 2014, Senescence and apoptosis: Dueling or complementary cell fates?, EMBO Rep. source
Not checked in the free run.
- cites [3] Zhu, 2015, The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs, Aging Cell source
Not checked in the free run.
- cites [7] Gorgoulis, 2019, Cellular Senescence: Defining a Path Forward, Cell source
Not checked in the free run.
May combine two claims.
Interpretationnone givenAll senescent cells must be able to survive in a nondividing state while protecting themselves from positive feedback loops linked to the constant activation of the DNA damage response.
“Despite this diversity, all senescent cells must be able to survive in a nondividing state while protecting themselves from positive feedback loops linked to the constant activation of the DNA damage response.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSenescent cells display high metabolic activities, remain viable, and actively suppress apoptosis.
“These cells display high metabolic activities [1], remain viable, and actively suppress apoptosis [2,3].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [1] Yu, 2013, Synthetic lethal metabolic targeting of cellular senescence in cancer therapy, Nature source
Not checked in the free run.
- cites [2] Childs, 2014, Senescence and apoptosis: Dueling or complementary cell fates?, EMBO Rep. source
Not checked in the free run.
- cites [3] Zhu, 2015, The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs, Aging Cell source
Not checked in the free run.
May combine two claims.
PremisecitationReplicative senescence is induced after serial propagation of normal human cells in culture and is caused by telomere erosion and the consequent increase in DNA lesions.
“It is induced after serial propagation of normal human cells in culture and is caused by telomere erosion and the consequent increase in DNA lesions [9,10,11,12].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [9] Bodnar, 1998, Extension of Life-Span by Introduction of Telomerase into Normal Human Cells, Science source
Not checked in the free run.
- cites [10] Reaper, 2003, A DNA Damage Checkpoint Response in Telomere-Initiated Senescence, Nature source
Not checked in the free run.
- cites [11] Gire, 2004, DNA damage checkpoint kinase Chk2 triggers replicative senescence, EMBO J. source
Not checked in the free run.
- cites [12] Herbig, 2004, Telomere Shortening Triggers Senescence of Human Cells through a Pathway Involving ATM, p53, and p21CIP1, but Not p16INK4a, Mol. Cell source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Premisenone givenThere are different types of senescent cells, and senescence can be induced in response to many DNA damage signals.
“There are different types of senescent cells, and senescence can be induced in response to many DNA damage signals.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationElimination of senescent cells can promote stem cell proliferation and delay the appearance of aging features.
“Importantly, elimination of senescent cells can promote stem cell proliferation and delay the appearance of aging features [13,14,15].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [13] Baker, 2016, Naturally occurring p16Ink4a-positive cells shorten healthy lifespan, Nature source
Not checked in the free run.
- cites [14] Chang, 2016, Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice, Nat. Med. source
Not checked in the free run.
- cites [15] Yosef, 2016, Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL, Nat. Commun. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAll these factors can induce DNA damage and senescence in normal and cancer cells in some contexts.
“All these factors can induce DNA damage and senescence in normal and cancer cells (in some contexts) [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] 2008, Living on a break: Cellular senescence as a DNA-damage response, Nat. Rev. Cancer source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCellular senescence is generally an irreversible proliferative arrest in damaged normal cells that have exited the cell cycle.
“Cellular senescence is generally an irreversible proliferative arrest in damaged normal cells that have exited the cell cycle.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Yu, 2013, Synthetic lethal metabolic targeting of cellular senescence in cancer therapy, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe hallmarks of cellular senescence include prolonged cell cycle arrest, transcriptional changes, acquisition of a bioactive secretome known as SASP, macromolecular damage, and deregulated metabolism.
“The hallmarks of cellular senescence include: prolonged cell cycle arrest, transcriptional changes, acquisition of a bioactive secretome, known as the senescence-associated secretory phenotype (SASP), macromolecular damage, and deregulated metabolism [7].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Gorgoulis, 2019, Cellular Senescence: Defining a Path Forward, Cell source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningSenescence escape is required for tumor progression to overt malignancy.
“Therefore, it has been proposed that senescence escape is required for tumor progression to overt malignancy [18,21].”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenSenescent cells are heterogeneous and perform various biological functions.
“Senescent cells are heterogeneous and perform various biological functions.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningIn cultured fibroblasts, p21 levels reach a peak during the final two to three passages before senescence, but p21 may not be essential for senescence because its expression does not persist in senescent cells.
“In cultured fibroblasts, p21 levels reach a peak during the final two to three passages before senescence, but it may not be essential for senescence because its expression does not persist in senescent cells.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA decrease in the activity or levels of CDK inhibitors can lead to senescence escape, and their inactivation results in senescent cell reentry into the cell cycle.
“A decrease in the activity or levels of CDK inhibitors can lead to senescence escape, and their inactivation results in senescent cell reentry into the cell cycle.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationInactivation of p21 allows human senescing fibroblasts to override senescence arrest and extends their proliferative potential, probably because in these cells CDK2 activity cannot be sufficiently reduced.
“Inactivation of p21 allows human senescing fibroblasts to override senescence arrest and extends their proliferative potential, probably because in these cells CDK2 activity cannot be sufficiently reduced [41,42].”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Premisecitationp21 inhibition in fully senescent fibroblasts leads to aberrant S phase reentry with some DNA replication, but this is not sufficient to drive these cells through a complete cell cycle.
“Conversely, p21 inhibition in fully senescent fibroblasts leads to aberrant S phase reentry with some DNA replication, but this is not sufficient to drive these cells through a complete cell cycle [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Ma, 1999, Microinjection of anti-p21 antibodies induces senescent Hs68 human fibroblasts to synthesize DNA but not to divide, Cancer Res.
Not checked in the free run.
May combine two claims.
Interpretationnone givenInhibition of the cell cycle machinery is the defining characteristic and is critical for both the establishment and maintenance of all cellular senescence phenotypes.
“Although the causes of senescence are multiple, inhibition of the cell cycle machinery is the defining characteristic and is critical for both the establishment and maintenance of all cellular senescence phenotypes.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSenescent cells are not effectively removed in aging tissues, which might reflect the age-related decline in immune functions.
“However, senescent cells are not effectively removed in aging tissues and this might reflect the age-related decline in immune functions [26].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Serrano, 2014, Cellular senescence: From physiology to pathology, Nat. Rev. Mol. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationReplicative senescence is bypassed upon loss of p21 but not upon loss of p16 function.
“Replicative senescence is bypassed upon loss of p21 [41] but not upon loss of p16 function [45,46].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [41] Brown, 1997, Bypass of Senescence After Disruption of p21 CIP1/WAF1 Gene in Normal Diploid Human Fibroblasts, Science source
Not checked in the free run.
- cites [45] Wei, 2003, Loss of retinoblastoma but not p16 function allows bypass of replicative senescence in human fibroblasts, EMBOJ source
Not checked in the free run.
- cites [46] Bond, 2004, Direct evidence from siRNA-directed “knock down” that p16INK4a is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferation, Exp. Cell Res. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningActive p16 signaling can compensate for p53 activity decline after full senescence establishment.
“It has been proposed that active p16 signaling can compensate for p53 activity decline after full senescence establishment [49,50].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [49] Jacobs, 2004, Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence, Curr. Biol. source
Not checked in the free run.
- cites [50] Bond, 1999, Control of Replicative Life Span in Human Cells: Barriers to Clonal Expansion Intermediate Between M1 Senescence and M2 Crisis, Mol. Cell. Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationCells without cyclin B1-CDK1 activity are refractory to reactivation upon damage resolution and do not progress into mitosis, marking a point-of-no-return for irreversible cell cycle arrest in G2.
“Consequently, these cells without cyclin B1–CDK1 activity are refractory to reactivation upon damage resolution, and they do not progress into mitosis, thus marking a point-of-no-return for the irreversible cell cycle arrest in G2 [58,62,63].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [58] Krenning, 2014, Transient Activation of p53 in G2 Phase Is Sufficient to Induce Senescence, Mol. Cell source
Not checked in the free run.
- cites [62] Cascales, 2014, Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase, Cell Cycle source
Not checked in the free run.
- cites [63] Cascales, 2017, Residual Cdk1/2 activity after DNA damage promotes senescence, Aging Cell source
Not checked in the free run.
May combine two claims.
PremisereasoningActivation of p53 at G2 leads to p21 upregulation, followed by the nuclear sequestration of cyclin B1 and mitosis entry inhibition.
“Activation of p53 at G2 leads to p21 upregulation, followed by the nuclear sequestration of cyclin B1 and mitosis entry inhibition.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCyclin B1-CDK1 complexes bound to p21 in the nucleus are inactive and cannot be activated upon CDK1 dephosphorylation by phosphatase CDC25C.
“In fact, cyclin B1–CDK1 complexes bound to p21 in the nucleus are inactive and cannot be activated upon CDK1 dephosphorylation by phosphatase CDC25C [60,61].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [60] Baus, 2003, Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts, EMBO J. source
Not checked in the free run.
- cites [61] Gire, 2004, p21-Mediated Nuclear Retention of Cyclin B1-Cdk1 in Response to Genotoxic Stress, Mol. Biol. Cell source
Not checked in the free run.
May combine two claims.
PremisecitationCells with low baseline p16 levels do not undergo OIS but show anchorage-independent growth, a feature of cell transformation.
“Moreover, cells with low baseline p16 levels do not undergo OIS but show anchorage-independent growth (a feature of cell transformation) [54].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Benanti, 2004, Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence, Mol. Cell. Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationIn this setting, p16 responds adequately to telomere damage because p53 inactivation only partially relieves the cell cycle arrest imposed by telomere signaling.
“In this setting, p16 responds adequately to telomere damage because p53 inactivation only partially relieves the cell cycle arrest imposed by telomere signaling.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] Jacobs, 2004, Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence, Curr. Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationDDR can also signal to p16, although p16 may act as a secondary mechanism to mediate the senescence-related proliferative arrest following telomere dysfunction.
“DDR can also signal to p16, although p16 may act as a secondary mechanism to mediate the senescence-related proliferative arrest following telomere dysfunction [48,49].”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenSome senescence markers identify the early stage, such as p53 and p21, while others identify the late stage, such as p16 and ARF.
“Some markers identify the early stage (p53 and p21), while others identify the late stage (p16 and ARF, gene products of the CDKN2A locus).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenAlthough frequently used, p53 and p16 are not exclusively senescence markers, but can indicate other biological functions depending on the cell context.
“Although frequently used, p53 and p16 are not exclusively senescence markers, but can indicate other biological functions depending on the cell context.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThis mitotic fidelity loss with age generates daughter cells with aneuploidy and micronuclei that ultimately lead to permanent cell cycle arrest in G1 and full senescence phenotypes.
“This mitotic fidelity loss with age generates daughter cells with aneuploidy and micronuclei that ultimately lead to permanent cell cycle arrest in G1 and full senescence phenotypes [65].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [65] Macedo, 2018, FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence, Nat. Commun. source
Not checked in the free run.
May combine two claims.
PremisecitationMitotic duration increases with age, whereas mitotic transcripts decrease, leading to a higher rate of chromosome mis-segregation events during mitosis.
“Mitotic duration increases with age, whereas mitotic transcripts decrease, leading to a higher rate of chromosome mis-segregation events during mitosis.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe signaling pathway responsible for OIS is p53-dependent in murine cells, while the RB pathway might play a predominant role in human cells.
“It appears that the signaling pathway responsible for OIS is p53-dependent in murine cells, while the RB pathway might play a predominant role in human cells.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe p53 and RB pathways are needed for OIS initiation and maintenance in most systems, but their specific requirement may differ in humans and mice and might be cell type-dependent.
“The p53 and RB pathways are needed for OIS initiation and also maintenance in most systems, but their specific requirement may differ in humans and mice and might be cell type-dependent.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe activation of only one or both pathways for the execution and maintenance of the senescence program is dictated by the type of stress signal, the tissue, and the species of origin, or by a compensatory response to signaling imbalances.
“The activation of only one or both pathways for the execution and maintenance of the senescence program is dictated by the type of stress signal, the tissue, and the species of origin [67], or by a compensatory response to signaling imbalances.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Jones, 2008, Many roads lead to oncogene-induced senescence, Oncogene source
Not checked in the free run.
May combine two claims.
PremisecitationNeither p53 nor p16 are implicated in human mammary epithelial cells or melanocytes undergoing Ras-induced senescence.
“However, neither p53 nor p16 are implicated in human mammary epithelial cells [77] or melanocytes [78] undergoing Ras-induced senescence.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [77] Cipriano, 2011, TGF- signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [78] Denoyelle, 2006, Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway, Nat. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationOverexpression of BMI1, CBX7, or CBX8 results in the direct repression of p16 and senescence delay in human and mouse cells.
“Overexpression of BMI1 [80], CBX7 [81], or CBX8 [82] results in the direct repression of p16 and senescence delay in human and mouse cells.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [80] Jacobs, 1999, The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus, Nature source
Not checked in the free run.
- cites [81] Gil, 2004, Polycomb CBX7 has a unifying role in cellular lifespan, Nat. Cell Biol. source
Not checked in the free run.
- cites [82] Dietrich, 2007, Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus, EMBO J. source
Not checked in the free run.
May combine two claims.
PremisecitationTelomere shortening is the signal for replicative senescence in human fibroblasts because telomerase reconstitutes telomere function and restores the proliferative capacity that ultimately leads to cell immortalization.
“Telomere shortening is the signal for replicative senescence in human fibroblasts because telomerase reconstitutes telomere function and restores the proliferative capacity that ultimately leads to cell immortalization [8,9].”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAcute telomere deprotection by inactivation of the shelterin protein TRF2 leads to robust telomeric ATM signaling, NHEJ-dependent telomere end-to-end fusion, and rapid cell cycle arrest.
“Similarly, acute telomere deprotection by inactivation of the shelterin protein TRF2 leads to robust telomeric ATM signaling, NHEJ-dependent telomere end-to-end fusion, and rapid cell cycle arrest [71,95].”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationThe mean telomere length in human senescent fibroblasts ranges between 6 and 8 kbp, but senescent cells might contain a few extremely short telomeres that have lost completely their protective function and expose telomere-free ends, leading to DDR activation and cell cycle arrest.
“The mean telomere length in human senescent fibroblasts ranges between 6 and 8 kbp, but senescent cells might contain a few extremely short telomeres [94] that have lost completely their protective function and expose telomere-free ends, leading to DDR activation and cell cycle arrest [10,57].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [94] Baird, 2003, Extensive allelic variation and ultrashort telomeres in senescent human cells, Nat. Genet. source
Not checked in the free run.
- cites [10] Reaper, 2003, A DNA Damage Checkpoint Response in Telomere-Initiated Senescence, Nature source
Not checked in the free run.
- cites [57] Jullien, 2013, Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response, Nucleic Acids Res. source
Not checked in the free run.
May combine two claims.
PremisecitationDuring senescence, PRC delocalization from the CDKN2A locus, transcriptional downregulation of EZH2, and recruitment of JMJD3 lead to removal of the repressive H3K27me3 mark at the CDKN2A locus and facilitate p16 transcription.
“During senescence, PRC delocalization from the CDKN2A locus, transcriptional downregulation of EZH2 [83], and recruitment of JMJD3 [84,85], a histone lysine demethylase that catalyzes H3K27 demethylation, lead to removal of the repressive H3K27me3 mark at the CDKN2A locus and facilitate p16 transcription.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [83] Bracken, 2007, The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells, Genes Dev. source
Not checked in the free run.
- cites [84] Agger, 2009, The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A–ARF locus in response to oncogene- and stress-induced senescence, Genes Dev. source
Not checked in the free run.
- cites [85] Barradas, 2009, Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS, Genes Dev. source
Not checked in the free run.
May combine two claims.
PremisecitationTRF2 overexpression delays replicative senescence onset, indicating that TRF2 capacity to sequester the telomere terminus via the t-loop conformation might suppress the DNA damage signal from too short telomere ends and protect them from ATM signaling.
“In agreement, TRF2 overexpression delays replicative senescence onset [101], indicating that TRF2 capacity to sequester the telomere terminus via the t-loop conformation [88] might suppress the DNA damage signal from too short telomere ends and protect them from ATM signaling.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationA clear loss of shelterin association with telomeres has been observed in senescent fibroblasts, which is consistent with the progressive displacement of these complexes from short telomeres.
“A clear loss of shelterin association with telomeres has been observed in senescent fibroblasts, which is consistent with the progressive displacement of these complexes from short telomeres [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Jullien, 2013, Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response, Nucleic Acids Res. source
Not checked in the free run.
May combine two claims.
PremisecitationTelomeres are repetitive DNA sequences bound by the six-subunit shelterin complex that facilitates the formation of telomere loops to hide the telomere end, thus protecting chromosome ends from DNA break signaling pathways.
“Telomeres are repetitive DNA sequences, bound by the six-subunit shelterin complex [86] that facilitates the formation of telomere loops (t-loop) to hide the telomere end [87,88], thus protecting the natural chromosome ends from signaling pathways that sense and act at DNA breaks.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [86] 2005, Shelterin: The protein complex that shapes and safeguards human telomeres, Genes Dev. source
Not checked in the free run.
- cites [87] Griffith, 1999, Mammalian Telomeres End in a Large Duplex Loop, Cell source
Not checked in the free run.
- cites [88] Doksani, 2013, Super-Resolution Fluorescence Imaging of Telomeres Reveals TRF2-Dependent T-loop Formation, Cell source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe activation in senescing cells of G2/M phase checkpoint markers clearly indicates that their telomeres are somehow dysfunctional, most likely after telomere losses during DNA replication.
“The activation in senescing cells of G2/M phase checkpoint markers clearly indicates that their telomeres are somehow dysfunctional, most likely after telomere losses during DNA replication [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Jullien, 2013, Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response, Nucleic Acids Res. source
Not checked in the free run.
May combine two claims.
PremisecitationMost somatic cells lack telomerase activity, and this progressive telomere erosion ultimately results in the loss of telomere function and triggers a permanent proliferative senescence arrest.
“However, most somatic cells lack telomerase activity, and this progressive telomere erosion ultimately results in the loss of telomere function and triggers a permanent proliferative senescence arrest [9].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Bodnar, 1998, Extension of Life-Span by Introduction of Telomerase into Normal Human Cells, Science source
Not checked in the free run.
May combine two claims.
InterpretationcitationAcute loss of telomere end protection is unlikely to mimic the events leading to replicative senescence because in senescent cells, fusions between dysfunctional sister chromatids in end-to-end joining events are more frequent than inter-chromosomal end-to-end fusions.
“This acute loss of telomere end protection is unlikely to mimic the events leading to replicative senescence because in senescent cells, fusions between dysfunctional sister chromatids in end-to-end joining events are more frequent than inter-chromosomal end-to-end fusions (a consequence of complete exposure of the telomeric tract to the NHEJ pathway) [57].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] Jullien, 2013, Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response, Nucleic Acids Res. source
Not checked in the free run.
May combine two claims.
PremisereasoningDamage signals are observed also at chromosome ends that still contain significant telomeric repeats, so complete disappearance of telomeric repeats is not required to signal dysfunction.
“However, as damage signals are observed also at chromosome ends that still contain significant telomeric repeats, complete disappearance of telomeric repeats is not required to signal dysfunction.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTRF2 binds all along the telomeric array and inhibits DSB repair completion by blocking the recruitment of ligase IV to DNA breaks that are located in or next to telomeric DNA.
“TRF2 binds all along the telomeric array [116] and inhibits DSB repair completion by blocking the recruitment of ligase IV to DNA breaks that are located in or next to telomeric DNA [109,115].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [116] Broccoli, 1997, Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2, Nat. Genet. source
Not checked in the free run.
- cites [109] Hewitt, 2012, Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence, Nat. Commun. source
Not checked in the free run.
- cites [115] Fumagalli, 2012, Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation, Nat. Cell Biol. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningDue to the accumulation of repair-resistant telomeres, the DDR is continually active, and cell cycle arrest is sustained.
“Therefore, due to the accumulation of repair-resistant telomeres, the DDR is continually active, and cell cycle arrest is sustained.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningConversely, DNA breaks in the rest of the genome are efficiently repaired, and DDR activation and cell cycle arrest are transient.
“Conversely, DNA breaks in the rest of the genome are efficiently repaired, and DDR activation and cell cycle arrest are transient.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningA threshold number of dysfunctional telomeres must accumulate before the signal is sufficiently high to enforce persistent DDR signaling and to force cells to exit in G2 through sustained p53 activation.
“Presumably, a threshold number of dysfunctional telomeres must accumulate before the signal is sufficiently high to enforce persistent DDR signaling and to force cells exit in G2 through sustained p53 activation.”
Quote in the paperNot a substantial claim- Rests on an assumption: The G2/M checkpoint only responds to 10–20 DNA breaks.
May combine two claims.
PremisecitationSenescence of MEFs in culture is independent of telomere shortening because mouse fibroblasts have long telomeres and express the enzyme telomerase but is induced by high ambient oxygen levels (20%) that cause oxidative damage.
“Likewise, senescence of MEFs in culture is independent of telomere shortening because mouse fibroblasts have long telomeres and express the enzyme telomerase but is induced by high ambient oxygen levels (20%) that cause oxidative damage [111].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [111] Parrinello, 2003, Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts, Nat. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationIn this case, telomere damage is attributed to specific features of telomeres that render them particularly susceptible to oxidation-induced damage, a type of damage that increases with aging.
“In this case, telomere damage is attributed to specific features of telomeres that render them particularly susceptible to oxidation-induced damage, a type of damage that increases with aging [91,110].”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningARF might not play a role in senescence induction as a first-line defense against oncogenic events in melanocytes, whereas ARF is an important component in melanoma suppression.
“ARF might not play a role in senescence induction as a first-line defense against oncogenic events in melanocytes, whereas ARF is an important component in melanoma suppression.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThis arrest can be suppressed by inactivating the ATM or CHK2 kinases, supporting the causative role of DNA damage signaling in response to oncogenic activation in OIS.
“Importantly, this arrest can be suppressed by inactivating the ATM or CHK2 kinases, supporting the causative role of DNA damage signaling in response to oncogenic activation in OIS [70].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Fumagalli, 2006, Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationRegulation of ARF expression in humans and mice differs significantly in response to oncogenic signals, possibly because of limited homology between mouse and human CDKN2A promoter sequences.
“However, the regulation of ARF expression in humans and mice differs significantly in response to oncogenic signals, possibly because of the limited homology between the mouse and human CDKN2A promoter sequences [124].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [124] Ortega, 2002, Cyclin D-dependent kinases, INK4 inhibitors and cancer, Biochim. Biophys. Acta BBA-Rev. Cancer
Not checked in the free run.
May combine two claims.
PremisecitationIncreasing ARF levels often correlate with more advanced stages of cancer development and less frequently with pronounced DDR activation in response to persistent oncogenic activation.
“It is now acknowledged that increasing ARF levels often correlate with more advanced stages of cancer development and less frequently with pronounced DDR activation in response to persistent oncogenic activation [129].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Evangelou, 2013, The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis, Cell Death Differ. source
Not checked in the free run.
May combine two claims.
Premisenone givenThe separate INK4A and ARF promoters can differentially respond to input signals and can be independently silenced in tumors.
“The separate INK4A and ARF promoters can differentially respond to input signals and can be independently silenced in tumors.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe two genes are largely coregulated in rodents, although some stimuli can selectively regulate p16 or ARF alone, whereas co-regulation of human p16 and p14ARF is uncommon.
“The two genes are largely coregulated in rodents, although some stimuli can selectively regulate p16 or ARF alone [128], whereas co-regulation of human p16 and p14ARF is uncommon [123].”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationSASP regulation is considerably heterogeneous and is influenced by cell type and the level and exposure duration to the initial senescence inducer.
“Although the SASP is a feature shared by different senescence types, its regulation is considerably heterogeneous and is influenced by the cell type and the level and exposure duration to the initial senescence inducer [149].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [149] Desprez, 2010, The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression, Annu. Rev. Pathol. Mech. Dis. source
Not checked in the free run.
May combine two claims.
PremisecitationGATA4 accumulates in senescent cells and induces the expression of IL-1α and TRAF3IP2 that activate NF-κB to initiate and amplify the SASP response.
“GATA4 accumulates in senescent cells and induces the expression of IL-1α and TRAF3IP2 (an E3 ubiquitin ligase) that activate NF-κB to initiate and amplify the SASP response [160].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Kang, 2015, The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4, Science source
Not checked in the free run.
May combine two claims.
PremisecitationThe chromatin reader BRD4 is recruited to super-enhancer elements adjacent to key SASP genes and is required for their expression.
“More directly, the chromatin reader BRD4 is recruited to super-enhancer elements that form adjacent to key SASP genes and is required for their expression [170].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [170] Tasdemir, 2016, BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance, Cancer Discov. source
Not checked in the free run.
May combine two claims.
PremisecitationcGAS catalyzes production of the second messenger cGMP that binds STING, resulting in phosphorylation of IRF3 and NF-κB and stimulating production of type I interferons and inflammatory cytokines.
“cGAS catalyzes the production of the second messenger cGMP that binds to stimulator of interferon genes (STING). This results in the phosphorylation of both interferon-regulatory factor 3 (IRF3) and of NF-κB transcription factors, thereby stimulating respectively the production of type I interferons and inflammatory cytokines [171,172,173,174].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [171] Dou, 2017, Cytoplasmic chromatin triggers inflammation in senescence and cancer, Nature source
Not checked in the free run.
- cites [172] Guey, 2017, Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence, Nat. Cell Biol. source
Not checked in the free run.
- cites [173] Yang, 2017, cGAS is essential for cellular senescence, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [174] Ablasser, 2019, cGAS in action: Expanding roles in immunity and inflammation, Science source
Not checked in the free run.
May combine two claims.
PremisecitationHMGB2 remodels chromatin architecture and binds to loci of key SASP genes, preventing their incorporation into transcriptionally repressive heterochromatin regions and facilitating their expression.
“Among the high mobility group (HMG) family members, HMGB2 is a non-histone chromatin-binding protein that remodels the chromatin architecture and binds to the loci of key SASP genes. Then, HMGB2 prevents their incorporation into transcriptionally repressive heterochromatin regions, facilitating their expression [169].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [169] Aird, 2016, HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci, J. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationActivation of the SASP program requires a sustained DDR signal but is independent of p53, p21, and p16.
“Activation of the SASP program requires a sustained DDR signal but is independent of p53, p21, and p16 (the mediators of cell cycle arrest in senescent cells) [147,148].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [147] Coppé, J.-P., Patil, C.K., Rodier, F., Sun, Y., Muñoz, D.P., Goldstein, J.N., Nelson, P.S., Desprez, P.-Y., and Campisi, J. (2008). Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor. PLoS Biol., 6. source
Not checked in the free run.
- cites [148] Rodier, 2009, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nat. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationATM signaling is required for the secretion of IL-6 and IL-8, the most conserved and robustly expressed inflammatory cytokines, but does not regulate the entire production of SASP factors.
“ATM signaling does not regulate the entire production of SASP factors, although it is required for the secretion of IL-6 and IL-8, the most conserved and robustly expressed inflammatory cytokines [148].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [148] Rodier, 2009, Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion, Nat. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationAt later stages of senescence, NOTCH1 expression decreases, entailing activation of C/EBPβ and subsequent production of the inflammatory SASP.
“This inhibition is transient, and at later stages of senescence, NOTCH1 expression decreases, entailing the activation of C/EBPβ and the subsequent production of the inflammatory SASP [150].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [150] Hoare, 2016, NOTCH1 mediates a switch between two distinct secretomes during senescence, Nat. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationThe nuclear envelope of micronuclei is unstable and can rupture, leading to exposure of micronuclear DNA that induces a cellular immune response via cGAS.
“The nuclear envelope of these micronuclei is unstable and can rupture, leading to the exposure of micronuclear DNA that induces a cellular immune response via cGAS [171,172,173].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [171] Dou, 2017, Cytoplasmic chromatin triggers inflammation in senescence and cancer, Nature source
Not checked in the free run.
- cites [172] Guey, 2017, Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence, Nat. Cell Biol. source
Not checked in the free run.
- cites [173] Yang, 2017, cGAS is essential for cellular senescence, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
May combine two claims.
PremisecitationThe mass and number of mitochondria are increased in senescent fibroblasts.
“Due to their functional defects, the mass and number of mitochondria are increased in senescent fibroblasts [212].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [212] Passos, J.F., Saretzki, G., Ahmed, S., Nelson, G., Richter, T., Peters, H., Wappler, I., Birket, M.J., Harold, G., and Schaeuble, K. (2007). Mitochondrial Dysfunction Accounts for the Stochastic Heterogeneity in Telomere-Dependent Senescence. PLoS Biol., 5. source
Not checked in the free run.
May combine two claims.
PremisecitationmiRNAs are differentially expressed during senescence and regulate key nodes of senescence signaling pathways through direct binding to mRNAs of p53, p16, SASP factors, and other senescence-regulatory proteins.
“Importantly, miRNAs are differentially expressed during senescence and regulate key nodes of the senescence signaling pathways through direct binding to the mRNAs of p53, p16, SASP factors, and other senescence-regulatory proteins [193].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [193] Ma, 2020, Regulation of cellular senescence by microRNAs, Mech. Ageing Dev. source
Not checked in the free run.
May combine two claims.
PremisecitationOther splicing regulators such as PTBP1 regulate alternative splicing of genes involved in intracellular trafficking and are required for the pro-inflammatory SASP.
“Other splicing regulators such as the RNA-binding protein polypyrimidine tract binding protein 1 (PTBP1), regulate the alternative splicing of genes involved in intracellular trafficking and are required for the pro-inflammatory SASP [203].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [203] Georgilis, 2018, PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells, Cancer Cell source
Not checked in the free run.
May combine two claims.
Premisecitationp53β is required for senescence induction, possibly through transcriptional repression.
“Functionally, p53β is required for senescence induction, possibly through transcriptional repression [202].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [202] Chen, 2017, Identification of a DNA Damage–Induced Alternative Splicing Pathway That Regulates p53 and Cellular Senescence Markers, Cancer Discov. source
Not checked in the free run.
May combine two claims.
PremisecitationThe level of splicing factor SRSF3 decreases in replicatively senescent human fibroblasts, and its knockdown promotes p53-mediated senescence by directly upregulating p53β.
“For example, the level of the splicing factor SRSF3 decreases in replicatively senescent human fibroblasts, and its knockdown promotes p53-mediated senescence by directly upregulating p53β, an alternatively spliced p53 isoform [201].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [201] Tang, 2013, Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence, Oncogene source
Not checked in the free run.
May combine two claims.
PremisecitationDamaged mitochondria are insensitive to mitophagy, and consequently mitochondrial number and size are not properly regulated in senescent cells.
“Moreover, damaged mitochondria are insensitive to mitophagy (i.e., selective autophagy of mitochondria), and consequently, mitochondrial number and size are not properly regulated in senescent cells [214].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [214] Kurz, 2008, Lysosomes and oxidative stress in aging and apoptosis, Biochim. Biophys. Acta BBA-Gen. Subj. source
Not checked in the free run.
May combine two claims.
PremisecitationSenescent cells display a very active but altered metabolism, with increased glycolysis and mTOR activity.
“Although senescent cells do not divide, they display a very active but altered metabolism, with increased glycolysis and mTOR activity [204].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [204] Wiley, 2016, From Ancient Pathways to Aging Cells—Connecting Metabolism and Cellular Senescence, Cell Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationDuring OIS, fatty acid metabolism is altered, glucose consumption is enhanced, and utilization of pyruvate in the tricarboxylic acid cycle and nucleotide deficiency are increased.
“Moreover, during OIS, fatty acid metabolism is altered, glucose consumption is enhanced, and the utilization of pyruvate in the tricarboxylic acid cycle and nucleotide deficiency are increased [119,216,217,218,219].”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [119] Aird, 2013, Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence, Cell Rep. source
Not checked in the free run.
- cites [216] Quijano, 2012, Oncogene-induced senescence results in marked metabolic and bioenergetic alterations, Cell Cycle source
Not checked in the free run.
- cites [217] Li, 2013, Oncogene-induced cellular senescence elicits an anti-Warburg effect, Proteomics source
Not checked in the free run.
- cites [218] Aird, 2014, Metabolic alterations accompanying oncogene-induced senescence, Mol. Cell. Oncol. source
Not checked in the free run.
- cites [219] Aird, 2015, Nucleotide metabolism, oncogene-induced senescence and cancer, Cancer Lett. source
Not checked in the free run.
May combine two claims.
PremisecitationSenescence induced by nucleotide deficiency causes aberrant DNA replication but can be overcome by ATM inactivation through restoration of glucose and glutamine consumption.
“Senescence induced by nucleotide deficiency causes aberrant DNA replication but can be overcome by ATM inactivation through restoration of glucose and glutamine consumption [220].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [220] Aird, 2015, ATM Couples Replication Stress and Metabolic Reprogramming during Cellular Senescence, Cell Rep. source
Not checked in the free run.
May combine two claims.
InterpretationcitationMitochondrial dysfunction, initiated by pathways different from DNA damage, can determine SASP quality because local extracellular factors such as pyruvate can modify the SASP in senescent cells.
“Therefore, mitochondrial dysfunction, initiated by pathways different from DNA damage, can determine the SASP quality because local extracellular factors, such as pyruvate, can modify the SASP in senescent cells [225].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [225] Wiley, 2016, Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype, Cell Metab. source
Not checked in the free run.
May combine two claims.
Premisecitationp53 restricts glycolysis activity of senescent cells through several mechanisms, while RB upregulates glycolytic genes, resulting in high glycolytic activity.
“In addition to stopping senescent cell proliferation, p53 and RB mediate senescence-related metabolic changes by balancing their effects on glycolysis: p53 restricts the glycolysis activity of senescent cells through several mechanisms [226], while RB upregulates glycolytic genes, resulting in high glycolytic activity [227].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [226] 2011, The Role of p53 in Metabolic Regulation, Genes Cancer source
Not checked in the free run.
- cites [227] Takebayashi, 2015, Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene-induced senescent cells, Aging Cell source
Not checked in the free run.
May combine two claims.
PremisecitationIn senescent cells, activity of lysosomal β-galactosidase is significantly increased as a consequence of increased lysosomal mass and becomes detectable experimentally at pH 6.0.
“In senescent cells, the activity of lysosomal β-galactosidase is significantly increased as a consequence of the increased lysosomal mass and becomes detectable experimentally at pH 6.0 [232].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [232] Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
May combine two claims.
PremisecitationSA-β Gal activity is one of the first and most used biomarkers of senescence, although it can be detected in non-senescent cells that are confluent or serum-starved.
“Senescence-associated β-galactosidase (SA-β Gal) activity is one of the first and most used biomarkers of senescence, although it has limitations because it can be detected in non-senescent cells that are confluent or serum-starved [233].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [233] Severino, 2000, Is β-Galactosidase Staining a Marker of Senescence in Vitro and in Vivo?, Exp. Cell Res. source
Not checked in the free run.
May combine two claims.
PremisecitationAMPK prevents cytoplasmic translocation of HuR, thereby increasing p21 and p16 mRNA stability and enhancing RB activity.
“AMPK also prevents cytoplasmic translocation of the mRNA-stabilization factor HuR, thereby increasing p21 and p16 mRNA stability and enhancing RB activity [224].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [224] Wang, 2003, Increased AMP:ATP Ratio and AMP-activated Protein Kinase Activity during Cellular Senescence Linked to Reduced HuR Function, J. Biol. Chem. source
Not checked in the free run.
May combine two claims.
Interpretationnone givenLipofuscin accumulation reflects reduced lysosomal activity, altered metabolism, and autophagy dysfunction.
“Lipofuscin accumulation reflects reduced lysosomal activity, altered metabolism, and autophagy dysfunction.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationAs p53 response efficiency declines during aging, aerobic glycolysis is increased as well as the proinflammatory SASP via NF-κB signaling.
“As the p53 response efficiency declines during aging [228], aerobic glycolysis is increased as well as the proinflammatory SASP via NF-κB signaling [155].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [228] Feng, 2007, Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations, Proc. Natl. Acad. Sci. USA source
Not checked in the free run.
- cites [155] Chien, 2011, Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity, Genes Dev. source
Not checked in the free run.
May combine two claims.
PremisecitationDuring senescence, mTORC1 activation due to sustained DDR promotes mitochondrial biogenesis, contributing to ROS-dependent DDR persistence and SASP regulation.
“Similarly, during senescence, mTORC1 activation due to sustained DDR does not favor growth but promotes mitochondrial biogenesis, thus contributing to the ROS-dependent DDR persistence and to SASP regulation [215].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [215] Marques, 2016, Mitochondria are required for pro-ageing features of the senescent phenotype, EMBO J. source
Not checked in the free run.
May combine two claims.
PremisecitationOIS relies on autophagic turnover of cytoplasmic material and specific autophagic degradation of nuclear lamin B1 in lysosomes, delivered by nucleus-to-cytoplasm transport.
“OIS relies not only on the autophagic turnover of cytoplasmic material but also on the specific autophagic degradation of nuclear lamin B1 in lysosomes, where it is delivered by nucleus-to-cytoplasm transport [247].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [247] Dou, 2015, Autophagy mediates degradation of nuclear lamina, Nature source
Not checked in the free run.
May combine two claims.
InterpretationreasoningProgressive protein misfolding/aggregation or massive SASP protein synthesis in senescent cells causes loss of proteostasis and activation of the unfolded protein response.
“As a consequence, progressive protein misfolding/aggregation or massive SASP protein synthesis in senescent cells cause the loss of the protein quality control homeostasis (or proteostasis) and activation of the unfolded protein response (UPR).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationContinuous DNA damage signaling is essential for maintenance of cell cycle arrest in senescence because inactivation of checkpoint kinases ATM, CHK2, and p53 results in escape from arrest.
“Continuous DNA damage signaling is essential for cell cycle arrest maintenance because inactivation of checkpoint kinases, such as ATM [10,12], CHK2 [11], and p53 [47,48], results in escape from this arrest.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [10] Reaper, 2003, A DNA Damage Checkpoint Response in Telomere-Initiated Senescence, Nature source
Not checked in the free run.
- cites [12] Herbig, 2004, Telomere Shortening Triggers Senescence of Human Cells through a Pathway Involving ATM, p53, and p21CIP1, but Not p16INK4a, Mol. Cell source
Not checked in the free run.
- cites [11] Gire, 2004, DNA damage checkpoint kinase Chk2 triggers replicative senescence, EMBO J. source
Not checked in the free run.
- cites [47] Gire, 1998, Reinitiation of DNA Synthesis and Cell Division in Senescent Human Fibroblasts by Microinjection of Anti-p53 Antibodies, Mol. Cell. Biol. source
Not checked in the free run.
- cites [48] Krtolica, 2003, Reversal of human cellular senescence: Roles of the p53 and p16 pathways, EMBO J. source
Not checked in the free run.
May combine two claims.
PremisecitationUnder basal conditions, SQSTM1/p62 interacts with GATA4 and mediates its degradation by selective autophagy.
“Under basal conditions, the autophagic adaptor SQSTM1/p62 interacts with GATA4 and mediates its degradation by selective autophagy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [160] Kang, 2015, The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4, Science source
Not checked in the free run.
May combine two claims.
PremisecitationThe TASCC, close to the nucleus, is highly enriched in mTOR and keeps mTOR away from the autophagy machinery to avoid its inactivation.
“The mTOR–autophagy spatial coupling compartment (TASCC), which is close to the nucleus, is highly enriched in mTOR and keeps mTOR away from the autophagy machinery, located away from the TASCC, to avoid its inactivation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [246] Narita, 2011, Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes, Science source
Not checked in the free run.
May combine two claims.
PremisecitationUPR signaling limits ER abnormal protein load and reduces ER stress by inhibiting protein translation, upregulating ER chaperones, and degrading misfolded proteins via the proteasome through ER-associated degradation.
“The UPR signaling seeks to limit ER abnormal protein load and to reduce ER stress by inhibiting protein translation [239], by upregulating various ER chaperones that contribute to the correct organization of misfolded proteins [240], and by degrading misfolded proteins via the proteasome through an ER-associated degradation process [241].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [239] Harding, 1999, Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase, Nature source
Not checked in the free run.
- cites [240] Yoshida, 2000, ATF6 Activated by Proteolysis Binds in the Presence of NF-Y (CBF) Directly to the cis -Acting Element Responsible for the Mammalian Unfolded Protein Response, Mol. Cell. Biol. source
Not checked in the free run.
- cites [241] Jarosch, 2000, A regulatory link between ER-associated protein degradation and the unfolded-protein response, Nat. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationIn oncogenic Ras-induced senescence, protein synthesis and autophagic degradation are simultaneously activated, and the same cell displays high autophagic activity and activated mTOR.
“In senescence induced by oncogenic Ras, protein synthesis and autophagic degradation are simultaneous activated, and the same cell displays high autophagic activity and activated mTOR, the autophagy inhibitor [244].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [244] Young, 2009, Autophagy mediates the mitotic senescence transition, Genes Dev. source
Not checked in the free run.
May combine two claims.
PremisecitationActive ATM triggers removal from SASP genes of the histone variant macroH2A1, leading to inhibition of their transcription and reduction in ER stress.
“Active ATM triggers the removal from SASP genes of the histone variant macroH2A1, leading to inhibition of their transcription and reduction in ER stress [168].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [168] Chen, 2015, MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype, Mol. Cell source
Not checked in the free run.
May combine two claims.
PremisecitationIL-6 facilitates maintenance of the senescent phenotype by inhibiting mitochondrial-mediated apoptosis and stimulating pro-survival activity of NF-κB in senescent cells.
“IL-6 also facilitates the senescent phenotype maintenance by inhibiting mitochondrial-mediated apoptosis and by stimulating the pro-survival activity of NF-κB in senescent cells [258].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [258] Catz, 2001, Transcriptional Regulation of Bcl-2 by Nuclear Factor KB and Its Signicance in Prostate Cancer, Oncogene source
Not checked in the free run.
May combine two claims.
PremisecitationInduction of senescence appears protective against p53-dependent apoptosis and high oxidative stress.
“Indeed, induction of senescence appears protective against p53-dependent apoptosis [146] and high oxidative stress [254,255].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [146] Seluanov, 2001, Change of the Death Pathway in Senescent Human Fibroblasts in Response to DNA Damage Is Caused by an Inability to Stabilize p53, Mol. Cell. Biol. source
Not checked in the free run.
- cites [254] Chen, 2000, Apoptosis or Senescence-like Growth Arrest: Influence of Cell-Cycle Position, P53, P21 and Bax in H2O2 Response of Normal Human FIbroblasts, Biochem. J. source
Not checked in the free run.
- cites [255] Sanders, 2013, Histone Modifications in Senescence-Associated Resistance to Apoptosis by Oxidative Stress, Redox Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationUpregulation of p21 contributes to apoptosis resistance by inhibiting p53-mediated apoptosis after DNA damage and by preventing cleavage of caspase-3 and activation of the JNK pathway.
“Upregulation of the cell cycle inhibitor p21 contributes to apoptosis resistance, for example, by inhibiting p53-mediated apoptosis after DNA damage [256,257] and by preventing the cleavage of the apoptosis effector caspase-3 and the activation of the JNK pathway (both required for apoptosis) [144].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [256] Gartel, 2002, The role of the cyclin-dependent kinase inhibitor p21 in apoptosis, Mol. Cancer Ther.
Not checked in the free run.
- cites [257] Xia, 2011, p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation, Oncogene source
Not checked in the free run.
- cites [144] Yosef, 2017, p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling, EMBO J. source
Not checked in the free run.
May combine two claims.
PremisecitationCulturing cells in low oxygen or in the presence of antioxidants delays senescence onset.
“Conversely, culturing cells in low oxygen or in the presence of antioxidants delays senescence onset [111,212,267,268].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [111] Parrinello, 2003, Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts, Nat. Cell Biol. source
Not checked in the free run.
- cites [212] Passos, J.F., Saretzki, G., Ahmed, S., Nelson, G., Richter, T., Peters, H., Wappler, I., Birket, M.J., Harold, G., and Schaeuble, K. (2007). Mitochondrial Dysfunction Accounts for the Stochastic Heterogeneity in Telomere-Dependent Senescence. PLoS Biol., 5. source
Not checked in the free run.
- cites [267] Saretzki, 2003, MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress, Aging Cell source
Not checked in the free run.
- cites [268] Takahashi, 2006, Mitogenic signalling and the p16INK4a–Rb pathway cooperate to enforce irreversible cellular senescence, Nat. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationRestoring autophagy activity in old satellite cells clears protein aggregates and reverses senescence.
“Conversely, restoring autophagy activity in old satellite cells clears protein aggregates and reverses senescence [262].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [262] Perdiguero, 2016, Autophagy maintains stemness by preventing senescence, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationChromatin rearrangements affect the transcriptional program of senescent cells and contribute to their transcriptome diversity.
“These chromatin rearrangements affect the transcriptional program of senescent cells and contribute to their transcriptome diversity [133,136,275].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [133] Melov, 2017, Unmasking Transcriptional Heterogeneity in Senescent Cells, Curr. Biol. source
Not checked in the free run.
- cites [136] Shelton, 1999, Microarray analysis of replicative senescence, Curr. Biol. source
Not checked in the free run.
- cites [275] Shah, 2013, Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape, Genes Dev. source
Not checked in the free run.
May combine two claims.
Premisecitationβ-interferons increase ROS production, leading to DNA damage and p53 activation.
“Indeed, β-interferons increase ROS production, leading to DNA damage and p53 activation [273,274].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [273] Takaoka, 2003, Integration of Interferon-a/b Signalling to P53 Responses in Tumour Suppression and Antiviral Defence, Nature source
Not checked in the free run.
- cites [274] Moiseeva, 2006, DNA Damage Signaling and P53-Dependent Senescence after Prolonged b-Interferon Stimulation, Mol. Biol. Cell source
Not checked in the free run.
May combine two claims.
PremisecitationSenescence induction following CXCR2 engagement is mediated by p53 and RB activation because CXCR2 depletion is sufficient for bypassing senescence.
“Senescence induction following CXCR2 engagement is mediated by p53 and RB activation because CXCR2 depletion is sufficient for bypassing senescence [153].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [153] Acosta, 2008, Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationROS can be directly transferred between cells through gap junctions or released through hydrogen peroxide into the environment, where they can induce senescence in surrounding cells.
“Moreover, ROS can be directly transferred between cells through gap junctions or released through hydrogen peroxide into the environment, where they can induce senescence in surrounding cells [270].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [270] Nelson, 2012, A senescent cell bystander effect: Senescence-induced senescence, Aging Cell source
Not checked in the free run.
May combine two claims.
PremisecitationDamaged mitochondrial DNA alters oxidative phosphorylation reactions and can further enhance ROS production.
“In turn, damaged mitochondrial DNA alters oxidative phosphorylation reactions and can further enhance ROS production [269].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [269] Passos, 2016, Demystifying the role of mitochondria in senescence, Mol. Cell. Oncol. source
Not checked in the free run.
May combine two claims.
PremisecitationIGFBP7 influences MAPK signaling and PAI-1 regulates PI3K pathway, and both contribute to senescence stabilization by inhibiting proliferative and mitogenic pathways.
“Other secreted proteins, such as IGFBP7 that influences MAPK signaling [271] and PAI-1 [272] that regulates the phosphoinositide 3-kinase (PI3K) pathway, also contribute to senescence stabilization by inhibiting proliferative and mitogenic pathways.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [271] Wajapeyee, 2008, Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7, Cell source
Not checked in the free run.
- cites [272] Kortlever, 2006, Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence, Nat. Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationReduced lamin B1 levels are observed in many senescence models, and its depletion causes senescence.
“Reduced lamin B1 levels are observed in many senescence models, and its depletion causes senescence [279,280,281].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [279] Sadaie, 2013, Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence, Genes Dev. source
Not checked in the free run.
- cites [280] Shimi, 2011, The role of nuclear lamin B1 in cell proliferation and senescence, Genes Dev. source
Not checked in the free run.
- cites [281] Freund, 2012, Lamin B1 loss is a senescence-associated biomarker, Mol. Biol. Cell source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe extended proliferative period exacerbates telomere shortening and leads to chromosomal fusions and anaphase bridges.
“This extended proliferative period exacerbates telomere shortening and leads to chromosomal fusions and anaphase bridges.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenIn other settings, senescent cells may facilitate cancer progression.
“In other settings, senescent cells may facilitate cancer progression.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCritically short uncapped telomeres, oncogene stresses, and mitochondrial dysfunction result in proliferative stress and senescence induction, halting proliferation of cells with mutations or genomic instability.
“Critically short, uncapped telomeres [9], oncogene stresses [51], and mitochondrial dysfunction [225] result in proliferative stress and senescence induction, thereby halting the proliferation of cells harboring mutations or genomic instability.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [9] Bodnar, 1998, Extension of Life-Span by Introduction of Telomerase into Normal Human Cells, Science source
Not checked in the free run.
- cites [51] Serrano, 1997, Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a, Cell source
Not checked in the free run.
- cites [225] Wiley, 2016, Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype, Cell Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationLoss of p53 and RB bypassed senescence in cultured human fibroblasts and allowed entry into crisis, considered a second barrier to cancer formation.
“Loss of p53 and RB bypassed senescence in cultured human fibroblasts, and allowed entry into crisis, which is considered as a second barrier to cancer formation [348].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [348] Shay, 1991, Defining the molecular mechanisms of human cell immortalization, Biochim. Biophys. Acta BBA-Rev. Cancer
Not checked in the free run.
May combine two claims.
InterpretationcitationSASP factor expression by senescent cells can facilitate cancer progression by promoting growth of pre-neoplastic cells and modifying tumor microenvironment.
“Paradoxically, SASP factor expression by senescent cells can also facilitate cancer progression by promoting growth of pre-neoplastic cells and by modifying the tumor microenvironment.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningMechanisms to evade senescence are required for malignant progression of melanocytes and involve additional mutations to prevent or bypass OIS.
“Mechanisms to evade senescence are required for malignant progression of melanocytes and involve additional mutations to prevent or bypass OIS, further underscoring the importance of senescence in counteracting tumor development.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSASP composition and strength are context-dependent and highly heterogeneous.
“The SASP composition and strength are context-dependent and highly heterogenous.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRecruitment and activation of T cells and natural killer cells at senescent cells in tumor microenvironment or altered macrophage polarization promote removal of senescent or damaged cells.
“Recruitment and activation of T cells and natural killer cells at the location of senescent cells in the tumor microenvironment or altered polarization of macrophages promote the removal of senescent or damaged cells [29,358,359,360].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [29] Krizhanovsky, 2008, Senescence of Activated Stellate Cells Limits Liver Fibrosis, Cell source
Not checked in the free run.
- cites [358] Xue, 2007, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature source
Not checked in the free run.
- cites [359] Iannello, 2013, p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells, J. Exp. Med. source
Not checked in the free run.
- cites [360] Sagiv, 2012, Granule exocytosis mediates immune surveillance of senescent cells, Oncogene source
Not checked in the free run.
May combine two claims.
InterpretationreasoningTelomere shortening may restrict and also promote tumor initiation.
“Thus, telomere shortening may restrict and also promote tumor initiation.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningPersistence of senescent tumor cells can be a source of chronic inflammation and resistance to chemotherapy.
“Consequently, persistence of senescent tumor cells can be a source of chronic inflammation and of resistance to chemotherapy [363].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [363] Ewald, 2010, Therapy-Induced Senescence in Cancer, JNCI J. Natl. Cancer Inst. source
Not checked in the free run.
May combine two claims.
Premisenone givenSenescence-inducing therapies rely on limiting cancer cell proliferation and also fibrosis formation during carcinogenesis.
“Senescence-inducing therapies rely on limiting cancer cell proliferation and also fibrosis formation during carcinogenesis.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningCancer cells in which the molecular pathways leading to senescence are not affected respond to chemotherapy by entering senescence, which leads to tumor regression through immune clearance of senescent cells.
“Cancer cells in which the molecular pathways leading to senescence are not affected respond to chemotherapy by entering senescence, which leads to tumor regression through immune clearance of senescent cells.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningFollowing drug-induced DNA damage, tumor cells are forced into senescence, stop dividing, and cancer growth might be blocked.
“Following drug-induced DNA damage, tumor cells are forced into senescence, they stop dividing, and cancer growth might be blocked.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTumor cells that escaped senescence after chemotherapy display stem cell characteristics and acquire higher tumor initiation potential in vivo.
“tumor cells that escaped senescence after chemotherapy display stem cell characteristics and acquire a higher tumor initiation potential in vivo [366].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [366] Milanovic, 2018, Senescence-associated reprogramming promotes cancer stemness, Nature source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenAn important limitation in studying senescent cells is the lack of specific biomarkers to properly identify and follow them.
“An important limitation in studying senescent cells is the lack of specific biomarkers to properly identify and follow them.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Premisenone givenMuch of the current knowledge on the senescent cell state comes from work performed in cultured cells.
“Much of the current knowledge on the senescent cell state comes from work performed in cultured cells.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenAcute senescence induction contributes to adequate tissue patterning during embryogenesis, limits tissue damage, and facilitates tissue repair to ensure organismal fitness.
“Acute senescence induction contributes to adequate tissue patterning during embryogenesis, limits tissue damage, and facilitates tissue repair to ensure organismal fitness.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn cell xenografts, matrix metalloproteinases secreted by senescent human fibroblasts increase tumor growth, probably by disrupting immunosurveillance by paracrine action in the microenvironment.
“In cell xenografts experiments, matrix metalloproteinases secreted by senescent human fibroblasts increase tumor growth [361], probably by disrupting the immunosurveillance by paracrine action in the microenvironment.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [361] Liu, 2007, Senescent Human Fibroblasts Increase the Early Growth of Xenograft Tumors via Matrix Metalloproteinase Secretion, Cancer Res. source
Not checked in the free run.
May combine two claims.
InterpretationcitationA major risk is that a population of post-chemotherapy senescent cancer cells may at some point re-enter the cell cycle, start to proliferate, become highly aggressive and chemo-resistant, and acquire stemness-like characteristics, leading to cancer relapse.
“a major risk is that a population of post-chemotherapy senescent cancer cells may at some point re-enter the cell cycle, start to proliferate, become highly aggressive and chemo-resistant, and acquire stemness-like characteristics, leading to cancer relapse [366,368].”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationCombining chemotherapeutic and anti-senescence agents (or senolytic drugs) allows selective elimination of senescent cells to restore tissue function, and potentially improve organ regeneration.
“combining chemotherapeutic and anti-senescence agents (or senolytic drugs) allows the selective elimination of senescent cells to restore tissue function, and potentially improve organ regeneration [7,141].”
Quote in the paperSubstantial claim0 of 2 sources checked
The paper relies on this without support.
The G2/M checkpoint only responds to 10–20 DNA breaks.
“This threshold number is not a single DNA break because the G2/M checkpoint only responds to 10–20 DNA breaks.”
The paper relies on this without support.
Endogenous expression levels of oncogenes are unlikely to cause OIS.
“As the endogenous expression levels of oncogenes are unlikely to cause OIS, the stochastic accumulation of mutations might be needed for OIS induction [118].”
The paper relies on this without support.
Cancer cells must replicate to produce a macroscopic tumor.
“because cancer cells must replicate to produce a macroscopic tumor.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mitochondrial abnormalities with an increase in ROS synthesis and impairment in biogenesis and mitophagy are a mechanism underlying senescence.
“mitochondrial abnormalities with an increase in ROS synthesis and impairment in biogenesis and mitophagy [10]”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
cGAS product conflicts with the enzyme name given
MinorThe text identifies cGAS as cyclic GMP-AMP synthase but then says it produces cGMP, a different molecule.
“cytosolic DNA-sensor cyclic GMP–AMP synthase (cGAS).”
“cGAS catalyzes the production of the second messenger cGMP that binds to stimulator of interferon genes (STING).”
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · see citing works
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · see citing works
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · see citing works
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · see citing works
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · see citing works
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · see citing works
Characteristics of SARS-CoV-2 and COVID-19
Hu, B., Guo, H., Zhou, P., & Shi, Z.-L. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00459-7 · Cited by 5,291 · see citing works
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · see citing works
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · cited 4× · see citing works
“Critically short, uncapped telomeres [9], oncogene stresses [51], and mitochondrial dysfunction [225] result in proliferative stress and senescence induction, thereby halting the proliferation of cells harboring mutations or genomic instability.”
BackgroundInfluentialExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · see citing works
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · see citing works
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · see citing works
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · see citing works
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891 · see citing works
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886 · see citing works
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 3× · see citing works
“When this transgenic model is bred in a progeroid mouse genetic background, clearance of p16-positive senescent cells decreases the age-associated dysfunctions and attenuates progression of aged-related disorders [296].”
BackgroundProtein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
Harding, H. P., Zhang, Y., & Ron, D. (1999) · Nature · doi:10.1038/16729 · Cited by 3,310 · see citing works
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 3× · see citing works
“Indeed, when senescent cells are not efficiently cleared and accumulate in tissues (for instance in the presence of continuous damage), the continued production of SASP factors can contribute to local inflammation and to the chronic inflammatory milieu, via paracrine and systemic SASP that aggravate tissue dysfunction…”
BackgroundShelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · see citing works
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 1× · see citing works
“SASP effects are beneficial or detrimental depending on the cell type, senescence stimulus, and the neighboring environment [24].”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,891 · see citing works
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,855 · cited 18× · see citing works
“Shelterin allows the efficient suppression of non-homologous end joining (NHEJ) and ATM activation at chromosome ends [89].”
BackgroundInfluentialCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · see citing works
Mechanism and medical implications of mammalian autophagy
Dikic, I., & Elazar, Z. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0003-4 · Cited by 2,771 · see citing works
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · see citing works
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · see citing works
An inflammatory cytokine signature predicts COVID-19 severity and survival
Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605 · see citing works
Bushati, N., & Cohen, S. M. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123406 · Cited by 2,563 · see citing works
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,562 · cited 5× · see citing works
“For example, inhibition of the anti-apoptotic BCL2, BCL-W, and BCL-XL proteins induces apoptosis of senescent cells and their elimination in mice [3,14].”
BackgroundInfluentialOxidative stress shortens telomeres
von Zglinicki, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02110-2 · Cited by 2,524 · see citing works
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · see citing works
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · see citing works
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · see citing works
Senolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287 · see citing works
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 5× · see citing works
“It was originally proposed that heterochromatin repackaging into SAHF transcriptionally sequesters proliferation-driving genes, such as RB/E2F target genes, and reinforces the growth arrest irreversibility [167,253,276].”
BackgroundInfluentialA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 5× · see citing works
“The switch from transient to irreversible growth arrest involves positive feedback loops in which mitochondrial dysfunction via ROS [215,250], pro-inflammatory SASP factors [147,154,252], extensive chromatin remodeling [253], and/or nuclear lamina and chromatin degradation [105,171,247] reinforce DDR signaling (Figure…”
BackgroundInfluentialCepharanthine potently enhances the sensitivity of anticancer agents in K562 cells
Ikeda, R., Che, X., Yamaguchi, T., Ushiyama, M., Zheng, C., Okumura, H., Takeda, Y., Shibayama, Y., Nakamura, K. T., Jeung, H., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00057.x · Cited by 2,268 · see citing works
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232 · see citing works
Oxidative stress and autophagy: The clash between damage and metabolic needs
Filomeni, G., De Zio, D., & Cecconi, F. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.150 · Cited by 2,195 · see citing works
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · see citing works
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108 · see citing works
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107 · see citing works
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 5× · see citing works
“However, the secretome of senescent tumor cells can also drive tumor progression by promoting inflammation and potentially stimulating the growth and invasiveness of nearby tumor cells [148,154,163].”
BackgroundInfluentialAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045 · see citing works
Senescence of activated stellate cells limits liver fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.06.049 · Cited by 2,029 · see citing works
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · see citing works
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993 · see citing works
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · see citing works
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · see citing works
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · see citing works
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · cited 3× · see citing works
“senescence to different neighboring cell types [153,154,263,271,272,358].”
BackgroundAssociation between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761 · see citing works
cGAS surveillance of micronuclei links genome instability to innate immunity
Mackenzie, K. J., Carroll, P., Martin, C.-A., Murina, O., Fluteau, A., Simpson, D. J., Olova, N., Sutcliffe, H., Rainger, J. K., Leitch, A., et al. (2017) · Nature · doi:10.1038/nature23449 · Cited by 1,752 · see citing works
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730 · see citing works
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · see citing works
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621 · see citing works
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619 · see citing works
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · cited 1× · see citing works
“In a mouse model of lung fibrosis, depletion of senescent cells improves lung function, even if fibrosis is still visible, indicating that the SASP may contribute to fibrosis [325].”
BackgroundJacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580 · see citing works
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566 · see citing works
Jeon, O. H., Kim, C., Laberge, R.-M., Demaria, M., Rathod, S., Vasserot, A. P., Chung, J. W., Kim, D. H., Poon, Y., David, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4324 · Cited by 1,515 · see citing works
Mitotic progression following DNA damage enables pattern recognition within micronuclei
Harding, S. M., Benci, J. L., Irianto, J., Discher, D. E., Minn, A. J., & Greenberg, R. A. (2017) · Nature · doi:10.1038/nature23470 · Cited by 1,508 · see citing works
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486 · see citing works
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · see citing works
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457 · see citing works
Baar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454 · see citing works
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428 · see citing works
DNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409 · see citing works
Yap, K. L., Li, S., Muñoz-Cabello, A. M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M. J., & Zhou, M.-M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.021 · Cited by 1,391 · see citing works
Autophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355 · see citing works
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351 · see citing works
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · cited 1× · see citing works
“Transgenic mouse models without or with inducible telomerase [300,301] allowed establishing a link between short telomeres and the onset of aging phenotypes [300,302,303], progeroid syndromes [304], and chronic inflammatory and degenerative conditions [305,306].”
BackgroundHerbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344 · cited 17× · see citing works
“Shelterin allows the efficient suppression of non-homologous end joining (NHEJ) and ATM activation at chromosome ends [89].”
BackgroundInfluentialCellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338 · see citing works
Cytoplasmic chromatin triggers inflammation in senescence and cancer
Dou, Z., Ghosh, K., Vizioli, M. G., Zhu, J., Sen, P., Wangensteen, K. J., Simithy, J., Lan, Y., Lin, Y., Zhou, Z., et al. (2017) · Nature · doi:10.1038/nature24050 · Cited by 1,335 · see citing works
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275 · cited 4× · see citing works
“Critically short, uncapped telomeres [9], oncogene stresses [51], and mitochondrial dysfunction [225] result in proliferative stress and senescence induction, thereby halting the proliferation of cells harboring mutations or genomic instability.”
BackgroundInfluentialEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 1× · see citing works
“Transgenic mouse models without or with inducible telomerase [300,301] allowed establishing a link between short telomeres and the onset of aging phenotypes [300,302,303], progeroid syndromes [304], and chronic inflammatory and degenerative conditions [305,306].”
BackgroundAge and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267 · see citing works
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261 · cited 1× · see citing works
“A pilot clinical study reported that senolytic treatments have therapeutic effects in patients with idiopathic pulmonary fibrosis [324].”
BackgroundL1 drives IFN in senescent cells and promotes age-associated inflammation
De Cecco, M., Ito, T., Petrashen, A. P., Elias, A. E., Skvir, N. J., Criscione, S. W., Caligiana, A., Brocculi, G., Adney, E. M., Boeke, J. D., et al. (2019) · Nature · doi:10.1038/s41586-018-0784-9 · Cited by 1,255 · cited 4× · see citing works
“Alternatively, an increase in the transcription of long-interspersed element-1 (LINE-1 or L1), the only human retro-transposable element, during senescence could partly contribute to the accumulation of DNA fragments in the cytoplasm [177].”
BackgroundInfluentialRadiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 1× · see citing works
“Surprisingly, developmental senescence is not required for embryogenesis because embryos lacking p21 show minimal or no developmental defects [56].”
BackgroundSenescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233 · see citing works
Mechanisms and functions of cellular senescence
Herranz, N., & Gil, J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95148 · Cited by 1,232 · see citing works
Lamin A-Dependent Nuclear Defects in Human Aging
Scaffidi, P., & Misteli, T. (2006) · Science · doi:10.1126/science.1127168 · Cited by 1,224 · see citing works
Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
Glück, S., Guey, B., Gulen, M. F., Wolter, K., Kang, T.-W., Schmacke, N. A., Bridgeman, A., Rehwinkel, J., Zender, L., & Ablasser, A. (2017) · Nature Cell Biology · doi:10.1038/ncb3586 · Cited by 1,196 · cited 1× · see citing works
“Therefore, CCFs formation relies on the constitutive interaction between lamin B1 and LC3, and CCFs formation is required to reinforce OIS by initiating the SASP program [171,172].”
BackgroundSenescent intimal foam cells are deleterious at all stages of atherosclerosis
Childs, B. G., Baker, D. J., Wijshake, T., Conover, C. A., Campisi, J., & van Deursen, J. M. (2016) · Science · doi:10.1126/science.aaf6659 · Cited by 1,195 · see citing works
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · see citing works
Targeting cellular senescence prevents age-related bone loss in mice
Farr, J. N., Xu, M., Weivoda, M. M., Monroe, D. G., Fraser, D. G., Onken, J. L., Negley, B. A., Sfeir, J. G., Ogrodnik, M. B., Hachfeld, C. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4385 · Cited by 1,182 · see citing works
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170 · see citing works
Laberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160 · see citing works
Senescence-associated reprogramming promotes cancer stemness
Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., et al. (2018) · Nature · doi:10.1038/nature25167 · Cited by 1,131 · see citing works
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1× · see citing works
“Therefore, it has been proposed that senescence escape is required for tumor progression to overt malignancy [18,21].”
BackgroundOxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., & Campisi, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1024 · Cited by 1,116 · see citing works
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106 · see citing works
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · see citing works
Cellular Senescence in Aging Primates
Herbig, U., Ferreira, M., Condel, L., Carey, D., & Sedivy, J. M. (2006) · Science · doi:10.1126/science.1122446 · Cited by 1,101 · see citing works
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085 · see citing works
Alternative splicing and evolution: diversification, exon definition and function
Keren, H., Lev-Maor, G., & Ast, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2776 · Cited by 1,082 · see citing works
Autophagy mediates the mitotic senescence transition
Young, A. R. J., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J. F. J., Tavaré, S., Arakawa, S., Shimizu, S., Watt, F. M., et al. (2009) · Genes & Development · doi:10.1101/gad.519709 · Cited by 1,078 · see citing works
cGAS in action: Expanding roles in immunity and inflammation
Ablasser, A., & Chen, Z. J. (2019) · Science · doi:10.1126/science.aat8657 · Cited by 1,077 · see citing works
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · see citing works
Lamin B1 loss is a senescence-associated biomarker
Freund, A., Laberge, R.-M., Demaria, M., & Campisi, J. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-10-0884 · Cited by 1,046 · see citing works
Chien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046 · see citing works
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · see citing works
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032 · see citing works
Feedback between p21 and reactive oxygen production is necessary for cell senescence
Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.5 · Cited by 1,019 · cited 28× · see citing works
“DNA damage signaling is also involved in the initiation of stress-induced premature senescence in response to acute cellular stresses, such as oxidative damage generated by ROS [117] and oncogene activation [69,70].”
BackgroundInfluentialGeriatric muscle stem cells switch reversible quiescence into senescence
Sousa-Victor, P., Gutarra, S., García-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardí, M., Ballestar, E., González, S., Serrano, A. L., et al. (2014) · Nature · doi:10.1038/nature13013 · Cited by 1,010 · see citing works
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · see citing works
cGAS is essential for cellular senescence
Yang, H., Wang, H., Ren, J., Chen, Q., & Chen, Z. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705499114 · Cited by 1,009 · see citing works
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008 · see citing works
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 2× · see citing works
“For example, age-related increased p16 expression in hematopoietic stem cells, central nervous system, and pancreatic islets is associated with a decrease in self-renewal capacity that is partly improved by p16 inhibition [292,318,319].”
BackgroundJun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998 · see citing works
Rogov, V., Dötsch, V., Johansen, T., & Kirkin, V. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.014 · Cited by 992 · see citing works
The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.
Kang, C., Xu, Q., Martin, T. D., Li, M. Z., Demaria, M., Aron, L., Lu, T., Yankner, B. A., Campisi, J., & Elledge, S. J. (2015) · Science · doi:10.1126/science.aaa5612 · Cited by 982 · see citing works
Unmasking Transcriptional Heterogeneity in Senescent Cells
Hernandez-Segura, A., de Jong, T. V., Melov, S., Guryev, V., Campisi, J., & Demaria, M. (2017) · Current Biology · doi:10.1016/j.cub.2017.07.033 · Cited by 972 · cited 7× · see citing works
“For instance, in senescent cells, biosynthetic activity is decreased due to the downregulation of genes required for DNA, RNA, and protein synthesis, as well as of genes with a role in glucose and fatty acid metabolism [133].”
BackgroundInfluentialIncreasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972 · cited 1× · see citing works
“For example, age-related increased p16 expression in hematopoietic stem cells, central nervous system, and pancreatic islets is associated with a decrease in self-renewal capacity that is partly improved by p16 inhibition [292,318,319].”
BackgroundYoshida, H., Okada, T., Haze, K., Yanagi, H., Yura, T., Negishi, M., & Mori, K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6755-6767.2000 · Cited by 934 · see citing works
Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2
Broccoli, D., Smogorzewska, A., Chong, L., & de Lange, T. (1997) · Nature Genetics · doi:10.1038/ng1097-231 · Cited by 926 · see citing works
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.
Gartel, A. L., & Tyner, A. L. (2002) · PubMed · Cited by 924 · see citing works
Xu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E. R., Pirtskhalava, T., White, T. A., Johnson, K. O., Stout, M. B., Mezera, V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515386112 · Cited by 915 · cited 1× · see citing works
“In old mice, SASP inhibition reduces adipose tissue and systemic inflammation and enhances physical function [329].”
BackgroundSenescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915 · see citing works
Hewitt, G., Jurk, D., Marques, F. D. M., Correia-Melo, C., Hardy, T., Gackowska, A., Anderson, R., Taschuk, M., Mann, J., & Passos, J. F. (2012) · Nature Communications · doi:10.1038/ncomms1708 · Cited by 908 · see citing works
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · see citing works
Kurz, D. J., Decary, S., Hong, Y., & Erusalimsky, J. D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3613 · Cited by 899 · see citing works
Stein, G. H., Drullinger, L. F., Soulard, A., & Dulić, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2109 · Cited by 868 · see citing works
Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice
Jaskelioff, M., Muller, F. L., Paik, J.-H., Thomas, E., Jiang, S., Adams, A. C., Sahin, E., Kost-Alimova, M., Protopopov, A., Cadiñanos, J., et al. (2011) · Nature · doi:10.1038/nature09603 · Cited by 857 · cited 2× · see citing works
“Transgenic mouse models without or with inducible telomerase [300,301] allowed establishing a link between short telomeres and the onset of aging phenotypes [300,302,303], progeroid syndromes [304], and chronic inflammatory and degenerative conditions [305,306].”
BackgroundTelomeric DNA damage is irreparable and causes persistent DNA-damage-response activation
Fumagalli, M., Rossiello, F., Clerici, M., Barozzi, S., Cittaro, D., Kaplunov, J. M., Bucci, G., Dobreva, M., Matti, V., Beausejour, C. M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2466 · Cited by 851 · see citing works
Bracken, A. P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Mönch, K., Minucci, S., Porse, B. T., Marine, J.-C., et al. (2007) · Genes & Development · doi:10.1101/gad.415507 · Cited by 850 · see citing works
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848 · see citing works
Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., et al. (2003) · Nature · doi:10.1038/nature01850 · Cited by 847 · see citing works
Telomeres and telomerase: Their mechanisms of action and the effects of altering their functions
Blackburn, E. H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.11.036 · Cited by 838 · see citing works
Therapy-induced senescence in cancer.
Ewald, J. A., Desotelle, J. A., Wilding, G., & Jarrard, D. F. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq364 · Cited by 824 · see citing works
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823 · see citing works
Chronic inflammation induces telomere dysfunction and accelerates ageing in mice
Jurk, D., Wilson, C., Passos, J. F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5172 · Cited by 814 · see citing works
Brown, J. P., Wei, W., & Sedivy, J. M. (1997) · Science · doi:10.1126/science.277.5327.831 · Cited by 804 · see citing works
AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
González, A., Hall, M. N., Lin, S.-C., & Hardie, D. G. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.015 · Cited by 797 · see citing works
Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence
Passos, J. F., Saretzki, G., Ahmed, S., Nelson, G., Richter, T., Peters, H., Wappler, I., Birket, M. J., Harold, G., Schaeuble, K., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050110 · Cited by 796 · cited 2× · see citing works
“Conversely, culturing cells in low oxygen or in the presence of antioxidants delays senescence onset [111,212,267,268].”
BackgroundMitochondria are required for pro-ageing features of the senescent phenotype
Correia‐Melo, C., Marques, F. D., Anderson, R., Hewitt, G., Hewitt, R., Cole, J., Carroll, B. M., Miwa, S., Birch, J., Merz, A., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201592862 · Cited by 796 · see citing works
Senescence Induced by Altered Telomere State, Not Telomere Loss
Karlseder, J., Smogorzewska, A., & de Lange, T. (2002) · Science · doi:10.1126/science.1069523 · Cited by 796 · see citing works
Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks
Sedelnikova, O. A., Horikawa, I., Zimonjic, D. B., Popescu, N. C., Bonner, W. M., & Barrett, J. C. (2004) · Nature Cell Biology · doi:10.1038/ncb1095 · Cited by 790 · see citing works
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C. J., Raguz, S., Acosta, J. C., Innes, A. J., Banito, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3225 · Cited by 788 · see citing works
Cyclin D-dependent kinases, INK4 inhibitors and cancer
Ortega, S., Malumbres, M., & Barbacid, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00037-9 · Cited by 774 · see citing works
Non-Cell-Autonomous Tumor Suppression by p53
Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D. F., Bolden, J. E., Zhao, Z., Thapar, V., Joyce, J. A., Krizhanovsky, V., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.020 · Cited by 766 · cited 3× · see citing works
“Additionally, the secretome of directly affected tumor cells or adjacent senescent stromal fibroblasts can induce paracrine senescence of nearby tumor cells [270] and can recruit immune cells to contribute to cancer cell removal, reinforcing the tumor suppressive role of senescent tumor cells [263,266].”
BackgroundMicroarray analysis of replicative senescence
Shelton, D. N., Chang, E., Whittier, P. S., Choi, D., & Funk, W. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80420-5 · Cited by 764 · see citing works
A senescent cell bystander effect: senescence‐induced senescence
Nelson, G., Wordsworth, J., Wang, C., Jurk, D., Lawless, C., Martin‐Ruiz, C., & von Zglinicki, T. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00795.x · Cited by 755 · see citing works
Zhang, R., Poustovoitov, M. V., Ye, X., Santos, H. A., Chen, W., Daganzo, S. M., Erzberger, J. P., Serebriiskii, I. G., Canutescu, A. A., Dunbrack, R. L., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.10.019 · Cited by 699 · see citing works
DNA damage response and cellular senescence in tissues of aging mice
Wang, C., Jurk, D., Maddick, M., Nelson, G., Martin‐Ruiz, C., & Von Zglinicki, T. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00481.x · Cited by 696 · see citing works
Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species
Lee, A. C., Fenster, B. E., Ito, H., Takeda, K., Bae, N. S., Hirai, T., Yu, Z.-X., Ferrans, V. J., Howard, B. H., & Finkel, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7936 · Cited by 691 · see citing works
Pietras, E. M., Mirantes-Barbeito, C., Fong, S., Loeffler, D., Kovtonyuk, L. V., Zhang, S., Lakshminarasimhan, R., Chin, C. P., Techner, J.-M., Will, B., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3346 · Cited by 689 · see citing works
Lin, C.-L., Bristol, L. A., Jin, L., Dykes‐Hoberg, M., Crawford, T. O., Clawson, L., & Rothstein, J. D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80997-6 · Cited by 672 · see citing works
Autophagy mediates degradation of nuclear lamina
Dou, Z., Xu, C., Donahue, G., Shimi, T., Pan, J.-A., Zhu, J., Ivanov, A., Capell, B. C., Drake, A. M., Shah, P. P., et al. (2015) · Nature · doi:10.1038/nature15548 · Cited by 655 · see citing works
Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., & Campisi, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905299106 · Cited by 654 · see citing works
The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.
Ritschka, B., Storer, M., Mas, A., Heinzmann, F., Ortells, M. C., Morton, J. P., Sansom, O. J., Zender, L., & Keyes, W. M. (2017) · Genes & Development · doi:10.1101/gad.290635.116 · Cited by 650 · see citing works
Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637 · cited 2× · see citing works
“senescence to different neighboring cell types [153,154,263,271,272,358].”
BackgroundA key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Kaplon, J., Zheng, L., Meissl, K., Chaneton, B., Selivanov, V. A., Mackay, G., van der Burg, S. H., Verdegaal, E. M. E., Cascante, M., Shlomi, T., et al. (2013) · Nature · doi:10.1038/nature12154 · Cited by 633 · see citing works
Parrinello, S., Coppe, J.-P., Krtolica, A., & Campisi, J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01635 · Cited by 631 · see citing works
A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Narita, M., Narita, M., Krizhanovsky, V., Nuñez, S., Chicas, A., Hearn, S. A., Myers, M. P., & Lowe, S. W. (2006) · Cell · doi:10.1016/j.cell.2006.05.052 · Cited by 629 · see citing works
DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion
Celli, G. B., & de Lange, T. (2005) · Nature Cell Biology · doi:10.1038/ncb1275 · Cited by 623 · see citing works
Eggert, T., Wolter, K., Ji, J., Ma, C., Yevsa, T., Klotz, S., Medina-Echeverz, J., Longerich, T., Forgues, M., Reisinger, F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.003 · Cited by 609 · see citing works
Targeting senescent cells enhances adipogenesis and metabolic function in old age
Xu, M., Palmer, A. K., Ding, H., Weivoda, M. M., Pirtskhalava, T., White, T. A., Sepe, A., Johnson, K. O., Stout, M. B., Giorgadze, N., et al. (2015) · eLife · doi:10.7554/elife.12997 · Cited by 604 · see citing works
Telomeres shorten at equivalent rates in somatic tissues of adults
Daniali, L., Benetos, A., Susser, E., Kark, J. D., Labat, C., Kimura, M., Desai, K. K., Granick, M., & Aviv, A. (2013) · Nature Communications · doi:10.1038/ncomms2602 · Cited by 601 · see citing works
Mitotic Misregulation and Human Aging
Ly, D. H., Lockhart, D. J., Lerner, R. A., & Schultz, P. G. (2000) · Science · doi:10.1126/science.287.5462.2486 · Cited by 599 · see citing works
Jurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., Gonos, E. S., Thrasivoulou, C., Jill Saffrey, M., Cameron, K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00870.x · Cited by 598 · see citing works
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells
Chekulaeva, M., & Filipowicz, W. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.04.009 · Cited by 595 · see citing works
Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes
Narita, M., Young, A. R. J., Arakawa, S., Samarajiwa, S. A., Nakashima, T., Yoshida, S., Hong, S., Berry, L. S., Reichelt, S., Ferreira, M., et al. (2011) · Science · doi:10.1126/science.1205407 · Cited by 594 · see citing works
The dynamic nature of senescence in cancer
Lee, S., & Schmitt, C. A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0249-2 · Cited by 588 · see citing works
Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582 · see citing works
Impaired immune surveillance accelerates accumulation of senescent cells and aging
Ovadya, Y., Landsberger, T., Leins, H., Vadai, E., Gal, H., Biran, A., Yosef, R., Sagiv, A., Agrawal, A., Shapira, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07825-3 · Cited by 578 · see citing works
Accumulation of senescent cells in Mitotic tissue of aging primates
Jeyapalan, J. C., Ferreira, M., Sedivy, J. M., & Herbig, U. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.008 · Cited by 571 · see citing works
Extensive allelic variation and ultrashort telomeres in senescent human cells
Baird, D. M., Rowson, J., Wynford-Thomas, D., & Kipling, D. (2003) · Nature Genetics · doi:10.1038/ng1084 · Cited by 570 · see citing works
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · see citing works
Connecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561 · see citing works
Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases
Barnes, P. J., Baker, J. R., & Donnelly, L. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1975tr · Cited by 559 · see citing works
Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition
Pereira, B. I., Devine, O. P., Vukmanovic-Stejic, M., Chambers, E. S., Subramanian, P., Patel, N., Virasami, A., Sebire, N. J., Kinsler, V., Valdovinos, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10335-5 · Cited by 556 · see citing works
Shah, P. P., Donahue, G., Otte, G. L., Capell, B. C., Nelson, D. M., Cao, K., Aggarwala, V., Cruickshanks, H. A., Rai, T. S., McBryan, T., et al. (2013) · Genes & Development · doi:10.1101/gad.223834.113 · Cited by 550 · see citing works
The role of nuclear lamin B1 in cell proliferation and senescence
Shimi, T., Butin-Israeli, V., Adam, S. A., Hamanaka, R. B., Goldman, A. E., Lucas, C. A., Shumaker, D. K., Kosak, S. T., Chandel, N. S., & Goldman, R. D. (2011) · Genes & Development · doi:10.1101/gad.179515.111 · Cited by 547 · see citing works
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., et al. (2013) · Nature · doi:10.1038/nature12437 · Cited by 541 · see citing works
Lysosome-mediated processing of chromatin in senescence
Ivanov, A., Pawlikowski, J., Manoharan, I., van Tuyn, J., Nelson, D. M., Rai, T. S., Shah, P. P., Hewitt, G., Korolchuk, V. I., Passos, J. F., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201212110 · Cited by 539 · see citing works
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
Catz, S. D., & Johnson, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204926 · Cited by 538 · see citing works
Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Anderson, R., Lagnado, A., Maggiorani, D., Walaszczyk, A., Dookun, E., Chapman, J., Birch, J., Salmonowicz, H., Ogrodnik, M., Jurk, D., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100492 · Cited by 532 · see citing works
Takahashi, A., Ohtani, N., Yamakoshi, K., Iida, S.-I., Tahara, H., Nakayama, K., Nakayama, K. I., Ide, T., Saya, H., & Hara, E. (2006) · Nature Cell Biology · doi:10.1038/ncb1491 · Cited by 528 · see citing works
NOTCH1 mediates a switch between two distinct secretomes during senescence
Hoare, M., Ito, Y., Kang, T.-W., Weekes, M. P., Matheson, N. J., Patten, D. A., Shetty, S., Parry, A. J., Menon, S., Salama, R., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3397 · Cited by 522 · see citing works
Determinants of telomere length across human tissues
Demanelis, K., Jasmine, F., Chen, L. S., Chernoff, M., Tong, L., Delgado, D., Zhang, C., Shinkle, J., Sabarinathan, M., Lin, H., et al. (2020) · Science · doi:10.1126/science.aaz6876 · Cited by 515 · see citing works
Control of Cyclin Ubiquitination by CDK-Regulated Binding of Hct1 to the Anaphase Promoting Complex
Zachariae, W., Schwab, M., Nasmyth, K., & Seufert, W. (1998) · Science · doi:10.1126/science.282.5394.1721 · Cited by 511 · see citing works
Coppé, J.-P., Rodier, F., Patil, C. K., Freund, A., Desprez, P.-Y., & Campisi, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257071 · Cited by 506 · see citing works
Liu, D., & Hornsby, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3452 · Cited by 499 · see citing works
LINE1 Derepression in aged wild-type and SIRT6-deficient mice drives inflammation
Simon, M., Van Meter, M., Ablaeva, J., Ke, Z., Gonzalez, R. S., Taguchi, T., De Cecco, M., Leonova, K. I., Kogan, V., Helfand, S. L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.014 · Cited by 498 · see citing works
Senescent cell clearance by the immune system: Emerging therapeutic opportunities
Prata, L. G. P. L., Ovsyannikova, I. G., Tchkonia, T., & Kirkland, J. L. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.003 · Cited by 497 · see citing works
(1995) · PubMed · Cited by 496 · see citing works
Super-Resolution Fluorescence Imaging of Telomeres Reveals TRF2-Dependent T-loop Formation
Doksani, Y., Wu, J. Y., de Lange, T., & Zhuang, X. (2013) · Cell · doi:10.1016/j.cell.2013.09.048 · Cited by 493 · cited 2× · see citing works
“In agreement, TRF2 overexpression delays replicative senescence onset [101], indicating that TRF2 capacity to sequester the telomere terminus via the t-loop conformation [88] might suppress the DNA damage signal from too short telomere ends and protect them from ATM signaling.”
BackgroundAMPK at the Nexus of Energetics and Aging
Burkewitz, K., Zhang, Y., & Mair, W. B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.002 · Cited by 483 · see citing works
A regulatory link between ER-associated protein degradation and the unfolded-protein response
Friedlander, R., Jarosch, E., Urban, J., Volkwein, C., & Sommer, T. (2000) · Nature Cell Biology · doi:10.1038/35017001 · Cited by 474 · see citing works
Essential role of limiting telomeres in the pathogenesis of Werner syndrome
Chang, S., Multani, A. S., Cabrera, N. G., Naylor, M. L., Laud, P., Lombard, D., Pathak, S., Guarente, L., & DePinho, R. A. (2004) · Nature Genetics · doi:10.1038/ng1389 · Cited by 462 · see citing works
Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan
Grosse, L., Wagner, N., Emelyanov, A., Molina, C., Lacas-Gervais, S., Wagner, K.-D., & Bulavin, D. V. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.002 · Cited by 460 · see citing works
De Cecco, M., Criscione, S. W., Peckham, E. J., Hillenmeyer, S., Hamm, E. A., Manivannan, J., Peterson, A. L., Kreiling, J. A., Neretti, N., & Sedivy, J. M. (2013) · Aging Cell · doi:10.1111/acel.12047 · Cited by 459 · see citing works
From Ancient Pathways to Aging Cells—Connecting Metabolism and Cellular Senescence
Wiley, C. D., & Campisi, J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.010 · Cited by 440 · see citing works
Pro-senescence therapy for cancer treatment
Nardella, C., Clohessy, J. G., Alimonti, A., & Pandolfi, P. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3057 · Cited by 437 · see citing works
Agger, K., Cloos, P. A. C., Rudkjær, L., Williams, K., Andersen, G., Christensen, J., & Helin, K. (2009) · Genes & Development · doi:10.1101/gad.510809 · Cited by 427 · see citing works
Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426 · cited 1× · see citing works
“Importantly, p21 depletion ameliorates the regenerative capacity of proliferative tissues, such as the intestine and hematopoietic stem cells, in late-generation telomerase-deficient mice that experience telomere shortening and age-related degeneration [43].”
Background
Flagged first, then by citations
4 of the 375 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 436 · see citing works
Bao, H., Cao, J., Chen, M., Min, C., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., Chen, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 389 · see citing works
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 336 · see citing works
Silwal, P., Nguyen-Thai, A. M., Mohammad, H. A., Wang, Y., Robbins, P. D., Lee, J. Y., & Vo, N. V. (2023) · Biomolecules · doi:10.3390/biom13040686 · Cited by 222 · see citing works
Sharma, A., Anand, S. K., Singh, N., Dwivedi, U. N., & Kakkar, P. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113614 · Cited by 198 · see citing works
The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence
Varesi, A., Chirumbolo, S., Campagnoli, L. I. M., Pierella, E., Piccini, G. B., Carrara, A., Ricevuti, G., Scassellati, C., Bonvicini, C., & Pascale, A. (2022) · Antioxidants · doi:10.3390/antiox11071224 · Cited by 145 · see citing works
Inflammation: A New Look at an Old Problem
Gusev, E., & Zhuravleva, Y. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094596 · Cited by 142 · see citing works
Molecular and Cellular Mechanisms of Osteoporosis
Zhivodernikov, I. V., Kirichenko, T. V., Markina, Y. V., Postnov, A. Y., & Markin, A. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115772 · Cited by 144 · see citing works
Ali, D., Tencerova, M., Figeac, F., Kassem, M., & Jafari, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.981487 · Cited by 122 · see citing works
“increased expression of cell cycle regulators/tumor suppressors such as p16 and p53), mitochondrial dysfunction, and resistance to apoptosis, reviewed in (21, 22).”
BackgroundCellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
Jha, S. K., Rubis, G. D., Devkota, S. R., Zhang, Y., Adhikari, R., Jha, L. A., Bhattacharya, K., Mehndiratta, S., Gupta, G., Singh, S. K., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102315 · Cited by 122 · see citing works
The Implications of Aging on Vascular Health
Ahmed, B., Rahman, A. A., Lee, S., & Malhotra, R. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011188 · Cited by 129 · see citing works
Jiang, W., Chen, H., Lin, Y., Cheng, K., Zhou, D., Chen, R., Song, C., Zeng, L., & Yu, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115552 · Cited by 98 · see citing works
Regenerative inflammation: When immune cells help to re‐build tissues
Caballero‐Sánchez, N., Alonso‐Alonso, S., & Nagy, L. (2022) · FEBS Journal · doi:10.1111/febs.16693 · Cited by 97 · see citing works
An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes
Gasmi, A., Nasreen, A., Lenchyk, L. V., Lysiuk, R., Peana, M., Shapovalova, N., Piscopo, S., Komisarenko, M. A., Shanaida, M., Smetanina, K., et al. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673251025230919105818 · Cited by 80 · see citing works
Giroud, J., Bouriez, I., Paulus, H., Pourtier, A., Debacq‐Chainiaux, F., & Pluquet, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310788 · Cited by 77 · see citing works
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons
Stojanović, B., Jovanovic, I., Stojanovic, M. D., Stojanović, B., Kovačević, V., Radosavljević, I., Jovanović, D., Kovačević, M. M., Zornić, N., Arsić, A. A., et al. (2025) · Antioxidants · doi:10.3390/antiox14080987 · Cited by 83 · see citing works
Hallmarks and mechanisms of cellular senescence in aging and disease
Ajoolabady, A., Praticò, D., Bahijri, S., Eldakhakhny, B. M., Tuomilehto, J. O., Wu, F., & Ren, J. T. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02655-x · Cited by 79 · see citing works
Bientinesi, E., Lulli, M., Becatti, M., Ristori, S., Margheri, F., & Monti, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111689 · Cited by 61 · see citing works
Hernández, M. E. O., Luján, L. M. L., Burboa‐Zazueta, M. G., Castillo-Castro, T. D., Vega, E. D. L. R., Galvez-Ruiz, J. C., López, S. T., López‐Torres, M. A., & Assanga, S. B. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083463 · Cited by 61 · see citing works
The Role of Glial Cell Senescence in Alzheimer's Disease
Alshaebi, F., Sciortino, A., & Kayed, R. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70051 · Cited by 60 · see citing works
Mitochondrial dysfunction and aging: multidimensional mechanisms and therapeutic strategies
Wei, P., Zhang, X., Yan, C., Sun, S., Chen, Z., & Lin, F. (2025) · Biogerontology · doi:10.1007/s10522-025-10273-4 · Cited by 60 · see citing works
Wang, X., Wang, J., Zhao, X., Wu, H., Li, J., Cheng, Y. F., Guo, Q., Cao, X., Liang, T., Sun, L., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04209-0 · Cited by 59 · see citing works
Aging and injury drive neuronal senescence in the dorsal root ganglia
Donovan, L. J., Brewer, C. L., Bond, S. F., Laslavic, A. M., Lopez, A. P., Colman, L., Jordan, C. E., Hansen, L., Gonzalez, O. C., Pujari, A., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01954-x · Cited by 57 · see citing works
Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies
Lazic, A., Balint, V., Ninković, D. S., Perić, M., & Stevanović, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094995 · Cited by 58 · see citing works
Integrated Stress Response (ISR) Pathway: Unraveling Its Role in Cellular Senescence
Kalinin, A., Zubkova, E., & Menshikov, M. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417423 · Cited by 58 · see citing works
Oxidative stress and cellular senescence: Roles in tumor progression and therapeutic opportunities
Jin, P., Feng, X., Huang, C., Li, J., Wang, H. Z., Wang, X., Li, L., & Ma, L. (2024) · MedComm – Oncology · doi:10.1002/mog2.70007 · Cited by 57 · see citing works
Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy
Desai, N., Sahel, D. K., Sawant, B. K. S., Postwala, H. I., Shah, Y. B., Chavda, V. P., Fernandes, C., Khatri, D. K., & Vora, L. K. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400370 · Cited by 54 · see citing works
Mitochondria-targeted senotherapeutic interventions
Atayik, M. C., & Çakatay, U. (2022) · Biogerontology · doi:10.1007/s10522-022-09973-y · Cited by 52 · see citing works
Chromatin and the Cellular Response to Particle Radiation-Induced Oxidative and Clustered DNA Damage
Danforth, J. M., Provencher, L., & Goodarzi, A. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.910440 · Cited by 52 · see citing works
Adem, Y., Galderisi, U., & Alessio, N. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1148761 · Cited by 51 · see citing works
New insights into the role of cellular senescence and chronic wounds
Yang, H., Zhang, X., & Bo, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1400462 · Cited by 51 · see citing works
Lipid and glucose metabolism in senescence
Liu, B., Meng, Q., Gao, X., Sun, H., Xu, Z., Wang, Y., & Zhou, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1157352 · Cited by 53 · see citing works
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102296 · Cited by 49 · see citing works
Mitochondrial dysfunction in oocytes: implications for fertility and ageing
Wang, T., Xu, P., Yuan, J., Chen, H., Guo, X., Gao, J., Wang, Y., Yao, D., Li, X., Liu, B., et al. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01764-6 · Cited by 47 · see citing works
Guo, Y., Cen, K., Chen, Q., Dai, Y., Mai, Y., & Hong, K. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128390 · Cited by 45 · see citing works
The Molecular Mechanism of Polyphenols in the Regulation of Ageing Hallmarks
Pereira, Q. C., dos Santos, T. W., Fortunato, I. M., & Ribeiro, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065508 · Cited by 49 · see citing works
Yamaguchi, N., Horio, E., Sonoda, J., Yamagishi, M., Miyakawa, S., Murakami, F., Hasegawa, H., Katahira, Y., Mizoguchi, I., Fujii, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413562 · Cited by 48 · see citing works
Autophagy and senescence: the molecular mechanisms and implications in liver diseases
Li, Q., Lin, Y., Liang, G., Xiao, N., Zhang, H., Yang, X., Yang, J., & Liu, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316880 · Cited by 43 · see citing works
Deregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 43 · see citing works
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Jin, P., Duan, X., Li, L., Zhou, P., Zou, C., & Xie, K. (2024) · MedComm · doi:10.1002/mco2.542 · Cited by 46 · see citing works
Klepacki, H., Kowalczuk, K., Łepkowska, N., & Hermanowicz, J. M. (2025) · Cells · doi:10.3390/cells14130942 · Cited by 44 · see citing works
Livshits, G., & Kalinkovich, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102267 · Cited by 42 · see citing works
Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment
Kharouf, N., Flanagan, T. W., Hassan, S.-Y., Shalaby, H., Khabaz, M., Hassan, S.-L., Megahed, M., Haïkel, Y., Santourlidis, S., & Hassan, M. (2023) · Cancers · doi:10.3390/cancers15123147 · Cited by 40 · see citing works
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
Gergues, M., Bari, R., Koppisetti, S., Gosiewska, A., Kang, L., & HARIRI, R. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565278 · Cited by 42 · see citing works
Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake
Rysz, J., Franczyk, B., Rysz-Górzyńska, M., & Gluba-Brzózka, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010183 · Cited by 41 · see citing works
Lossaint, G., Horvat, A., Gire, V., Bačević, K., Mrouj, K., Charrier‐Savournin, F., Georget, V., Fisher, D., & Dulić, V. (2022) · Journal of Cell Science · doi:10.1242/jcs.259114 · Cited by 40 · see citing works
Self-citationRenal tubular epithelial cell quality control mechanisms as therapeutic targets in renal fibrosis
Bao, Y., Shan, Q., Lu, K., Yang, Q., Liang, Y., Kuang, H., Wang, L., Hao, M., Peng, M., Zhang, S., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.01.001 · Cited by 39 · see citing works
Unraveling the molecular and immunological landscape: Exploring signaling pathways in osteoporosis
Amroodi, M. N., Maghsoudloo, M., Amiri, S., Mokhtari, K., Mohseni, P., Pourmarjani, A., Jamali, B., Khosroshahi, E. M., Asadi, S., Tabrizian, P., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116954 · Cited by 41 · see citing works
Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging
Zhou, N.-J., Bao, W.-Q., Zhang, C., Jiang, M., Liang, T.-L., Ma, G.-Y., Liu, L., Pan, H., & Li, R.-Z. (2025) · npj Aging · doi:10.1038/s41514-025-00250-z · Cited by 44 · see citing works
Sienkiewicz, M., Sroka, K., Binienda, A., Jurk, D., & Fichna, J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102083 · Cited by 34 · see citing works
Song, C., Zhou, D., Cheng, K., Liu, F., Cai, W., Mei, Y., Chen, J., Huang, C., & Liu, Z. (2023) · JOR Spine · doi:10.1002/jsp2.1311 · Cited by 36 · see citing works
Contribution of viral and bacterial infections to senescence and immunosenescence
Reyes, A., Ortiz, G., Duarte, L. F., Fernández, C., Hernández‐Armengol, R., Palacios, P. A., Prado, Y., Andrade, C. A., Rodríguez‐Guilarte, L., Kalergis, A. M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1229098 · Cited by 36 · see citing works
Harries, L. W. (2022) · FEBS Journal · doi:10.1111/febs.16462 · Cited by 35 · see citing works
Andrés, C. M. C., de la Lastra, J. M. P., Munguira, E. B., Andrés, C., Plou, F. J., & Lebeña, E. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063521 · Cited by 34 · see citing works
Statins in Chronic Kidney Disease—Effects on Atherosclerosis and Cellular Senescence
Fularski, P., Krzemińska, J., Lewandowska, N., Młynarska, E., Saar, M., Wronka, M., Rysz, J., & Franczyk, B. (2023) · Cells · doi:10.3390/cells12131679 · Cited by 33 · see citing works
Dong, S., Zhang, J., Fu, Y., Tang, G., Chen, J., Sun, D., Qi, Y., & Zhou, N. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05691-w · Cited by 33 · see citing works
Inflammation-Driven Genomic Instability: A Pathway to Cancer Development and Therapy Resistance
Rembiałkowska, N., Kocik, Z., Kłosińska, A., Kübler, M., Pałkiewicz, A., Rozmus, W., Sędzik, M., Wojciechowska, H., & Gajewska-Naryniecka, A. (2025) · Pharmaceuticals · doi:10.3390/ph18091406 · Cited by 41 · see citing works
Oxidative Stress, Inflammation, and Cellular Senescence in Neuropathic Pain: Mechanistic Crosstalk
Stojanović, B., Bevc, I. M., Stojanovic, M. D., Stojanović, B., Lazarević, T., Spasić, M., Petrovic, M., Stefanovic, I., Marković, M., Nešić, J., et al. (2025) · Antioxidants · doi:10.3390/antiox14101166 · Cited by 33 · see citing works
Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy
Özdemir, A., Demir, Y. D. Ş., Yeşilyurt, Z. E., & Ark, M. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.002 · Cited by 33 · see citing works
Ochi, S., Roy, B., Prall, K., Shelton, R. C., & Dwivedi, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02263-0 · Cited by 34 · see citing works
Ali, I., Zhang, H., Zaidi, S. A. A., & Zhou, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102273 · Cited by 34 · see citing works
Senescence and SASP Are Potential Therapeutic Targets for Ischemic Stroke
Ouvrier, B., Ismael, S., & Bix, G. J. (2024) · Pharmaceuticals · doi:10.3390/ph17030312 · Cited by 32 · see citing works
Alessio, N., Acar, M. B., Squillaro, T., Aprile, D., Ayaz‐Güner, Ş., Bernardo, G. D., Peluso, G., Özcan, S., & Galderisi, U. (2023) · Cell Proliferation · doi:10.1111/cpr.13401 · Cited by 30 · see citing works
Aging Triggers Mitochondrial Dysfunction in Mice
Rosa, F. L. L., de Souza, I. I. A., Monnerat, G., de Carvalho, A. C. C., & Maciel, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310591 · Cited by 30 · see citing works
Cheng, Y., Zhang, M., Xu, R. H., Fu, L., Xue, M., Xu, C., Tang, C., Fang, T., Liu, X., Sun, B., et al. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112391 · Cited by 30 · see citing works
Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins
Cianciulli, A., Calvello, R., Porro, C., Lofrumento, D. D., & Panaro, M. A. (2024) · Cells · doi:10.3390/cells13060505 · Cited by 32 · see citing works
Remodeling of the Cardiac Extracellular Matrix Proteome During Chronological and Pathological Aging
Santinha, D. R., Vilaça, A., Estronca, L. M. B. B., Schüler, S. C., Bartoli, C., Sandre‐Giovannoli, A. D., Figueiredo, A., Quaas, M., Pompe, W., Ori, A., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100706 · Cited by 29 · see citing works
Huang, Y., Xiao, L., Xu, S., Zu, D., Liu, H., He, H., Bao, Q., He, Y., Liang, C., Shi, Y., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.012 · Cited by 30 · see citing works
Cellular Senescence, Inflammation, and Cancer in the Gastrointestinal Tract
Choi, E. L., Taheri, N., Chandra, A., & Hayashi, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129810 · Cited by 28 · see citing works
Application of mesenchymal stem cells for anti-senescence and clinical challenges
Wang, Y., Gao, T., & Wang, B. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03497-z · Cited by 27 · see citing works
Alessio, N., Aprile, D., Peluso, G., Mazzone, V., Patrone, D., Bernardo, G. D., & Galderisi, U. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01469-1 · Cited by 26 · see citing works
STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development
Zhang, X., Chen, Y., Liu, X., Li, G., Zhang, S., Zhang, Q., Cui, Z., Qin, M., Simon, H., Terzić, J., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2024.217410 · Cited by 27 · see citing works
Song, C., Liu, F., Wu, X., Zhou, D., Mei, Y., Yan, Q., Yan, Q., Liu, Z., & Chen, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114131 · Cited by 25 · see citing works
Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence
Barriuso, D., Alvarez-Frutos, L., Gutiérrez, L. G., Motiño, O., Kroemer, G., Palacios, R., & Senovilla, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076374 · Cited by 23 · see citing works
Sun, R., Feng, J., & Wang, J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0621 · Cited by 26 · see citing works
Bientinesi, E., Ristori, S., Lulli, M., & Monti, D. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111957 · Cited by 24 · see citing works
Research progress on interferon and cellular senescence
Wang, D., Chen, K., Wang, Z., Wu, H., & Li, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202400808rr · Cited by 23 · see citing works
Chronic kidney disease and aging: dissecting the p53/p21 pathway as a therapeutic target
Goyal, K., Afzal, M., Altamimi, A. S. A., Babu, M. A., Ballal, S., Kaur, I., Kumar, S., Kumar, M., Chauhan, A. S., Ali, H., et al. (2024) · Biogerontology · doi:10.1007/s10522-024-10173-z · Cited by 21 · see citing works
Phenotyping senescent mesenchymal stromal cells using AI image translation
Weber, L., Lee, B. S., Imboden, S., Hsieh, C., & Lin, N. Y. C. (2023) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2023.100120 · Cited by 21 · see citing works
Zheng, Y., Wang, L., Wang, J., Zhao, T., & Wang, J. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673271261231213051410 · Cited by 20 · see citing works
Premature aging and metabolic diseases: the impact of telomere attrition
Jinesh, S., Özüpek, B., & Aditi, P. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1541127 · Cited by 21 · see citing works
Li, C., Zhou, L., Sun, H., & Yang, M. S. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s463297 · Cited by 20 · see citing works
Yu, H., Xie, Y., Lan, L., Ma, S., Mok, S. W. F., Wong, I. N., Wang, Y., Zhong, G., Yuan, L., Zhao, H., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.07.021 · Cited by 20 · see citing works
Involvement of SIRT1-mediated aging in liver diseases
Zhang, Y., Gong, C., Tao, L., Zhai, J., Huang, F., & Zhang, S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1548015 · Cited by 20 · see citing works
Human Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions
Chmielewski, P., Data, K., Strzelec, B., Farzaneh, M., Anbiyaiee, A., Zaheer, U., Uddin, S., Sheykhi-Sabzehpoush, M., Mozdziak, P., Zabel, M., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0280 · Cited by 16 · see citing works
Kuehl, J., Xue, Y., Yuan, F., Ramanagoudr‐Bhojappa, R., Pickel, S. U., Kalb, R., Chandrasekharappa, S. C., Wang, W., Zhang, Y., & Schindler, D. (2025) · Journal of Clinical Investigation · doi:10.1172/jci187323 · Cited by 19 · see citing works
Wang, X., Xu, Y., Zhang, S., Zhu, X., Zhang, H., & Liu, Y. (2023) · Acta Physiologica · doi:10.1111/apha.14059 · Cited by 19 · see citing works
The functional role of cellular senescence during vascular calcification in chronic kidney disease
Fang, Y., Zhao, Y., Huang, J., Yang, X., Liu, Y., & Zhang, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1330942 · Cited by 20 · see citing works
Jia, X., Liu, H., Yin, G., Xiang, W., Zhao, H., Zhang, X. K., Xue Ming, T. A. N. G., Cheng, X., Kuo, C.-F., Liu, C., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135802 · Cited by 19 · see citing works
Role of cellular senescence in hepatic diseases (Review)
Xing, Y., & Zhu, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5623 · Cited by 18 · see citing works
Morgan, M. P., Finnegan, E., & Das, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.002 · Cited by 18 · see citing works
Martín-Vicente, P., López‐Martínez, C., Rioseras, B., & Albaiceta, G. M. (2024) · Annals of Intensive Care · doi:10.1186/s13613-023-01236-4 · Cited by 18 · see citing works
Vasileva, B., Staneva, D., Grozdanova, T., Petkov, H., Trusheva, B., Alipieva, K. I., Popova, M., Miloshev, G. A., Bankova, V. S., & Georgieva, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8368717 · Cited by 18 · see citing works
Frey, Y., Haj, M., Ziv, Y., Elkon, R., & Shiloh, Y. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1257 · Cited by 18 · see citing works
Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments
Zhang, Z., Liu, P., Song, Y., Ma, L., Xu, Y., Lei, J., Tong, B., Zhu, D., Liang, H., Wang, H., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70417 · Cited by 18 · see citing works
Barroso, T., Melo-Alvim, C., Ribeiro, L., Casimiro, S., & Costa, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713385 · Cited by 17 · see citing works
Giuliani, K. T. K., Nag, P., Adams, B. C., Wang, X., Hong, S., Grivei, A., Johnston, R. L., Waddell, N., Ho, K. K. C., Tian, Y., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07386-6 · Cited by 16 · see citing works
The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer
Balaraman, A. K., Afzal, M., Moglad, E. H. O., Babu, M. A., Priya, G. P., Bansal, P., Rajotiya, S., Kondapavuluri, B. K., Kazmi, I. A., Alzarea, S. I., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10194-2 · Cited by 16 · see citing works
Wu, M., Han, J., Wu, H., & Liu, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1216376 · Cited by 16 · see citing works
Gureghian, V., Herbst, H., Kozar, I., Mihajlović, K., Malod‐Dognin, N., Ceddia, G., Angeli, C., Margue, C., Randic, T., Philippidou, D., et al. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00640-z · Cited by 16 · see citing works
- Authors
- Roger, L., Tomas, F., & Gire, V.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Gire, Véronique
- ORCID
- Gire, Véronique
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-12-06
- Volume
- 22
- Issue
- 23
- Pages
- 13173
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8658264
- OpenAlex
- W4200606392
- Cited by
- 395
- References
- 375
- Citations by year
- 2026: 65 · 2025: 139 · 2024: 90 · 2023: 69 · 2022: 31 · 2021: 1
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, senescence-associated secretory phenotype, DNA damage response, proliferative arrest, senescence induction, senescence heterogeneity, senescence-associated inflammation, heterochromatin, cellular metabolism, transcriptional programs, aging, cancer prevention
- MeSH terms
- Senescence-Associated Secretory Phenotype, Aging, Animals, DNA Damage, Humans, Inflammation, Signal Transduction, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review